27TH CONFERENCE OF THE EUROPEAN WOUND …...amsterdam, the netherlands 3 - 5 may 2017 programme in...

AMSTERDAM, THE NETHERLANDS3 - 5 MAY 2017

PRO

GR

AM

ME

IN COOPERATION WITH WCS KNOWLEDGE CENTRE WOUND CARE

EWMA 201727TH CONFERENCE OF THE EUROPEAN WOUND MANAGEMENT ASSOCIATION

WWW.EWMA2017.ORG

WWW.EWMA.ORG

WWW.WCS.NL

CHANGE, OPPORTUNITIES AND CHALLENGES– WOUND MANAGEMENT IN CHANGING HEALTHCARE SYSTEMS

DOWNLOAD THE CONFERENCE APP

SEARCH FOR

EWMA 2017IN APP STORE OR GOOGLE PLAY

ABSTRACTS SPEAKERS EXHIBITION PROGRAMM

E

FLO

OR

PLAN

S

EWMA APP

INDEX

Welcome 5

Organisation 7

Venue Map 8

About EWMA 10 About WCS 11

Programme Overview 12

Detailed Programme Wednesday 25 Thursday 32 Friday 43

Session Descriptions Key Sessions 52 Workshops 59 Focus Sessions 63 Guest Sessions 65 Honorary Lecture 80 Diabetic Foot Stream 82 Antimicrobial Stewardship 86 International Partner Organisation Session 87

Education Activities 88

EWMA UCM The EWMA University Conference Model 90

E-poster Presentations Overview 92 Screen 1 93 Screen 2 97 Screen 3 102 Screen 4 107 E-poster with no Oral Presentation 112 Case Studies and Professional Communication 116

EWMA Cooperating Organisations 126

General Information 131

Social Events 137

Industry Sponsored Satellite Symposia 140

Industry Sponsored Satellite Workshops 153

Exhibitors 155

Exhibition Map 178

3

WOUND COURSES ENDORSED BY EWMA

Institutions and companies with courses, online education and seminars endorsed by EWMA

As part of EWMA’s aim to identify high standard education programmes for healthcare professionals, we offer the possibility to have courses and seminars reviewed and endorsed by EWMA.

For more information, go to www.ewma.org or contact the EWMA Secretariat ([email protected]).

ALEXANDRIA CONTINUOUS MEDICAL EDUCATION

ACCREDITATION COUNCIL

JIANGSU NURSING ASSOCIATION

DEAR PARTICIPANTIt is our great pleasure to welcome you to the 27th Conference of the European Wound Management Association, EWMA 2017. The conference is organised in cooperation with WCS Knowledge Centre Wound Care.

During three exciting conference days, participants will experience a diverse programme that includes keynote sessions, free paper sessions, workshops, full-day streams, guest sessions, and sponsored satellite symposia.

The conference theme is: CHANGE, OPPORTUNITIES AND CHALLENGES- WOUND MANAGEMENT IN CHANGING HEALTHCARE SYSTEMS

National healthcare systems in Europe are continuously changing, reorganising and adapting to respond to changing demographics and budget restrictions. This sets the context in which wound healing and wound carers must navigate to provide the best possible treatment for the individual patient.

At the same time technology is rapidly developing, providing new methods and means of treatment and organisation.

The 27th EWMA conference will have its focus on the changes, opportunities and challenges provided by these continuous processes for wound management across Europe and beyond.

A warm welcome to Amsterdam!

José Verdú Soriano Severin Läuchli René BaljonEWMA EWMA WCSScientific Recorder President President

Phot

o: iA

mst

erda

m

5

Visit EWMA on our

Social Media Platforms

Follow us and get the latest updates about the EWMA 2017 Conference

as well as other EWMA activities:

www.facebook.com/EWMA.Wound

www.linkedin.com/company/ european-wound-management-association

Twitter: @ewmatweet

Instagram: @ewmapics

International Lymphoedema Framework Conference

Co-hosted by the Italian Lymphoedema Framework

21-24 June 2017Siracusa · Italy

www.2017ILFconference.org

Venue: Teatro Massimo Comunale

SIMULTANEOUS

TRANSLATION

TO ITALIAN

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

7

WCS KNOWLEDGE CENTRE WOUND CARE

LOCAL ORGANISING COMMITTEERené BaljonJoke CampoDick van DuijnConny Keijzer

WCS BOARDRené Baljon, President

Dick van Duijn, Secretary

Conny Keijzer, Treasurer

Joke Campo, Board Member, oncology wounds and coordinator WCS Academy

Peter Quataert, Board Member, pressure ulcers

Jessica Bakker, Board Member, dermatology

Patricia van Mierlo, Board Member, surgical wounds and ostomy

Annemiek Mooi, Board Member, leg ulcers

Rob van Komen, Board Member, burns

Veronique Oostendorp, Board Member, diabetic foot

Karin Timm, Board Member, WCS Media

EUROPEAN WOUND MANAGEMENT ASSOCIATION

EWMA EXECUTIVE COMMITTEESeverin Läuchli, President

Sue Bale, President Elect Salla Seppänen, Immediate Past President

Alberto Piaggesi, Honorary Secretary

José Verdú Soriano, Scientific Recorder

Luc Gryson, Treasurer

COUNCIL MEMBERSSelcuk BaktirogluGregory BohnBarbara den Boogert-RuimschotelJulie Jordan O’BrienMark CollierMagdalena Annersten GershaterGeorgina GethinKirsi IsoherranenEdward JudeKylie Sandy-HodgettsChristian MünterAndrea PokornáSebastian ProbstSara RowanRobert StrohalJan StryjaHubert Vuagnat

EWMA SCIENTIFIC COMMITTEEJosé Verdú Soriano, EWMA Scientific Recorder

Sue Bale, EWMA

Wouter Brekelmans, NOVW

Mark Collier, EWMA

Louk van Doorn, NOVW

Britt Ebbeskog, SSiS

Magdalena Annersten Gershater, EWMA

Georgina Gethin, EWMA

Kirsi Isoherranen, EWMA

Arkadiusz Jawien, PWMA

Edward Jude, EWMA

Rob van Komen, WCS

Severin Läuchli, EWMA

Christian Münter, EWMA

Veronique Oostendorp, WCS

Alberto Piaggesi, EWMA

Sebastian Probst, EWMA

Peter Quataert, WCS

Salla Seppänen, EWMA

Maciej Sopata, PWMA

Eila Sterner, SSiS

Jan Stryja, EWMA

Hubert Vuagnat, EWMA

7

Find EWMA on

AddressEWMA SecretariatNordre Fasanvej 113, 2DK-2000 FrederiksbergDenmarkTel.: +45 7020 [email protected]

8

E-POSTER AREA& POLYMEM LOUNGE

CAFÉ

CAFÉ

RESTAURANT

TO SESSION ROOMSELICIUM 1+2, G & E SESSION

& MEETING ROOMS

3E473E46

3E45

3E44

3E43

3E423E41

3E40

3E20

3E14

3E16

3E18

3E12

3E10

3E08

3E06

3E04

3E01

3D233D22

3D213D20

3D18

3D16

3D143D13

3D12

3D10 3D09

3D08

3D063D05

3D043D03

3D02

3D01

3C173C16

3C153C14

3C103C09

3C08

3C06

3C053C04

3C03

3C02

3C01

3B293B28

3B273B26

3B253B24

3B22

3B193B18

3B173B16

3B14

3B12 3B11

3B10

3B05

3B04

3B02

3B01

3A46

3A40

3A36

3A34

3A30

3A26

3A22

3A20

3A14

3A12

3A11

3A10

3A08

3A01

2E35

2E34

2E32

2E30

2E20

2E12

2E10

2E09

2E08

2E06

2E04

2E03

2E02

2E01

2D46

2D44

2D42

2D41

2D40

2D34

2D30

2D282D26

2D22

2D20

2D162D14

2D12

2D06

2D02

2D01

2C36

2C312C30

2C25

2C21

2C112C10

2C052C04

2C03

2C02

2C01

2B30

2B282B26

2B20

2B12

2B10

2B06

2B04

2B02

2B01

2A30

2A28

2A26

2A24

2A22

2A20

2A18

2A16

2A14

2A12

2A08

2A04

2A03

2A02

2A01

2C20

EWMA EDUCATION

LOUNGE

EXHIBITION

VENUE MAP

TO FORUM,EMERALD ROOM,E & G SESSION &

MEETING ROOMS

EXHIBITOR SERVICE

EWMAORGANISERS

OFFICE

REG

ISTRA

TION

EWMAINVITED LOUNGE

CAFÉ AMSTERDAM

SPEAKERS UPLOAD

CENTER & EWMA

INVITED SPEAKER CHECK-IN

BAG

HA

ND

OU

T

ENTRANCE G

AUDITORIUMCLOAK-ROOM

AU

DITO

RIU

MLO

UN

GE

FORUM

DOWNSTAIRS FROM 1ST FLOORTO FORUM

CME LOG & PRINT

TO EMERALD ROOM

GROUND FLOOR

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

9

1ST. FLOOR

G101-102

G103

EMERALDROOM

G104-105

G106-107

G108

G109

G110

G111

ELICIUM 2ELICIUM 1

E101 E102

E103

E104

E105-106

E107

E108

DOWNSTAIRS TO FORUMON GROUND FLOOR

UPSTAIRS TO2ND. FLOOR; D201-2043RD. FLOOR; D301-304

TO REGISTRATION,EXHIBITION,

AUDITORIUM,ENTRANCE G

TO EXHIBITION,e-POSTERS

1ST FLOOR

10

Building bridges – from west to east, from south to northOstomy – Continence – Wound

European Nurses with academic nature and good clinical experience for ostomy, incontinence and wound care

www.ecet2017.org

13th Conference of the European Council of Enterostomal Therapists

ECET2017EN

GLIS

H · G

ERMAN · FRENCH · SPANISH · POLISH ·

OFFICIAL

CONFERENCE

LANGUAGES

About EWMAThe European Wound ManagementAssociation (EWMA) was founded in1991. The association works to promotethe advancement of education andresearch into native epidemiology,pathology, diagnosis, preventionand management of wounds of allaetiologies.

EWMA is an umbrella organisationlinking wound management associationsacross Europe and a multi disciplinarygroup bringing together individualsand organisations interested in woundmanagement.

EWMA works to reach its objectives bybeing an educational resource, holdingconferences, supporting/carrying outinternational projects related to woundmanagement, actively supporting theimplementation of existing knowledgewithin wound management, providinginformation and publications on allaspects of wound management.

EWMA Secretariat,Nordre Fasanvej 113, 2.DK-2000 FrederiksbergDenmark

Tel: +45 7020 0305Fax: +45 7020 0315

[email protected]

www.ewma.org

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

11

WCS Knowledge Centre Wound CareSince the founding of the Woundcare Consultant Society (WCS) in 1984, the organisation aims to respond to the increasing demand for sound information about nursing and care, that deals with the care of a wide variety of wounds.

To bridge the gap between industry and what was done in practice, the WCS brought a colour classification (black-yellow-red) model on the market, a model that excelled in its simplicity and is still used worldwide.

A significant change for the WCS took place in 2007 when the association changed to a foundation and started to function as a knowledge centre. The objective of the WCS is to function as a national knowledge centre in the field of wound and skin care. Moreover, the WCS aims to enhance the knowledge of healthcare professionals to improve the quality of wound and skin care. The foundation seeks to achieve this objective by:

1. organising courses, seminars and lectures2. providing, supporting and promoting

publications3. promoting and encouraging research4. and all other acts that are related or may

be conducive.

Since then the WCS became known as WCS Knowledge Centre Wound Care

The WCS has had a considerable contribution to the development of wound care in the last decades in the Netherlands; including• the development of a trade union for

woundcare nurses in the Netherlands (V&VN Wondexpertise),

• starting a post-graduate programme to become a woundcare nurse or wound consultant at the Erasmus MC in Rotterdam,

• the development of criteria which Wound Care Expertise Centres have to live up to,

• being an initiator in founding the Wound Platform in the Netherlands,

• participating in many different wound-related guideline committees.

At the moment the WCS participates in a multidisciplinary committee which develops a quality standard for complex wound care, defining how wound care in complex wounds can be best organised. This committee is commissioned by the Dutch Healthcare government. The WCS is very delighted to be host of the EWMA 2017 in Amsterdam.

Facts and figures:• 1,800 subscriptions on the WCS News in

the Netherlands and 500 in Belgium• >70,000 site visitors per year:

www.wcs.nl• >25,000 contacts through monthly e-mail

newsletters• 700 course members per year• 10 different courses, trainings and

masterclasses• 23,000 readers of the WCS news in the

Netherlands• >2,500 publications in the WCS news

since its introduction• Wound Care Book: 14th issue.

The most extraordinary fact of all is that we are still a voluntary organisation.

René Baljon, Chairman of WCS Knowledge Centre Wound Care

12

PROGRAMME OVERVIEW WEDNESDAYTIME AUDITORIUM ELICIUM 2 ELICIUM 1 FORUM SESSION ROOM

G102-103 EMERALD ROOM SESSION ROOM G104-105

SESSION ROOM G106-107

SESSION ROOM E102

SESSION ROOM E105-106

MEETING ROOM

TUESDAY 2 MAY15.00-18.00 Registration, badge and bag collection

WEDNESDAY 3 MAY

WE

DN

ES

DAY

3 M

AY ·

Reg

istra

tion

07.3

0-18

.30

· E

xhib

ition

10.

30-1

8.00

09.15-10.00 Opening Ceremony

( )10.00-11.30 Opening plenary

key session: Change, opportuni-ties and challenges - wound manage-ment in changing healthcare systems

( )

10.30-11.30 MEETING ROOM G109:Industry Sponsored Workshop

11.30-13.45 Break

12.30-13.30 Industry Sponsored Satellite Symposium

( )


( )

11.45-12.30 e-Poster screen 1: Meet the experts: My Worst Nightmares (Diabetic Foot)

12.45-13.45 e-Poster session: Diabetic Foot

11.45-13.30 e-Poster sessions: Antimicrobials and Infection, Dressings 1, Negative Pressure Wound Therapy

13.45-15.00 Free Paper Session: Pressure Ulcer 1

( )

Free Paper Session: Negative Pressure Wound Therapy

( )

Free Paper Session: Burns and Dressings

EWMA symposium: Change, Oppor-tunities and Challenges - the vision of IWGDF for global diabetic foot care, management and prevention

( )

Brandwonden Free Paper Session: Health Economics & Outcome

Introduction to wound manage-ment for under-graduate nurses

Guest session: World Alliance for Wound & Lymphe-dema Care guest session (WAWLC)

Free Paper Session: Education, QoL and Pain 14.15-15.15

MEETING ROOM G109:Industry Sponsored Workshop

15.00-15.30 Break

15.00-15.30 e-Poster sessions: Pressure Ulcer 1, Leg Ulcer 1, Burns 1

Break

Dutch Session

e-Posters Session

EWMA Education

EWMA Session

Free Paper Session

Guest Session

Key Session

Opening Ceremony

Satellite Symposium

Veterinary Session

Workshop

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

13




SESSION ROOM E102


MEETING ROOM

TUESDAY 2 MAY15.00-18.00 Registration, badge and bag collection

WEDNESDAY 3 MAY

WE

DN

ES

DAY

3 M

AY ·

Reg

istra

tion

07.3

0-18

.30

· E

xhib

ition

10.

30-1

8.00

09.15-10.00 Opening Ceremony

( )10.00-11.30 Opening plenary

key session: Change, opportuni-ties and challenges - wound manage-ment in changing healthcare systems

( )

10.30-11.30 MEETING ROOM G109:Industry Sponsored Workshop

11.30-13.45 Break


( )


( )

11.45-12.30 e-Poster screen 1: Meet the experts: My Worst Nightmares (Diabetic Foot)

12.45-13.45 e-Poster session: Diabetic Foot

11.45-13.30 e-Poster sessions: Antimicrobials and Infection, Dressings 1, Negative Pressure Wound Therapy

13.45-15.00 Free Paper Session: Pressure Ulcer 1

( )

Free Paper Session: Negative Pressure Wound Therapy

( )

Free Paper Session: Burns and Dressings

EWMA symposium: Change, Oppor-tunities and Challenges - the vision of IWGDF for global diabetic foot care, management and prevention

( )

Brandwonden Free Paper Session: Health Economics & Outcome

Introduction to wound manage-ment for under-graduate nurses

Guest session: World Alliance for Wound & Lymphe-dema Care guest session (WAWLC)

Free Paper Session: Education, QoL and Pain 14.15-15.15


15.00-15.30 Break

15.00-15.30 e-Poster sessions: Pressure Ulcer 1, Leg Ulcer 1, Burns 1

( ) Spoken language: English. Simultaneous translation: Dutch Spoken language: English. No simultaneous translation Spoken language: Dutch. No simultaneous translation ( ) Spoken language: Italian. Simultaneous translation: English

To be continued next page ►

Due to CME regulations no industry names or logos are allowed in the overview programme.Detailed programme of industry sessions is available on pages 140-153

14




SESSION ROOM E102


MEETING ROOM

WEDNESDAY 3 MAY (CONTINUED)

WE

DN

ES

DAY

3 M

AY

Reg

istra

tion

07.3

0-18

.30

· E

xhib

ition

10.

30-1

8.00


Industry Sponsored Satellite Symposium






16.30-16.45

16.45-18.00 Key Session: Use of oxygen therapies in wound healing: Focus on topical and hyperbaric oxygen treatment

( )

Key Session: Chronic wounds in the fragile aging patient - Joint key session of EWMA and ISTAP

( )

Guest session: JA-CHRODIS: Building on JA-CHRODIS, what can we do to reduce the burden of chronic diseases?

Key session: Diabetic Foot

( )

Diabetische voet EWMA Focus Session: Allergology

EWMA Focus Session: Hidradenitis suppurativa

Workshop: Infection and wound care

Guest session: Dystrophic Epidermolysis Bullosa Research Association (DEBRA)

EWMA Education Session: Teaching excellence frameworks – parameters of showing and achieving teaching excellence

MEETING ROOM D203-204:Workshop: Wound DebridementLimited number of seats

18.00-23.00 GET-TOGETHER EVENING!Venue: RAI Amsterdam in the Auditorium Lounge. Tickets must be purchased

Break

Dutch Session

e-Posters Session

EWMA Education

EWMA Session

Free Paper Session

Guest Session

Key Session

Opening Ceremony

Satellite Symposium

Veterinary Session

Workshop

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

15




SESSION ROOM E102


MEETING ROOM

WEDNESDAY 3 MAY (CONTINUED)

WE

DN

ES

DAY

3 M

AY

Reg

istra

tion

07.3

0-18

.30

· E

xhib

ition

10.

30-1

8.00








16.30-16.45

16.45-18.00 Key Session: Use of oxygen therapies in wound healing: Focus on topical and hyperbaric oxygen treatment

( )

Key Session: Chronic wounds in the fragile aging patient - Joint key session of EWMA and ISTAP

( )

Guest session: JA-CHRODIS: Building on JA-CHRODIS, what can we do to reduce the burden of chronic diseases?

Key session: Diabetic Foot

( )

Diabetische voet EWMA Focus Session: Allergology

EWMA Focus Session: Hidradenitis suppurativa

Workshop: Infection and wound care

Guest session: Dystrophic Epidermolysis Bullosa Research Association (DEBRA)


MEETING ROOM D203-204:Workshop: Wound DebridementLimited number of seats

18.00-23.00 GET-TOGETHER EVENING!Venue: RAI Amsterdam in the Auditorium Lounge. Tickets must be purchased



16

PROGRAMME OVERVIEW THURSDAYTIME ELICIUM 2 ELICIUM 1 FORUM SESSION ROOM



SESSION ROOM E102

SESSION ROOM E105-106 MEETING ROOM

THURSDAY 4 MAY

THU

RS

DAY

4 M

AY ·

Reg

istra

tion

07.0

0-18

.00

· E

xhib

ition

9.0

0-16

.30

08.00-09.30 Free Paper Session: Basic Science

( )

EWMA-FIP-IFP symposium: Care of the diabetic foot by podiatrists: a comparative study on a global scale

Audio-Visual workshop: Making compressi-on therapy for ulcer treatment easier

( )

Workshop: Eczema in leg ulcer patients

Cooperating organisations workshop

Free Paper Session: Diabetic Foot 1

Free Paper Session: Wound Assessment

Free Paper Session: e-Health and telemedicine

09.00-11.00VWHAOpening 09.00-09.05How to live and deal with bacteria in wounds

09.30-10.00 Break

09.30-10.00 e-Poster sessions: Wound Assessment 1, Home Care, Pain and Quality of Life

10.00-11.00 Free Paper Session: Acute Wounds

( )

EWMA-FIP-IFP symposium: The collaboration between the FIP-IFP and the IWGDF: standardized high level competence packages for dedi - cated practitioners in the area of diabetic foot care

Free Paper Session: Devices & Intervention

( )

Wondzorg en voeding

International Partner Session Korean Wound Management Society (KWMS): Diabetic Foot Ulcer Management and Quality of Life


Workshop: How do maggots operate?

EWMA Focus Session: How to measure success in wound healing – from a dermatologists perspective

MEETING ROOM D203-204:Workshop: Core Outcome Set for Reporting of Trials in Venous Leg Ulceration

11.00-11.15


( ) ( )



( )

Decubitus 11.20-13.00VWHAHow to live and deal with bacteria in woundscontinued


12.15-14.30 Break


( )


( )14.00-15.00VWHAcontinues next page

Break

Dutch Session

e-Posters Session

EWMA Education

EWMA Session

Free Paper Session

Guest Session

Key Session

Opening Ceremony

Satellite Symposium

Veterinary Session

Workshop

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

17




SESSION ROOM E102


THURSDAY 4 MAY

THU

RS

DAY

4 M

AY ·

Reg

istra

tion

07.0

0-18

.00

· E

xhib

ition

9.0

0-16

.30

08.00-09.30 Free Paper Session: Basic Science

( )

EWMA-FIP-IFP symposium: Care of the diabetic foot by podiatrists: a comparative study on a global scale

Audio-Visual workshop: Making compressi-on therapy for ulcer treatment easier

( )

Workshop: Eczema in leg ulcer patients

Cooperating organisations workshop


Free Paper Session: Wound Assessment

Free Paper Session: e-Health and telemedicine

09.00-11.00VWHAOpening 09.00-09.05How to live and deal with bacteria in wounds

09.30-10.00 Break

09.30-10.00 e-Poster sessions: Wound Assessment 1, Home Care, Pain and Quality of Life

10.00-11.00 Free Paper Session: Acute Wounds

( )

EWMA-FIP-IFP symposium: The collaboration between the FIP-IFP and the IWGDF: standardized high level competence packages for dedi - cated practitioners in the area of diabetic foot care

Free Paper Session: Devices & Intervention

( )

Wondzorg en voeding

International Partner Session Korean Wound Management Society (KWMS): Diabetic Foot Ulcer Management and Quality of Life


Workshop: How do maggots operate?


MEETING ROOM D203-204:Workshop: Core Outcome Set for Reporting of Trials in Venous Leg Ulceration

11.00-11.15


( ) ( )



( )

Decubitus 11.20-13.00VWHAHow to live and deal with bacteria in woundscontinued


12.15-14.30 Break


( )


( )14.00-15.00VWHAcontinues next page




18




SESSION ROOM E102


THURSDAY 4 MAY (CONTINUED)

THU

RS

DAY

4 M

AY ·

Reg

istra

tion

07.0

0-18

.00

· E

xhib

ition

9.0

0-16

.30

14.00-15.00VWHA - What to do in practice?

12.30-13.15 e-Poster screen 1: Meet the experts: Challenges in Palliative Wound care

13.30-14.15 e-Poster session: Health Economics and Outcome

12.30-14.15 e-Poster sessions: Devices and Intervention, Basic Science, Dressings 2

14.30-15.30 Key Session: Negative Pressure Wound Therapy - overview, challenges and perspectives

( )

EWMA-FIP-IFP symposium: Podiatry practice on wound management

Key Session: Healing wounds, saving limbs - Management of arterial ulcers

( )

Psychologische impact van wonden

Guest session: The European Society for Clinical Nutrition and Metabolism (ESPEN): Nutrition and wound healing

Workshop: How to identify atypical wounds

EWMA Focus Session: Larval debridement therapy: modern breakthroughs in an ancient solution

Workshop: How to read a paper. Understanding basic statistics


15.00-17.15VWHA Free Communications

15.30-16.00 Break 15.00-19.00MEETING ROOM D203-204:Wound Care Innovation Symposium

15.30-16.00 e-Poster sessions: Burns 2, Wound Assessment 2, Leg Ulcer 2






Industry Sponsored Satellite Symposium16.15-17.00

Workshop oncologische wonden

17.00-17.15

17.15-18.30 Key Session: Quality of care and cost effectiveness

( )

Guest session: Association of Diabetic Foot Surgeons (A-DFS)

Key Session: Prevention and treatment of scars

( )

Chirurgische wonden en Wondinfectie

Guest session: International Lymphoedema Framework (ILF)

EWMA Focus Session: Oncological wounds and focus on breast cancer

Guest session: European Council of Enterostomal Therapy (ECET): Good clinical Practise in Stomatherapy

VWHA - Award for the best Oral Presentation

17.30-18.00VWHA AGM

Break

Dutch Session

e-Posters Session

EWMA Education

EWMA Session

Free Paper Session

Guest Session

Key Session

Opening Ceremony

Satellite Symposium

Veterinary Session

Workshop

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

19




SESSION ROOM E102


THURSDAY 4 MAY (CONTINUED)

THU

RS

DAY

4 M

AY ·

Reg

istra

tion

07.0

0-18

.00

· E

xhib

ition

9.0

0-16

.30

14.00-15.00VWHA - What to do in practice?

12.30-13.15 e-Poster screen 1: Meet the experts: Challenges in Palliative Wound care

13.30-14.15 e-Poster session: Health Economics and Outcome

12.30-14.15 e-Poster sessions: Devices and Intervention, Basic Science, Dressings 2

14.30-15.30 Key Session: Negative Pressure Wound Therapy - overview, challenges and perspectives

( )

EWMA-FIP-IFP symposium: Podiatry practice on wound management

Key Session: Healing wounds, saving limbs - Management of arterial ulcers

( )

Psychologische impact van wonden

Guest session: The European Society for Clinical Nutrition and Metabolism (ESPEN): Nutrition and wound healing

Workshop: How to identify atypical wounds


Workshop: How to read a paper. Understanding basic statistics


15.00-17.15VWHA Free Communications

15.30-16.00 Break 15.00-19.00MEETING ROOM D203-204:Wound Care Innovation Symposium

15.30-16.00 e-Poster sessions: Burns 2, Wound Assessment 2, Leg Ulcer 2






Industry Sponsored Satellite Symposium16.15-17.00

Workshop oncologische wonden

17.00-17.15

17.15-18.30 Key Session: Quality of care and cost effectiveness

( )

Guest session: Association of Diabetic Foot Surgeons (A-DFS)

Key Session: Prevention and treatment of scars

( )

Chirurgische wonden en Wondinfectie

Guest session: International Lymphoedema Framework (ILF)


Guest session: European Council of Enterostomal Therapy (ECET): Good clinical Practise in Stomatherapy

VWHA - Award for the best Oral Presentation

17.30-18.00VWHA AGM



20

PROGRAMME OVERVIEW FRIDAYTIME ELICIUM 2 ELICIUM 1 FORUM SESSION ROOM



SESSION ROOM E102


FRIDAY 5 MAY

FRID

AY 5

MAY

· R

egis

tratio

n 07

.30-

14.0

0 ·

Exh

ibiti

on 9

.00-

14.3

0

08.00-09.30 Key Session: Microbiology of wounds. From basic to clinical Science

( )

Key Session: Advanced therapies in Wound management - A look into the future of wound management

( )

Workshop:Diabetic Foot Screening

EWMA-EPUAP joint session: The Joint EPUAP-EWMA PU Prevention & patient safety advocacy project

Guest session: European Burns Association (EBA)

Guest session: Wounds Australia

International Compression Club (ICC) session: Basics

EWMA UCM Session: Therapeutic Patient Education in Wound care: from theory to practice

09.30-10.15 Break

International Compression Club (ICC) session: Therapy I

09.30-10.15 e-Poster sessions: Acute Wounds, Prevention, Pressure Ulcer 2, Education

10.15-11.15 Antimicrobial Stewardship in Wound Manage-ment – a Joint symposium of EWMA and BSAC

( )

Free Paper Session: Leg Ulcer


( )

Workshop: Clean hands – clean wounds

Workshop: Positioning patients with pressure ulcers

Workshop: Care of burns patients that are not hospitalized

Guest session V & VN wound expertise: Who is the case manager in Complex Wound Management

Diabetic foot – assessments, offloading and footwear

11.15-11.30


( )

EWMA Focus Session: Venous Leg Ulcers from the dermatologist’s perspective

Honorary lecture: Karel Bakker

( )

Free Paper Session: Pressure Ulcer 2

Free Paper Session: Home Care

Wondplatform Nederland guest session: Concept Quality standard complex wound care in the Netherlands

12.30-14.00 Break




12.45-13.15 MEETING ROOM G108:EWMA AGM

Break

Dutch Session

e-Posters Session

EWMA Education

EWMA Session

Free Paper Session

Guest Session

Key Session

Opening Ceremony

Satellite Symposium

Veterinary Session

Workshop

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

21




SESSION ROOM E102


FRIDAY 5 MAY

FRID

AY 5

MAY

· R

egis

tratio

n 07

.30-

14.0

0 ·

Exh

ibiti

on 9

.00-

14.3

0

08.00-09.30 Key Session: Microbiology of wounds. From basic to clinical Science

( )

Key Session: Advanced therapies in Wound management - A look into the future of wound management

( )

Workshop:Diabetic Foot Screening


Guest session: European Burns Association (EBA)

Guest session: Wounds Australia

International Compression Club (ICC) session: Basics

EWMA UCM Session: Therapeutic Patient Education in Wound care: from theory to practice

09.30-10.15 Break

International Compression Club (ICC) session: Therapy I

09.30-10.15 e-Poster sessions: Acute Wounds, Prevention, Pressure Ulcer 2, Education


( )

Free Paper Session: Leg Ulcer


( )

Workshop: Clean hands – clean wounds

Workshop: Positioning patients with pressure ulcers

Workshop: Care of burns patients that are not hospitalized

Guest session V & VN wound expertise: Who is the case manager in Complex Wound Management

Diabetic foot – assessments, offloading and footwear

11.15-11.30


( )


Honorary lecture: Karel Bakker

( )

Free Paper Session: Pressure Ulcer 2

Free Paper Session: Home Care


12.30-14.00 Break




12.45-13.15 MEETING ROOM G108:EWMA AGM




22




SESSION ROOM E102


FRIDAY 5 MAY (CONTINUED)14.00-15.30 Key Session:

Surgical Site Infections across sectors – what can be done to improve prevention?

( )

Guest session: European Society for Vascular Surgery (ESVS)

Key Session: Psychological impact of chronic illness or chronic wounds?

( )

Guest session European Tissue Repair Society (ETRS): Advanced therapies in wound healing

Guest session: European Society of Plastic, Reconstructive and Aesthetic Surgery (ESPRAS)

International Compression Club (ICC) session: Therapy II

15.30-16.00 Closing Ceremony and Prizes

16.00-16.30

16.30-18.00 International Compression Club (ICC) working groups

16.30-18.00MEETING ROOM E103:International Compression Club (ICC) working groups


Break

Dutch Session

e-Posters Session

EWMA Education

EWMA Session

Free Paper Session

Guest Session

Key Session

Opening Ceremony

Satellite Symposium

Veterinary Session

Workshop

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

23




SESSION ROOM E102


FRIDAY 5 MAY (CONTINUED)14.00-15.30 Key Session:

Surgical Site Infections across sectors – what can be done to improve prevention?

( )

Guest session: European Society for Vascular Surgery (ESVS)

Key Session: Psychological impact of chronic illness or chronic wounds?

( )

Guest session European Tissue Repair Society (ETRS): Advanced therapies in wound healing

Guest session: European Society of Plastic, Reconstructive and Aesthetic Surgery (ESPRAS)

International Compression Club (ICC) session: Therapy II

15.30-16.00 Closing Ceremony and Prizes

16.00-16.30

16.30-18.00 International Compression Club (ICC) working groups





Diabetic Foot Study Groupof the EASD

Porto · Portugal8 - 10 September 2017

VenueSheraton Hotel, Porto, Portugal

Early registration deadline 23 May 2017

Conference themeAdvancement of knowledge on all aspects of diabetic foot care

Main subjects during conference

● Epidemiology ● Basic and clinical science ● Diagnostics ● Classification ● Foot clinics ● Biomechanics, Osteoarthropathy ● Orthopaedic surgery ● Infection ● Revascularisation ● Uraemia ● Wound healing/outcome

- Be updated on diabetic foot research happening across Europe

- Understand risk factors for foot ulceration and Charcot foot

- How technology can help in preventing foot ulcers and facilitate wound healing

- Practice and innovation of Diabetic Foot Wound Treatment

www.dfsg.org

Association of Diabetic Foot

Surgeons

Venue NH Laguna Palace Hotel Venice, Italy

Main Topics l What’s new on amputation prevention strategies worldwide

l Offloading

l Surgical approach of infection and osteomyelitis

l Prophylactic surgery

l Charcot foot: Medical and surgical treatment

l Timing of revascularization and local surgical treatment

l Video sessions from the operating room

l Clinical cases

l Poster and Communication sessions

l Workshops

Important dates

Abstract submission deadline 27 June 2017Early Registration deadline 2 August 2017

Register or submit your abstract on www.a-dfs.org

3rd Symposium9 - 11 November 2017

Venice · Italy

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

25

DETAILED PROGRAMMETUESDAY 2 MAY

15.00-18.00

Registration, badge and bag collection Registration area

WEDNESDAY 3 MAY

09.15-10.00

Opening Ceremony ( )José Verdú Soriano, EWMA RecorderSeverin Läuchli, EWMA PresidentRené Baljon, WCS President

Auditorium

10.00-11.30

Opening plenary key session: ( )Change, opportunities and challenges- wound management in changing healthcare systemsChairs: Severin Läuchli, Sue Bale

Auditorium

001 The EU perspective towards better prevention and care of chronic diseasesMarina Maggini

002 The changing U.S. healthcare climate: What does it mean for wound care?Marcia Nusgart

003 Woundcare; you'll never walk alone!! Dutch approachIris van Bennekom

Changing healthcare systems – the role of nurses Frances Hughes

004 Change, Opportunities and Challenges in EuropeSeverin Läuchli

10.30-11.30

Industry Sponsored Workshop Information available page 153

Room G109

11.30-13.45

Break

11.30-12.30

Meet the Experts: My worst Nightmares - Diabetic Foot Alberto Piaggesi

E-poster Screen 1

11.45-13.30

e-Poster session: Antimicrobials and Infection Chair: Annette Høgh

E-poster Screen 2

11.45-13.30

e-Poster session: Dressings 1 Chair: Jan Rice

E-poster Screen 3

11.45-13.30

e-Poster session: Negative Pressure Wound Therapy Chair: Lenka Veverková

E-poster Screen 4

12.30-13.30

Industry Sponsored Satellite Symposium ( )Information available page 141

Elicium 2

12.30-13.30


Forum

12.45-13.45

e-Poster session: Diabetic Foot Chair: Barbara den Boogert

E-poster Screen 1

26

13.45-15.00

Free Paper Session Pressure Ulcer 1 ( )Chairs: Sue Bale, Maciej Sopata

Auditorium

005 Awareness and Concordance to 'Pressure relief' regimen for Pressure ulcer Prevention in Spinal Cord InjuyLiang Liu

006 Using the toilet involves a risk for a deep tissue injury in frail patientsAmit Gefen

007 Dry skin and pressure ulcers: A multi-centre cross-sectional prevalence study in hospitals and nursing homesAndrea Lichterfeld-Kottner

008 Pressure ulcers in Iceland: Quality contol projectBerglind Chu, Jóna Margrét Guðmundsdóttir

009 National audit of pressure ulcers, moisture lesions and other woundsMichael Clark

010 Informal approach to improve pressure ulcer diagnosis and grading in care home staffHeather Hodgson

13.45-15.00

Free Paper Session Negative Pressure Wound Therapy ( )Chairs: Christian Münter, Jan Stryja

Elicium 2

011 Negative pressure wound therapy in the treatment of infectious complications after sternotomyTimur Ruzmatov

012 High negative pressure wound therapy drains in surgical treatment of soft tissue sarcomas of the extremitiesAnton Khazov

013 Endoscopic negative pressure wound therapy* of upper gastrointestinal anastomotic leakages: First experiencesKirill Shishin

014 Systematic Review of Negative Pressure Wound Therapy for Head and Neck Wounds with Fistula: Outcomes and ComplicationsHsu-Tang Cheng

015 Effectiveness of negative pressure wound therapy/closed incision management in the prevention of post surgical wound complications: a systematic review and meta analysisKylie Sandy-Hodgetts

016 Minithoracostomy with programmed single-port vats debridement and vacuum assisted closure - may be the new way to treat chronic pleural empyena with rigid lungGestkov Kirill

13.45-15.00

Free Paper Session Burns and Dressings Chairs: Rob van Komen, Geoffrey Sussmann

Elicium 1

018 Silkworm silk as an alternative to nylon mesh with collagen for the treatment of acute superficial burns of the hand and face - An intra-individual studyJennifer Schiefer

019 Impact of chronic wounds and MMP modulating dressings on functional disability in patients treated in community settingsSylvie Meaume

020 Biological wound matrices with native dermis-like collagen efficiently modulate protease activityMatthias Mörgelin

WEDNESDAY 3 MAY (continued)

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

27

021 Early burn wound excision: The way to survivalVijay Langer

022 Microsurgical transfer of vascularized tissue complexes to treat deep tissue defects in childrenSergey Goiyana

13.45-15.00

Change, Opportunities and Challenges ( ) – the vision of IWGDF for global diabetic foot care, management and preventionChair: Kristien van Acker

Forum

IntroductionKristien Van Acker

When off loading is a high priority in diabetic foot wound management, but you don’t have the access?A cooperation IWGDF & WHO ties to give global solutions for the coming years for all power regions worldwide.Neil Baker

Diabetic Foot Care in India over the last 15 years: changes, opportunities and challenges for the Indian DF study group (DFSI)Sanjeev Kelkar

The impact of an IWGDF - Train the Foot Trainer program in the Western Pacific Region.Reflections from the hosting Country, Thailand.Gulapar Srisawasdi

Panel discussion

13.45-15.00

Dutch stream: Brandwonden Chair: Andre van Es

Room G102-103

Behandeling acute brandwondenzorg in relatie tot de richtlijn.J.Dokter

Hydrochirurgische tangitiele excisie, State of the artI.M.M.H. Oen

Verpleegkundige aspecten bij senioren en (brand)wondenzorgA. Melissant-den Hollander

13.45-15.00

Free Paper Session Health Economics & Outcome Chairs: Finn Gottrup, Peter Quataert

Room G104-105

023 Core outcome sets (COS) for clinical trials in incontinence-associated dermatitis and pressure ulcer prevention researchJan Kottner

024 The effect of nursing interventions aiming to increase tissue tolerance, on maintaining tissue integrity and cost-effectiveness analysis: Turkish casePınar Avşar

025 Status of wound care units in SpainJosé Verdu Soriano

026 Wounds as Prognostic Factors in patients with advanced illnessVincent Maida

027 Outcomes of wound treatment in specialist wound clinicsMichael Clark

028 Wound care in East Iceland. Prevalence, wound care and recourse cost of careGuðný Einarsdóttir


28

13.45-15.00

EWMA Undergraduate Nurses session Room G106-107

Career options for nurses in wound management and Introduction to WCSKarin Timm

Wound management in clinical practice - What can we do as students?The skills, knowledge and practice needed in the undergraduate curriculumSamantha Holloway

Pressure ulcers - key challenges in prevention and managementBarbara Esther den Boogert-Ruimschotel

Diabetic Foot Ulcers - key challenges in prevention and managementEdward Jude

13.45-15.00

World Alliance for Wound & Lymphedema Care guest session (WAWLC)Chairs: David Keast, Hubert Vuagnat

Room E102

Wound Care in HaitiFrancius Adler

Experience with Lymphatic Filariasis (LF) in Leogane, Haiti Heather Hettrick

The wound management cycle: An approach to Wound CareDavid Keast

Therapies using local resourcesEmily Haesler

Follow up after 5 yearly courses on modern adapted wound care in CameroonHubert Vuagnat

13.45-15.00

Free Paper Session Education, Quality of Life and Pain Chairs: Luc Gryson, Andrea Pokorná

Room E105-106

029 The impact of wounding on health related quality of lifeHelen Strapp

030 Knowledge and experience of wound consultant nurses in pain management in patient with woundMarkéta Koutná

031 The defining characteristics of Nanda international nursing diagnoses (acute and chronic pain) in patient with chronic woundsAndrea Pokorna

032 The development of the "chronic oedema "Wet leg" (lymphorrhoea) pathway Karen Morgan

033 Students’ perceptions of technology enhanced learning within a post graduate wound management education programme. A pilot studyJulie Jordan O’Brien

034 Effect of educational intervention on knowledge of nurses and physicians toward Pressure Ulcer preventionZahra Khazaeipour

035 Topical medical cannabis (TMC): A novel treatment modality for wound managementVincent Maida

14.15-15.15


Room G109


SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

29


15.00-15.30

Break

15.00-15.30

e-Poster Session: Pressure Ulcer 1 Chair: Tania Santos

E-poster Screen 1

15.00-15.30

e-Poster Session: Leg Ulcer 1 Chair: Esther Armans Moreno

E-poster Screen 2

15.00-15.30

e-Poster Session: Burns 1 Chair: Anna-Barbara Schlüer

E-poster Screen 3

15.30-16.30

Industry Sponsored Satellite Symposium Information available page 142

Elicium 2

15.30-16.30


Elicium 1

15.30-16.30


Forum

15.30-16.30


Emerald Room

15.30-16.30


Room G106-107

15.30-16.30


Room E102

15.30-16.30


Room E105-106

16.45-18.00

Key Session: Use of oxygen therapies in wound care ( ) – EWMA document releaseChairs: Finn Gottrup, Joachim Dissemond

Auditorium

Chair introductionFinn Gottrup

O2 in generalPeter Østrup Jensen

Topical Oxygen TherapiesJoachim Dissemond

Hyperbaric Oxygen therapy of woundsJacek Kot

Patient perspectiveCarol Baines

16.45-18.00

Key Session: Chronic Wounds in the Fragile Aging Patient ( ) – Joint key session of EWMA and ISTAPChairs: Alberto Piaggesi, Hubert Vuagnat

Elicium 2

036 Demographics of aging, polypathologies and costsAlberto Piaggesi

037 Global skin agingHubert Vuagnat

038 The biology of skin aging, dermatoporosisGurkan Kaya

039 Skin tearsValentina vanzi

040 Skin tearsKimberly LeBlanc

30


16.45-18.00

JA-CHRODIS guest session: Building on JA-CHRODIS, what can we do to reduce the burden of chronic diseases?Chair: Carlos Segovia Pérez

Elicium 1

JA-CHRODIS – 12 steps towards reducing the burden of chronic diseasesCarlos Segovia Pérez

Prevention and management of diabetes – a European SWOT analysisMarina Maggini

Management of the diabetic foot and education of professionals: a general overview across EuropeJan Apelqvist

Diabetes as a case study on strengthening health care for people with chronic diseasesJelka Zaletel

16.45-18.00

Key Session: Diabetic Foot ( ) Chairs: Edward Jude, Peter Quataert

Forum

041 Diabetic Foot Infection Management Jan Stryja

042 State of the art management of the diabetic footEdward Jude

043 Introduction to local wound care: what's new? Elevated levels of MMPs in DFU and impact on wound healingJose Luis Lazaro Martinez

16.45-18.00

Dutch stream: Diabetische voet Chair: Ellie Lenselink

Room G102-103

De validiteit van diverse definities van de 2.2 °C afkapwaarde gebruikt als waarschuwingssignaal voor dreigende diabetische voet ulcera.Anke Wijlens

Temperatuurmetingen bij de diabetische voetSicco Bus

Behandeling van kritische ischemie bij ouderenStijn Steunenberg

16.45-18.00

EWMA Focus Session: Allergology Emerald Room

Allergy: yes or no?Birgitte Maessen-Visch

16.45-18.00

EWMA Focus Session: Hiddranitis Suppurativa Room G104-105

Hiddranitis SuppurativaHessel van der Zee

16.45-18.00

Workshop: Infection and wound care Room G106-107

Using surveillance as a tool to prevent surgical wound infectionsPauline Harrington

16.45-18.00

Dystrophic Epidermolysis Bullosa Research Association (DEBRA) guest session

Room E102

Launch of the new Wounds International best practice guidelines: skin and wound care in EB Jane Clapham

Psychological impact of wounds in EB from a nursing perspectiveAnnette Downe

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

31


Itch in EBJose Duipmans

16.45-18.00

EWMA Education Session: Teaching excellence frameworks – parameters of showing and achieving teaching excellence Chairs: Kirsi Isoherranen, Luc Gryson

Room E105-106

044 Quality in continuous professional wound education – what, how and why?Edda Johansen

045 Teaching excellence in the Netherlands/how to bring science into education? Ron Legerstee

046 Wound curriculum for nurses – post-registration qualification wound managementAndrea Pokorna

047 Fundamentals in wound healing for physiciansChristian Münter

16.45-18.00

Workshop: Wound debridement Please note that there is a limited number of seats available.

Room D203-204

Maria Signer

Jürg Traber

Chantal Rosset

18.00- Get-together EventVenue: RAITickets must be purchased

32

THURSDAY 4 MAY

08.00-09.30

Free Paper Session Basic Science ( )Chairs: Selcuk Baktiroglu, Zena Moore

Elicium 2

048 Epidermal growth factor- like repeats and discoidin I-like domain 3(EDIL3): A potential new therapeutic tool for treatment of keloid scarJong Won Rhie

049 Bacopa procumbens extract enhance wound healing process regulating molecular effectors in a in vivo modelAdriana Martínez

050 Local application of human mesenchymal stromal cells derived from bone marrow or adipose tissue accelerated wound healing and neovascularization in diabetic ratRobert Bem

051 Development of the parameter of topical oxygen therapy and its effect on ischemic wound healingHongwei Liu

052 Deletation of endothelial Atg7 reveals a critical role of autophage in control of endothelial cell paracrine for skin wound healing in miceHongwei Liu

053 Oxygen-ros-redox complex*: A paradigm shift in the local therapy of different skin lesionsDamir Marincic

054 Characteristics of dermal fibroblasts in novel multifactorial 2D and 3D in vitro models of chronic woundAnna Zavadakova

055 The use of porcine dermis, polynucleotides-added hyaluronic acid and advanced medications in chronic ulcers: a comparative randomized trialGiovanni Francesco Marangi

08.00-09.30

EWMA-FIP-IFP symposium: Care of the diabetic foot by podiatrists: a comparative study on a global scaleChair: Vince Hetherington

Elicium 1

Experiences from French podiatrists in the care of the diabetic footChristian Jérôme

Experiences from Greek and Australian podiatrists in the care of the diabetic footEkaterina Kalykakis

Experiences from Canadian podiatrists in the care of the diabetic footBradley Sonnema

Experiences from American podiatrists in the care of the diabetic footVince Hetherington

Q&A

08.00-09.30

Workshop: Audio-Visual workshop Making compression ( ) therapy for ulcer treatment easier

Forum

Inelastic compression by bandages: effective but requiring educationHugo Partsch

Compression therapy by Velcro devices.Giovanni Mosti

Compression therapy by Ulcer Kits.P. Benigni

Questions and Answers

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

33

THURSDAY 4 MAY (continued)

08.00-09.30

Workshop: Eczema in leg ulcer patients Room G102-103

Luc Gryson

Michael Mühlstadt

08.00-09.30

Cooperating organisations workshop Chair: Salla Seppänen

Emerald Room

056 Finnish programme: special competence in wound managementKirsi Isoherranen

057 The impact of the economic crisis in Greece in patients with chronic ulcersMaria Charcharidou

058 Chronic wound care in TurkeyBengüsu Mirasoğlu

059 Create superior wound care with simple steps Barbara den Boogert-Ruimschotel

08.00-09.30

Free Paper Session Diabetic Foot 1 Chairs: Magdalena Annersten Gershater, Christian Münter

Room G104-105

060 Effect of Psidium Guajava Lynn on MMP-9 and TIMP-1 Ratio of Patient with Diabetic UlcerAndina Setyawati

061 A novel mini-invasive drainage technique to treat deep diabetic foot phlegmon: Ulcer piercingMarco Cavallini

062 Continuous oxygen ambulatory therapy heals chronic diabetic foot woundsPaul Hayes

063 Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trialFrances Game

064 Prevalence of local oedema surrounding diabetic foot ulcersMireille Boink

065 Long-term effect of autologous cell therapy on limb ischemia and ulcer healing in patients with diabetic footMichal Dubsky

066 Impact of adherence to guideline-recommended medical therapies on wound healing in type 2 diabetic patients with foot ulcerationChiara Goretti

067 Macrovascular complications, microcirculation and healing status with relationship to the risk of Obstructive Sleep Apnea Syndrome in patients with the diabetic footVladimira Fejfarova

08.00-09.30

Free Paper Session Wound Assessment Chairs: Louk van Doorn, Sebastian Probst

Room G106-107

068 Comparison of Popular Five System of Classification of Diabetic Foot Ulcers and Predictive Factors for Lower Extremity AmputationHwan Jun Choi

069 Real-Time Bacterial Fluorescence Imaging Guides patient care, wound management and Antimicrobial Stewardship In Patients with Diverse Wounds: a pilot studyRosemary Hill

34


070 The effect of phototherapy with light emitting diodes on chronic wounds healingIgor Frangež

071 Novel wound assessment using in vitro models with mass spectrometry imagingEmily Lewis

072 PHoTuS: monitoring changes in pH, Temperature and Size of Neuropathic ulcers over 12 weeks: an observational studyGeorgina Gethin

073 Investigating Point to Point Emissivity Variation of Wounded TissueGeorgina Gethin

074 Evaluation of Chronic Wound Clara Lourenço

075 Wound biopsies or wound swabs: does it matter for the detection of infection?Marieke Haalboom

08.00-09.30

Free Paper Session e-Health and telemedicine Chairs: José Verdú Soriano, Edward Jude

Room E102

076 Nurstrial: a secure smartphone application to conduct the national observatory of wounds and wounds healingFrancois Allaert

077 Use of telehealth reducing distance in remote Australian wound managementBrendan Rose

078 The wound care app solutionSara Sandroni

079 Asynchronous telemedicine: the new city-hospital linkCecile Moisan

080 A new comprehensive system to measure and monitor chronic woundsJosé Verdú Soriano

081 Implementation of telemedicine in the field of wounds' care and dermatologyJavorka Delic

09.00-09.05

International Conference of the Veterinary Wound Healing Association (VWHA): Welcome

Room E105-106

Opening by the VWHA PresidentJacintha Wilmink

09.05-13.00

International Conference of the Veterinary Wound Healing Association (VWHA): How to live and deal with bacteria in wounds

Room E105-106

Sampling for bacteriological culture. How to take the right sample. How does sampling methods affect culture results? What do culture results tell us?Eskild Henneberg

Bacteria in wounds of small animals: what can bacteriological culture teach us, and what do we do with the results in practice?Mirja Nolff

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

35


Indications for use of antibiotics in small animals with wounds. When should we use them, which should we use, and what are the best treatment regimes?Mirja Nolff

Bacteria in wounds of horse: what can bacteriological culture teach us, and what do we do with the results in practice?Lore van Hecke

Indications for use of antibiotics in horses with wounds. When should we use them, which should we use, and what are the best treatment regimes?Stine Jacobsen

11.00-11.20 Break

How do we recognize problems with bacteria in wounds, when signs of infection are absent?Eskild Henneberg

Topical antimicrobial treatment modalities – medical methods. Practical use and the scientific evidence behind.Stine Jacobsen

Topical antimicrobial treatments – physical methods. Practical use and the scientific evidence behind Matthias Kuhn & Stine Jacobsen

Outcome of ‘The Danish’ study on limb wounds in horses: do good guys (probiotics) improve healing and prevent the growth of bad guys?Jacintha Wilmink

09.30-10.00

Break

09.30-10.00

e-Poster Session: Wound Assessment 1 Chair: Tania Santos

E-poster Screen 1

09.30-10.00

e-Poster Session: Home Care, Pain and Quality of Life Chair: Annette Høegh

E-poster Screen 3

10.00-11.00

Free Paper Session Acute Wounds ( )Chairs: Kylie Sandy-Hodgetts, Julie Jordan O’Brien

Elicium 2

082 Wound coverage after high-energy war injuries - Humanitarien treatment to Syrian civil war patientsKassis Shokrey

083 Value of colostomy in severe cases of perineal woundsMohammed Abdulateef

084 A new classification system skin tears: International skin tear advisory panel (ISTAP) skin tear classification systemKimberly LeBlanc

085 The art of dressing selection: A consensus statement on skin tears and best practiceKimberly LeBlanc

086 Preoperative risk assessment tool to identify patients at risk of wound dehiscence following abdominal surgery: development and internal validation of the Surgical Wound Dehiscence Risk Assessment ToolKylie Sandy-Hodgetts

36


10.00-11.00

EWMA-FIP-IFP symposium: The collaboration between the FIP-IFP and the IWGDF : standardized high level competence packages for dedicated practitioners in the area of diabetic foot care

Elicium 1

Panel discussionEsther Garcia MoralesPauline WilsonNeil BakerKristien Van AckerMatthew G. Garoufalis

10.00-11.00

Free Paper Session Devices & Intervention ( )Chairs: Mark Collier, Geoffrey Sussmann

Forum

087 The effectiveness of standardized skin care regimens on skin dryness in nursing home residents: a randomized controlled parallel-group pragmatic trialElisabeth Hahnel

088 The investigation of lower limb tissue perfusion using toe pressure and laser Doppler flowmetry measurements in patients with peripheral arterial occlusive disease and diabetesMohammed Aslam

089 Clinical evaluation of fluorescence imaging in positively predicting the presence of bacteria in chronic woundsMonique Rennie

090 Clinical evaluation of a diode laser 1210 nm on post-surgical scar: Results of the “slash” RCT (Laser after scar laser assisted skin healing)Sebastien Pascal

091 Safety and effectiveness of therapeutic magnetic resonance (TMR) in diabetic foot ulcers (DFU): a prospective randomized controlled trialChiara Goretti

10.00-11.00

Dutch stream: Wondzorg en voeding Chair: Anke Wijlens

Room G102-103

De relatie tussen wondzorg en voedingJeanne de Vries

Krijg diabetes type 2 onder controle met voeding Hanno Pijl

Decubitus en voedingJos M.G.A. Schols

10.00-11.00

International Partner Session Korean Wound Management Society (KWMS): Diabetic Foot Ulcer Management and Quality of LifeChair: Jan Stryja

Emerald Room

Treatment of the Diabetic Foot: The Plastic Surgeon's PerspectiveMatthew Seung Suk Choi

The Role of Microsurgeon in Resurfacing Surgery for Diabetic Foot UlcerDonghyuk Shin

Healthcare related quality of life associated with diabetic foot ulcers in KoreaMyong Shin Kim

10.00-11.00

Free Paper Session Diabetic Foot 2 Chairs: Edward Jude, Wouter Breckelmans

Room G104-105

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

37


092 Effects of NPWT on tissue repair processes in patients with diabetic foot ulcers in comparison to standard treatmentEkaterina Zaitseva

093 The effect of podiatric intervention on dialysis patientsScott Schumacher

094 Factors related to ulcer healing process in type 2 diabetic patients with foot ulcerElisabetta Iacopi

095 First experience of infra red imaging for screening of diabetic foot conditionsRoman Liberzon

096 Efficacy of a pro-active screening for diabetic foot ulceration in the community autonomously performed by nursesLudovica Tamburini

10.00-11.00

Workshop: How do maggots operate Chair: Gwendolyn Cazander

Room G106-107

Introduction about larval therapyGwendolyn Cazander

Clinical application of larvae on woundsGwendolyn Cazander

The science behind the larva. About the past and the futurePeter. H. Nibbering

Practical application of larvae on wound modelsLouk van Doorn

Discussion and closure

10.00-11.00


Room E102

How to measure succes in wound healing? The dermatologist’s perspectiveBibi C. van Montfrans

10.00-11.00

Workshop: Core Outcome Set for Reporting of Trials in Venous Leg Ulceration (CoreVen) Consensus MeetingChairs: Andrea Nelson, Georgina Gethin

Room D203-204

Discussion of Phase 1 of the development of a Core Outcome Set for RCTs in Venous Leg UlcersSarah Hallas

Discussion of Phase 1 of the development of a Core Outcome Set for RCTs in Venous Leg UlcersAndrea Nelson

Discussion of Phase 1 of the development of a Core Outcome Set for RCTs in Venous Leg UlcersGeorgina Gethin

11.15-12.15

Industry Sponsored Satellite Symposium ( ) ( )Information available page 146

Elicium 2

11.15-12.15


Elicium 1

11.15-12.15


Forum

11.15-12.15


Room E108

38


11.15-12.15

Dutch stream: Decubitus Chair: Tonny de Groot

Room G102-103

Kosteneffectieve (voedings)zorg bij decubitusKaren Freijer

Interventies om hiel- en enkel decubitus te voorkomenTonny de Groot

Nieuwe classificatie incontinentie geassocieerde dermatitisDimitri Beeckman

12.15-14.30

Break

12.30-13.15

Meet the experts: Challenges in Palliative Wound care Georgina Gethin, Sebastian Probst

E-poster Screen 1

12.30-14.15

e-Poster session: Devices and Intervention Chair: Stella Amesz

E-poster Screen 2

12.30-14.15

e-Poster session: Basic Science Chair: Corinne Ward

E-poster Screen 3

12.30-14.15

e-Poster session: Dressings 2 Chair: Maarit Ahtiala

E-poster Screen 4

13.15-14.15


Elicium 2

13.15-14.15


Forum

13.30-14.15

e-Poster session: Health Economics and Outcome Chair: Jasmina Begic

E-poster Screen 1

14.00-15.00

International Conference of the Veterinary Wound Healing Association (VWHA): What to do in practice?

Room E105-106

Wound QuizVWHA council

Sponsored lecture: How to send a useful wound sample for bacteriologyYvette Schlotter

Sponsored lecture: Honey products for wound treatment, does the type of product and source of honey make a difference?Tineke Creemers

14.30-15.30

Key Session: Negative Pressure Wound Therapy ( ) – overview, challenges and perspectivesChairs: Malin Malmsjö, Jan Apelqvist

Elicium 2

Chair introductionJan Apelqvist

Mechanisms of actionMalin Malmsjö

Legal and patient safety issuesPeter Vowden

Discussion

14.30-15.30

EWMA-FIP-IFP symposium: Podiatry practice on wound managementChair: Vince Hetheringthon

Elicium 1

Teamwork in Healing Diabetic WoundsPauline Wilson

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

39


Techniques in Wound DebridementDebbie Wilson

Surgical treat and Salvage of the Diabetic FootLee Murphy

14.30-15.30

Key Session: Healing wounds, saving limbs ( ) – Management of arterial ulcersChairs: Jan Stryja, Arkadiusz Jawien

Forum

097 Introduction to arterial ulcers management, basic research,Romeo Martini

098 Surgical revascularisationDieter Mayer

Endovascular and hybrid approach in critical limb ischemia treatmentArkadiusz Jawien

099 Case study reports from clinical practice Wael Ahmed Tawfick

14.30-15.30

Dutch stream: Psychologische impact van wonden Chair: Rob van Komen

Room G102-103

Pijn: begrijpen, diagosticeren en behandelenMarion Giesberts

Leven met littekensMarthe Egberts

Terug naar het werk met littekensH. de Goei

14.30-15.30

The European Society for Clinical Nutrition and Metabolism (ESPEN) guest session: Nutrition and wound healing

Emerald Room

Benefits of nutritional support in wound healingMarina Panisic

How to improve food intake in older adults?Rainer Wirth

14.30-15.30

Workshop: How to identify atypical wounds Room G104-105

Atypical wound - tools to make the diagnosis and treat the patientKirsi Isoherranen

Calciphylaxis and Martorell woundsNicolas Kluger

14.30-15.30


Room G106-107

The Scientific modes of action of LDTYamni Nigam

LDT case studies: bridging the theory-practive gapKristof Balliu

14.30-15.30

Workshop: How to read a paper. Understanding basic statistics Room E102

Mark Collier

Georgina Gethin

14.30-15.30

Wounds Australia guest session Chair: Kylie Sandy-Hodgetts

Room G109

Chronic disease risk factors and chronic wounds: A universal challengeSuzanne Kapp

40


Projects under PressureCarol Baines

Risk factors for wound dehiscence following surgery: a review of the evidence and the clinical challengeKylie Sandy-Hodgetts

14.30-15.30


Room E108

15.00-17.30

International Conference of the Veterinary Wound Healing Association (VWHA): Free Communications

Room E105-106

100 Clinical impact of inoculation on equine experimental wounds healing by second intentionElin Jørgensen

101 A hypoxia response element in the VEGFA promoter is required for basal VEGFA expression in skin and for optimal granulationtissue formation during wound healingChristine Theoret

102 Skin organ culture: potential applications in wound healing researchVincenzo Miragliotta

15.45-16.00 Break

103 Comparison of autologous versus allogeneic epithelial-like stem cell treatment in an in vivo equine skin wound modelLore van Hecke

104 Comparison of antimicrobial effect of common wound care dressingDean Hendrickson

105 Sequential bacterial sampling of equine laparotomy incisions following surgical managment of colicDebby Archer

106 A retrospective case series of the incidence, treatment and outcome of equine wounds seen in out of hours primary care equine practice in the UKJessica Firth

107 Combined barbed absorbable suture material and skin adhesive to avoid the need for staples removal following laparotomy in horsesOlivier Lepage

Award for the best Oral Presentation

15.00-16.00

Wound Care Innovation Symposium: Opening Session Room D203-204

Welcome, Introductions and AgendaMitch Sanders

Biofilm Panel DiscussionMitch Sanders, Breda Cullen, Greg Schultz, Phil Bowler

Q&ASusan Paquette

15.30-16.00

Break

15.30-16.00

e-Poster session: Burns 2 Chair: Wouter Breckelmans

E-poster Screen 1

15.30-16.00

e-Poster session: Wound Assessment 2 Chair: Pedro L. Pancorbo-Hidalgo

E-poster Screen 2

15.30-16.00

e-Poster session: Leg Ulcer 2 Chair: Sonja Koller

E-poster Screen 3

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

41


16.00-17.00


Elicium 2

16.00-17.00


Elicium 1

16.00-17.00


Forum

16.00-17.00


Room G104-105

16.00-17.00


Room G106-107

16.00-17.00


Room E102

16.00-19.00

Wound Care Innovation Symposium: Innovation Session Chairs: Edwin den Braber, Gary Robinson

Room D203-204

WelcomeBent von Eitzen

Innovation Presentations

Panel Discussion

Innovation Award Presentation

Closing RemarksBent von Eitzen

16.15-17.00

Dutch stream: Workshop oncologische wonden Chair: Peter Quataert

Room G102-103

Margriet Lowik

Dorien Berends

Jeanet van Nood

16.30-17.30

Industry Sponsored Satellite Symposium Veterinary Wound Healing Association

Room E105-106

17.15-18.30

Key Session: Quality of care and cost effectiveness ( ) Chairs: Magdalena Gershater, Georgina Gethin

Elicium 2

108 Is price related to outcomes?Jan Apelqvist

109 Wound care in EuropeGiuseppe Turchetti

110 Using cost data to improve care – an example from the UKUna Adderley

17.15-18.30

Guest session: Association of Diabetic Foot Surgeons (A-DFS) Elicium 1

The increasing role of surgery in the multidisciplinary management of diabetic footLuca dalla Paola

Surgical debridement of chronic wounds: why, when and how?Alberto Piaggesi

Diabetic heel ulcers with calcaneal osteomyelitis: new treatment options with local antibiotic carriersArmin Koller

Local and regional flaps for soft tissue coverage of diabetic foot woundsThomas Zgonis

42


The foot with wound and deformity: what to treat first?Sigurd Kessler

17.15-18.30

Key Session: Prevention and treatment of scars ( )Chairs: Rob van Komen, Severin Läuchli

Forum

111 Fibroblast-derived Nrf2: an emerging role during wound healing and scarringPaul Hiebert

112 Signs of healing – signs of scarringEsther Middelkoop

113 Scar treatment for fragile skinJill Meirte

114 Treatment options for pathological scar tissueMichael Mühlstadt

17.15-18.30

Dutch stream: Chirurgische wonden en Wondinfectie Chair: Véronique Oostendorp

Room G102-103

Stimuleren van het gebruik van internationale standaarden ter voorkoming van wondinfectieJasper van der Slegt

Pre-operatieve behandeling van staphylococ aureus dragers. Gerda Lelieveld

Peri-operatieve zorg ter preventie van wondinfecties.Wim Schreurs

Functioneren van infectiepreventie protocollen.Lisette J.E.W.C. Gemert-Pijnen

17.15-18.30

Guest session: International Lymphoedema Framework (ILF) Emerald Room

The Lymphorac studyIsabelle Quere

Overgrowth syndromes and LymphoedemaVaughan Keeley

Chronic oedema in the community and wound healing challengesChristine Moffatt

17.15-18.30


Room G104-105

Immediate breast reconstructionMarije J Hoornweg

3D Technique for Nipple TattooEllen Kuijper-Kuip

17.15-18.30

Guest session European Council of Enterostomal Therapy (ECET): Good clinical Practise in Stomatherapy

Room E102

Gabriele Kroboth

Renata Batas

Werner Droste

17.30-18.00

Veterinary Wound Healing Association AGM Room E105-106

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

43

FRIDAY 5 MAY

08.00-09.30

Key Session: Microbiology of wounds. ( ) From basic to clinical ScienceChairs: José Verdú Soriano, Rose Cooper

Elicium 2

115 Inflammation vs. infectionRose A. Cooper

116 Understanding biofilmsThomas Bjarnsholt

117 Biofilms: From conception to managementSteven L Percival

118 Antimicrobial resistance Clinical practice of the knowledge: what do we know, what can we use in clinical practiceEdgar Peters

08.00-09.30

Key Session: Advanced therapies in Wound management ( ) – A look into the future of wound managementChairs: Alberto Piaggesi, Severin Läuchli

Forum

119 Regenerative Medicine: myth or reality?Franco Bassetto

120 Skin and dermal engineering in the year 2020Thomas Biederman

121 What the new biomaterials may bring to wound healingAlexandra P. Marques

122 Nanotechnologies and wound careAlberto Piaggesi

08.00-09.30

Workshop: Diabetic Foot Screening Room G102-103

Bela Pagrach

Anke Wijlens

08.00-09.30


Emerald Room

Background and context of the projectLisette Schoonhoven

Project aim and objectivesAndrea Pokorná

Achievements thus farZena Moore

Next stepsJosé Verdú Soriano

08.00-09.30

Guest session: European Burns Association (EBA) Room G104-105

Importance of psychosocial support in burn careHelma Hofland

Possibilities of the use of NPWT in the treatment of burnsIstvan Juhasz

Challenges in burn woundcareAndré Magnette

Organization of center to center and cross-border burn-care in the Netherlands. Lessons learned from previous mass casualtiesKees v.d. Vlies

44

FRIDAY 5 MAY (continued)

08.00-09.30

ICC session: Basics Room E102

Chronic edema and lymphedema. The same?Robert Damstra

Epidemiology-:Swollen legs, a new epidemicChristine Moffatt

Subfascial oedemaThomas Stumptner, Hugo Partsch

Key-note lecture: Hydromechanics and ICG imaging of edema fluid flow in edematous tissuesWaldemar Olszewsk

08.00-09.30

EWMA UCM session Chairs: Madeleine Flanagan, Tiny Coremans

Room E105-106

Living with chronic wounds - a daily challenge Véronique Urbaniak

Patient education - not just a leaflet Julie Jordan O'Brien

09.30-10.15

Break

09.30-10.15

e-Poster Session: Acute Wounds Chair: Lea Pulliainen

E-poster Screen 1

09.30-10.15

e-Poster Session: Prevention Chair: Jasmina Begic

E-poster Screen 2

09.30-10.15

e-Poster Session: Pressure Ulcer 2 Chair: Tania Santos

E-poster Screen 3

09.30-10.15

e-Poster Session: Education Chair: Corinne Ward

E-poster Screen 4

10.00-12.30

ICC session: Therapy I Room E102

Edema reduction visualized by ultrasoundMonika Gniadecka

New observations on visualization of movements and hydromechanics of tissue fluid in lymphedema during MLD, Linforoll massaging, IPC and bandagingMarzanna Zaleska

Stockings vs velcro devices in chronic edemaGiovanni Mosti

Reduction of volume of a stasis edema: stiff compression or not stiff compression?Jean Patrick Benigni, Jean-François Uhl, Maxime Chahim

C3 & Superimposed MCSAndré Cornu-Thenard

Bandages s Velcro devises in lymphedemaRobert Damstra

10.15-11.15

Antimicrobial Stewardship in Wound Management ( ) – a Joint symposium of EWMA and British Society for Antimicrobial Chemotherapy (BSAC)Chair: Rose Cooper

Elicium 2

Chair introductionRose Cooper

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

45


Non-antibiotic antimicrobial interventions in wound care; agents, resistance and beyond!Rose Cooper

Non-antibiotic alternatives in clinical practiceJan Stryja

Discussion

10.15-11.15

Free Paper Session Leg Ulcer Chairs: Sebastian Probst, Barbara den Boogert-Ruimschotel

Elicium 1

123 Chronic venous leg ulceration - are we missing a vital piece of the jigsaw?Julie Green

124 A survey of leg ulcer treatment in four nationsMarco Romanelli

125 Management of complications of mycobacterium ulcerans diseaseEmmanuel Adu

126 A pilot study on the effectiveness of autologous platelet rich plasma gel in the treatment of leg ulcersDomantas Rainys

127 Fat grafting as an adjunct to healing the chronic woundVijay Langer

128 Risk factors for development of venous leg ulcers. A matchde-paired case-control studyJosé Verdú Soriano

10.15-11.15

Free Paper Session Diabetic Foot 3 ( )Chairs: Kylie Sandy-Hodgetts, Louk van Doorn

Forum

129 Treating biofilm associated infection in diabetic ulcers by surgical debridement, simultaneous meshed skin grafts, and negative pressure dressingsHi-jin You

130 Reporting the assessment of new diabetic foot presentation in specialist clinic across Europe: focus on patient's perceptions and the possible impact on their managementMarco Meloni

131 Characteristics of new-patient referrals to specialist Diabetes foot care Services across EuropeElisabetta Iacopi

132 Exploration of serial changes in the microbiome in chronic diabetic foot ulcersTim Sloan

133 A survey of four nations practice of diabetic foot careChris Manu

10.15-11.15

Workshop: Clean hands – clean wounds Room G102-103

The WHO hand Hygiene Campaign- introductionEnrique Castro Sanchez

Role of hand hygiene in the management of surgical wounds Valya Weston

How to reduce transmission and infection by multi drug resistant organisms in wounds across health care settings Enrique Castro Sanchez

Best practice for improving hand hygieneErica Ehrhardt

46


10.15-11.15

Workshop: Positioning patients with pressure ulcers Emerald Room

Bas Robroek.

Sandy Egbreghts-Uchtmann

10.15-11.15

Workshop: Care of burns patients that are not hospitalized Room G104-105

Helma Hofland

Jo Myers

10.15-11.15

Guest session V & VN wound expertise: Who is the case manager in Complex Wound ManagementChairs: Samantha Holloway, Jacques Neyens

Room G106-107

The Role of the case manager complex wound management, Dutch nurses perspective Sandra Jansen

Who is the case manager of the complex wound management, International perspective Zena Moore

Panel discussionSamantha Holloway, Robert Meerwaldt, Jacques Neyens, Zena Moore, Sandra Janssen

10.15-11.15

Workshop: Diabetic foot – assessments, offloading and footwear Room E105-106

Alberto Piaggesi

11.30-12.30

Antimicrobial Stewardship in Wound Management ( ) – a Joint symposium of EWMA and British Society for Antimicrobial Chemotherapy (BSAC)Chair: Philip Howard

Elicium 2

Chair introduction: What can we learn from national approaches to AMSPhilip Howard

Euregional AMS strategy: An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID) Jan-Willem Dik

UK strategy for combatting resistancePhilip Howard

Discussion

11.30-12.30


Elicium 1

Venous leg ulcers - how to recognize them and differential diagnosisMiriam Loots

11.30-12.30

Honorary Lecture: Karel Bakker ( ) Forum

IntroductionAlberto Piaggesi

30 years of Diabetic Foot Care, setbacks and successesKarel Bakker

11.30-12.30

Free Paper Session Pressure Ulcer 2 Chairs: Andrea Pokorná, Veronique Oostendorp

Emerald Room

134 PUDRA - Pressure Ulcer Daily Risk Assessment demontrated continuous reduction in avoidable hospital acquired pressure ulcers over a seven month period and a p-value of pHeather Hodgson

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

47


135 Risk Factors of pressure ulcers predicting the outcome of the ICU patientsMaarit Ahtiala

136 Quality indicators for pressure ulcer prevention: A systematic mapping reviewAndrea Lichterfeld-Kottner, Elisabeth Hahnel

137 Incidence, timing and risk factors associated with healing a sitting-acquired pressure ulcer: Preliminary results from the auscan pressure ulcer risk scale studyKaren Campbell

138 Implementing evidence-based clinical practice guidelines within a longitudinal international study for sitting acquired pressure ulcersKaren Campbell

139 Risk-adjusted quality indicator on Pressure injury Development in Long-Term Care FacilitiesYun Jin Lee

11.30-12.30

Free Paper Session Home Care Chairs: Sara Rowan, Mark Collier

Room G104-105

140 Complex challenges, professional pride and joy. Home care nurses experience with providing health care to patients with hard-to-heal wounds (a master thesis)Elisabeth Aune

141 Comparing older and younger people who have chronic wounds: Factors affecting well-beingSuzanne Kapp

142 The development and pilot of the 'capacity to self-treat chronic wounds' checklist Suzanne Kapp

143 Domicilary delivery of negative pressure wound therapy (NPWT) in diabetic foot patients after surgical procedures compared with in-hospital management: Results of one year of follow upAlberto Piaggesi

11.30-12.30


Room G106-107

Robert Meerwaldt

Evie Kolsteren

12.45-13.45


Emerald Room

12.45-13.45


Room G104-105

12.45-13.45


Room G106-107

12.45-13.15

EWMA AGM Room E108

14.00-15.30

Key Session: Surgical Site Infections (SSI) across sectors ( ) – what can be done to improve prevention?Chair: Jan Stryja

Elicium 2

Chair introductionJan Stryja

48


144 Surgical Site Infections – no simple way how to hit the targetJan Stryja

145 Microbiological diagnostics and appropriate antibiotics for the surgical skin infectionsClaus Moser

146 Surgical Site Infections in the community setting Kylie Sandy-Hodgetts

147 Surgical Site Infections in the hospital settingThomas Serena

Discussion

14.00-15.30

Guest Session: European Society for Vascular Surgery (ESVS) Elicium 1

14.00-15.30

Key Session: Psychological impact of chronic illness ( ) or chronic wounds?Chairs: Salla Seppänen, Georgina Gethin

Forum

148 Critical review of the literature on the prevalence of chronic disease among people with wounds or the prevalence of chronic woundsKnut Kröger

149 Psychosocial impact of a wound on the individual and/or their familyMary Madden

150 Current evidence on psychological interventions in the prevention and management of chronic wounds. Helen Mc Gloin

www.ewma.org

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

49


14.00-15.30

Guest Session European Tissue Repair Society (ETRS): Advanced therapies in wound healingChair: Magda Ulrich

Emerald Room

Advanced therapies in wound healing: is there a need?Hilde Beele

Biological matrices for wound repairUrsula Mirastschijski

Cell therapy for burnsEsther Middelkoop

Development of human decellularized dermal matrices for the treatment of burn patientsJean-Pierre Draye

14.00-15.30

Guest Session: European Society of Plastic, Reconstructive and Aesthetic Surgery (ESPRAS)

Room G104-105

Body contouring after massive weight lossMaria da Luz Barroso

Negative pressure as a tool in treatment of post sternotomy infectionsFranjo Rudman

New method of relocation of NAC in female to male transsexualsSrecko Budi

Presentation of video on the 2018 ESPRAS Congress in Cyprus

14.00-16.00

ICC session: Therapy II Room E102

Compression therapy in lipedemaGyozo Szolnoky

Edema and its impact on functional mobility /function in generalSuzie Ehmann

New aspects of MLDLisbeth Vandermeeren

Which patients should receive MLD?Nele Devoogdt

Prevention of BCRL after surgeryKatarzyna Ochalek

Compression bra for dealing with breast edemaNick Gebruers

15.35-16.00

Closing Ceremony and Prizes ( ) Elicium 2

Closing and prizesJosé Verdú Soriano

EWMA 2018Arkadiusz Jawien, Beata Mrozikiewicz-Rakowska

16.30-18.00

ICC session: Working groups Room E102 Room E103 Room E104Meeting: Working Group Bandages

Meeting: Working Group IPC

Meeting: Working Group Stockings

WISSEN

SICHERHEIT

2. WundD·A·CH Dreiländerkongress 2017

St. Gallen, Schweiz28. - 30. September 2017

www.wunddach-kongress-2017.org

Abstract Deadline

1. Juni 2017Early Bird Registrierung

15. Juli 2017

Programmthemen

■ Venöses Ulcus cruris - aus verschiedenen Blickwinkeln

■ Diabetischer Fuß ■ Amputation ■ Lokaltherapie jenseits von

Wundauflagen ■ Neues aus der Grundlagenforschung ■ Inflammation in der chronischen Wunde ■ Sicherheit in der Wundbehandlung ■ Ethik in der Wundbehandlung ■ Wunden in der Palliativmedizin ■ Antimikrobielle Therapie ■ Interprofessionelles Team

in der Wundbehandlung ■ Wundbehandlung in der DACH Region ■ Allergien in der Wundbehandlung ■ Psychosoziale Aspekte beim

chron. Wundpatienten ■ Ko-Morbiditäten ■ Narben

Become a Member of EWMAMake a difference in clinical practice

Benefits of your EWMA Membership:n You support the development and improvement of wound care in Europe

n The EWMA Journal sent directly to you twice a year

n 15% discount on your registration fee for EWMA Conferences

n Right to apply for EWMA travel grants

n Right to vote and stand for election to the EWMA Council

n Updates on activities and developments within EWMA via the EWMA Newsletter, which is sent

three times a year

n Yearly membership fee € 25

n Yearly membership fee for members of cooperating organisations € 10

Please register as a EWMA member at WWW.EWMA.ORG

Krakow: New Frontiers in Wound Management

in cooperation with the Polish Wound Management Association

28th Conference of the European Wound Management Association

EWMA 2018

KRAKOW, POLAND 9 -11 MAY 2018

W W W.EWM A 2018.ORGW W W.EWM A .ORG

W W W.PTLR.ORG.PL

Krakow: New Frontiers in Wound Management

52

Wednesday 3 May 10.00-11.30

Room: Auditorium

( )

Opening Key Session: Change, Opportunities and Challenges – Wound Management in Changing Healthcare Systems

The opening key session will focus on the theme of the conference:

National healthcare systems in Europe are continuously changing, reorganising and adapting to respond to changing demographics and budget restrictions. This sets the context in which wound healing and wound carers must navigate to provide the best possible treatment for the individual patient. At the same time technology is rapidly developing, providing new methods and means of treatment and organisation.

In this opening session of the EWMA 2017 Conference, we will be introduced to different views on the current challenges and new openings in wound management, seen from a European, US and Dutch perspective. We hope that this will lead to some interesting debates about different and common visions and approaches.


Room: Auditorium

( )

Use of Oxygen Therapies in Wound Healing, with Special Focus on Topical and Hyperbaric Oxygen Treatment

This session will present the EWMA document, ”Use of oxygen therapies in wound care”.

The document provides practice-oriented guidance on the use of various forms of oxygen therapies for wound treatment.

It will include an overview of treatment options available and an assessment of the best available evidence for use.

In addition, the document will detail specific aspects and current discussions connected with the use of oxygen in wound healing.

KEY SESSION DESCRIPTIONS The EWMA 2017 key sessions consist of 12 key sessions and include a mix of new topics that are important to the European wound community in general, in addition to topics that have had enormous appeal during previous EWMA conferences. The sessions deal with the advancement of education and research in relation to the epidemiology, pathology, diagnosis, prevention, and management of wounds. Although mainly theoretical, key sessions will include time for discussion among lecturers and audiences.

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

53


Room: Elicium 2

( )

Chronic Wounds in the Fragile Aging Patient – Joint Key Session of EWMA and ISTAP

During this joint EWMA and ISTAP session, the public will have the opportunity to approach the questions of complex health issues in the elderly. Both clinical and economic problems will be discussed.

Regarding the skin, its physiology and physiopathology will be developed with a special insight on skin tears, a problem which, with the demographics of aging, clinicians will be more and more exposed.

Aims for the participants are to:• Be made aware about the elderlypatient’s medical specificities• Know about the costs generated• Know more about skin biology in old age• Know about its daily clinical repercussions• Be aware and better treat skin tears

54


Room: Forum

( )

Diabetic Foot Key Session

The session will focus on:

Diabetic foot ulceration (DFU) is known as one of the most severe complications of diabetes. Revascularisation plays a crucial role in achieving ulcer healing. Non-surgical, minimally invasive, revasculari-sation options for DFU have expanded over the last decade and have become a prominent tool to prevent amputation.

What is the role of endovascular treatment of the DFU nowadays? When should we consider this option, what are the opportunities? Should we look at the location of the ulcer? What is the evidence of the intervention on angiosome-base?

Systemic hyperbaric oxygen therapy (HBOT) has been proposed as a medical treatment for diabetic foot ulcers. The value of HBOT in the treatment of diabetic ulcers is still under debate. Available evidence suggests that HBOT may improve the healing of diabetic ulcers, but it comes from small trials with heterogeneous populations and interventions. As an example, the HODFU study (2010) showed that adjunctive treatment with HBOT facilitates healing of chronic foot ulcers in selected patients with diabetes. The DAMOCLES trial is performed in the Netherlands and it is unique for addressing patients with ischaemic diabetic foot ulcers who may also receive vascular reconstructions. What are the results? How should we use the outcomes? What should be/is the role of HBOT in treating DFU?

A series of multiple mechanisms can contribute to lack of healing in people with DFUs. The association of diabetes with impaired wound healing and other vascular complications is a serious public health issue. For example, Matrix Metalloproteinases (MMPs) play an integral role in wound healing. Their main function is degradation, by removal of damaged extracellular matrix (ECM) during the inflammatory phase, breakdown of the capillary basement mem-brane for angiogenesis and cell migration during the proliferation phase, and contraction and remodeling of tissue in the remodeling phase. For effective healing to occur, all wounds require a certain amount of these enzymes, which on the contrary could be very damaging at high concentrations causing excessive degradation and impaired wound healing. The imbalance in MMPs may increase the chronicity of a wound, a familiar problem seen in diabetic patients. What should we know about the molecular changes leading to stagnation? What are the possible treatment options?

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

55

Thursday 4 May 14.30-15.30

Room: Elicium 2

( )

EWMA Document Key Session: Negative Pressure Wound Therapy – Overview, Challenges and Perspectives

Since its introduction in clinical practice in the early 1990s, negative pressure wound therapy (NPWT) has become widely used in the management of complex wounds in both inpatient and outpatient care.

Increasingly, NPWT is being applied in the primary and home-care setting, where it is described as having the potential to improve the efficacy of wound management and help reduce the reliance on hospital-based care.

While the potential of NPWT is promising and the clinical use of the treatment is widespread, high-level evidence of its effectiveness and economic benefits remain sparse. Although an increasing number of papers on the effect of NPWT are being published, the treatment remains controversial from the policy maker and healthcare system’s points of view due to the low evidence level.

In response, EWMA has established an interdisciplinary working group to describe the present knowledge with regard to NPWT and provide an overview of its implications for organisation of care, documentation, communication, patient safety, and health economic aspects.

In this key session, international wound experts will present key findings from the recently published EWMA document entitled “Negative Pressure Wound Therapy - Overview, Challenges and Perspectives”

Copies of the publication will be freely available in the session.


Room: Forum

( )

Healing Wounds, Saving Limbs - Management of Arterial Ulcers

Objectives of the session are:• To demonstrate the main streams in revascularisation• To bring an overview of current guidelines• To emphasise the complex approach in ischaemic wound

management• To show the limits of revascularisation on case study reports


Room: Elicium 2

( )

Quality of Care and Cost Effectiveness

The objectives of the session are to demonstrate and discuss how good quality of care in wound management is cost effective if the use of quality indicators are implemented, and the consequences if they are not.

56


Room: Forum

( )

Prevention and Treatment of Scars

Every wound that heals leaves a scar. There are very few exceptions to this rule – e.g. foetal tissues can heal without scar formation. Scientific efforts are aimed towards using these mechanisms for reducing scar formation in adults. Once a scar is formed, the tissue differs in quality from normal healthy tissue and is often less resistant to re-injury. In this situation, preventive efforts must be maintained to avoid the reappearance of a wound. In the case of pathological scar formation – e.g. atrophic or hypertrophic scars or keloids – medical and surgical treatment can reduce the impact of this scar on the patient.

Friday 5 May 08.00-09.30

Room: Elicium 2

( )

Microbiology of Wounds. From Basic to Clinical Science

BackgroundDiagnosing and treating wound infections is a challenge for clinicians and also for the microbiology laboratory. Classically, culture methods have been applied to approach wound infections, but today we know that those methods are correct for planktonic infections but more conflicting for biofilm-related problems. New methods and approach-es are emerging to diagnose and treat bacterial and fungal biofilms, but clinical practice still remains a problem.

Objectives• To review the current knowledge about microbiology and wounds• To differentiate between planktonic versus biofilm infections on

wounds• How to diagnose both planktonic and biofilm infections• To reduce the gap between basic science and clinical science in

that subject• How to approach that problem from a clinical point of view

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

57

Friday 5 May 08.00-09.30

Room: Forum

( )

Advanced Therapies in Wound Management – A Look into the Future of Wound Management

With the “Advanced Therapies in Wound Management” initiative, EWMA will investigate the barriers and possibilities of advanced therapies in next generation wound management.

The primary deliverable will be a document including an introduction to the available technologies based on cellular therapies, tissue engineering and tissue substitutes, which are all technologies associated with the clinical discipline of regenerative medicine. The document will also describe new treatments based on physical therapies and the potential of sensors and software.

The overall aims of the document are to provide healthcare profes-sionals who are interested in investigating new treatment options with a neutral and exhaustive source of information and provide a point of referral for future discussions and negotiations with health care providers and payers.

This key session will introduce the EWMA initiative and the current considerations concerning barriers and possibilities of advanced therapies in next generation wound management.

Friday 5 May 14.00-15.30

Room: Elicium 2

( )

Surgical Site Infections (SSI) Across Sectors – What Can Be Done to Improve Prevention?

While guidelines for preventing and managing surgical site infections in hospitals are in place in many countries, there is still a need for guidance on how to deal with SSI management and prevention in community care. A set of recommendations on this topic covering primary as well secondary care, and targeting healthcare profes-sionals in hospital as well as community based nurses and general practitioners (GPs), does not yet exist. EWMA has therefore decided to focus on surgical site infections (SSI) in a new project aiming to provide guidance on management of SSI across the primary and secondary healthcare sectors.

The main objective of the EWMA SSI project is to produce a document which: • Maps the SSI incidence, prevalence and high risk areas, based on

published information and data available from SSI-registries• Present the available modern techniques for prevention and

treatment of surgical site infections, including assessment of cost effectiveness, patient mobility, pain etc.

• Provide best practice recommendations for SSI management and prevention in hospitals and community care

This key session will introduce the EWMA initiative and the current considerations concerning challenges and solutions in SSI manage-ment.

58

Friday 5 May 14.00-15.30

Room: Forum

( )

Psychological Impact of Chronic Illness or Chronic Wounds?

The objectives of the session are:

To present a critical review of the literature on the prevalence of chronic disease among people with wounds or the prevalence of chronic wounds.

To enable the audience to understand the psychological impact of a wound on the individual and/or their family.

To present current evidence on psychological interventions in the prevention and management of chronic wounds.

International Conference of the Veterinary Wound Healing AssociationThe (non)sense of antimicrobials during wound treatment

4th May • Amsterdam • the Netherlands

Are you a veterinary surgeon or nurse with a passion for wound management? Or are you from the human field and interested to experience what is going on in veterinary wound healing science, and to be inspired by another point of view?? Join!!

Our theme will offer a lot of information about bacteria and their possible influence on wound healing, and answer questions we all encounter in everyday veterinary practice. How can we diagnose whether bacteria are a problem, or not? And if they are a problem, how to target treatment?Do we need antibiotics for treatment or can we omit their use and treat with alternative antimicrobial strategies? When would it be better not to treat bacteria at all?

Just as last year, we will incorporate a free communication session in the afternoon. Brand new research about a variety of subjects in the field of veterinary wounds / wound management will be presented. Titles and programme: http://ewma.org/ewma-conference/2017/scientific/veterinary-wound-healing-association/

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

59


Meeting Room D203-204

Wound Debridement

Debridement is known and described by many woundcare experts as an essential process of wound bed preparation that promotes wound healing. This workshop helps participants become familiar with surgical/sharp debridement and its different techniques (biosurgical and mechanical). Participants will gain knowledge about wound evaluation, the goals of debridement (when and why), tricks and traps.

Attendees will be able to practice sharp debridement during the workshop and learn some helpful practical skills to further integrate this essential practice in their woundcare management.


Session Room G106-107

Infection and Wound Care

The first part of the workshop aims to highlight the importance of achieving optimal asepsis in the prevention of wound infections.

The second part of the workshop aims to highlight the importance of surveillance in preventing surgical wound infections and uses real examples from hospitals to demonstrate how this can be achieved.


Room: Forum

( )

Audio-Visual Workshop Making Compression Therapy for Ulcer Treatment Easier

The session will focus on bandages, compression stockings and Velcro-devices.

The session includes video-demonstration of proper application of the devices indicating interface pressures at rest and during movement.

WORKSHOP DESCRIPTIONS EWMA workshops are interactive and give participants an opportunity to address and discuss particular aspects of the themes of the individual sessions. The workshop lectures are typically held in a smaller setting than key sessions and free paper sessions. The contents of the workshops are a mix of theoretical and practical approaches; you can read more about the specific content of each workshop below.

60


Emerald Room

Cooperating Organisations Workshop

In this workshop, several partner organisations of EWMA (national associations in the field of wound research and management) will present and discuss achievements and challenges related to wound healing in their respective countries.

These topics will address:• Activities related to woundcare that have made a change in their

country• Research projects or ideas that these organisations want to submit

for collaboration with other national associations on woundcare• Opportunities and challenges that the organisation would like to

share and discuss with other wound care associations



Eczema in Leg Ulcer Patients

This session will provide an overview of common skin problems of the wound edge and the surrounding skin. Strategies for the prevention of wound-associated skin problems and some treatments will be described. The session focus will lie in the practical aspects of choosing a skincare regimen for different skin states of periwound skin. Different galenic formulations of skincare products will be presented and tested during the workshop.



How Do Maggots Operate?

Larval therapy is widely used today for the treatment of acute and chronic wounds in patients. Annually, more than 15.000 patients receive larval therapy in Europe. Although larvae were already applied on wounds in ancient times, the exact mechanisms of the action of larvae in wound treatment are only recently becoming better understood. The US Food and Drug Administration registered maggot debridement therapy (510(k) #33391 as a wound treatment method in 2004. The Inspectie voor de Gezondheidszorg (IGZ) in the Netherlands approved the larva Lucilia sericata as an unregistered medicine in 2014. Three randomised clinical trials (RCTs) have shown the debridement potential of larvae, while other beneficial effects of larvae on wounds, including anti-infection, immunomodu-lation, angiogenesis, and tissue remodelling and regeneration, have been widely reported clinically and are supported by numerous in vitro studies.

More research and development of evidence-based wound therapies are of the utmost importance, because treatment of (chronic) wounds is a daily and major problem in clinical practice. This problem will increase in the near future because of the incidence of diabetes and ageing in the population. Larval therapy is an essential addition to your (limited) evidence-based woundcare arsenal.

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

61

This workshop gives an overview of the clinical indications of the therapy, the scientific background and future research. Furthermore, you can practice larval therapy on models.


Meeting Room D203-204

Core Outcome Set for Reporting of Trials in Venous Leg Ulceration (CoreVen) Consensus Meeting

The aim of this workshop is to present results of the first stage in the development of a core outcome set for RCTs of interventions in the management of venous leg ulceration. Participants will be invited to discuss the findings and to help in the design of the next stage of this project.



How to Identify Atypical Wounds

This workshop aims to define and describe different types of atypical wounds, and to give tools for the participant to diagnose and treat an atypical wound. Several clinical cases are presented, and the patho physiology and treatment of i.e. Calciphylaxis and Martorell wounds are also discussed.


Session Room E102

How to Read a Paper. Understanding Basic Statistics

The session objectives are:• To enable the audience to identify key elements of a research

paper• What is the research question and primary outcome?• What are the objectives of the paper?• What are the results?• Have all outcomes been reported?• To critically discuss one research paper and understand:• Population and sample • P values• Relative Risk (RR)• Confidence intervals (CI)• To evaluate the external validity of the paper using a framework

for evaluation

Friday 5 May 08.00-09.30


Diabetic Foot Screening

An interactive workshop about the prevention of diabetic foot complications. Key elements are classification of risk, preventative advice, education and multidisciplinary approach.

62

Friday 5 May 10.15-11.15

Emerald Room

Positioning Patients with Pressure Ulcers

This workshop will focus on the interaction between the positioning of the patient and his wounds. The effect of recumbent or sitting positions and transfers on the healing process will be explained.

By means of a casus we would like to give more insight into various positions and transfer techniques, and examine the effects they may possibly have on already existing wounds.

We shall explain how we attempt not to hinder the healing of wounds. We opt for specific methods and treatments, making certain choices and use specific materials in order to reduce these risks.

Friday 5 May 10.15-11.15


Hand Hygiene

This workshop is held in connection with the WHO Hand Hygiene campaign on 5 May 2017 and in collaboration with the International Council of Nurses.

The workshop will focus on the importance and critical role of hand hygiene in relation to prevention of infections as well as reducing the use of antimicrobials. The programme will include arguments for the implementation of clear hand hygiene procedures, an introduction to concrete strategies for how to implement and manage these procedures, as well as proposals for how you may take on the role as a positive deviant in improving or changing practice in your organisation.

Friday 5 May 10.15-11.15


Care of Burn Patients Who Are Not Hospitalised in a Burn Centre

Burn Centres have an expertise goal; what is the meaning of that in relation to self-management of the patient in primary care (outpa-tient care), patient education, knowledge transfers to other organisa-tions and professions and outcomes in patient care?

Friday 5 May 10.15-11.15

Session Room E105-106

Diabetic Foot – Assessments, Offloading and Footwear

This workshop aims to define and describe a systematic clinical approach to the diabetic foot patient in an outpatient setting, giving both the whys and the hows of the clinical evaluation and of the offloading in the acute and post-acute phase, displaying live most of the techniques, possibly involving the participants.

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

63

FOCUS SESSION DESCRIPTIONS EWMA 2017 introduces a new session type: focus sessions.

The focus sessions are typically held in a small setting similar to workshops. However, focus sessions offer the participants the opportunity to go more in with one specific topic. EWMA 2017 offers 6 focus sessions:


G104-105

Hidradenitis Suppurativa

The session will focus on the Prevalence and comorbidities of hidradenitis suppurativa as well as the treatment and surgical management of hidradenitis suppurativa.


Emerald Room

Allergology

Topic: Allergy: yes or no?

Objectives: In this session the background of type I and type IV will be reviewed. The relevance of mainly type IV in daily life for patients with eczema and wounds will be discussed.

Thursday 4 May 10.00-11.30 Room: E102

How to measure success in wound healing – from a dermatologists perspective?

The objectives of the session are to make the participants acquainted with the definitions of outcome measurements, which outcome measurements the guidelines advise to use, and what measurements do we need in daily practice and for research purposes for treating complex wounds.

64


Room: G106-107

Larval debridement therapy: modern breakthroughs in an ancient solution

• Delegates should understand that the evidence base for LDT is increasing.

• Delegates should have an improved understanding of the microbiology underpinning the 3 reported clinical effects of LDT: debridement, anti-microbial activity, and improved wound healing outcomes.

• Delegates should have an improved understanding of the active substances within LDT secretions which contribute to these 3 clinical effects, with particular focus on the activity of trypsin and chymotrypsin on the wound bed; the broad-spectrum anti-micro-bial activity of LDT, including evidence of prevention and removal of biofilms; and the remodelling action of LDT secretions in vitro, including cell migration and neovascularisation.

• Delegates should understand the level of evidence available for each of the actions of LDT

• Delegates should be able to frame their understanding of the case studies presented within the context of the scientific evidence presented, with a new or increased understanding of the bio-chemical mechanisms that have given each clinical result.


Room: G104-105

Oncological wounds and focus on breast cancer

The session will focus on tattoo after breast reconstruction and breast reconstruction after mastectomy.

Friday 5 May 11.30-12.30

Room: Elicium 1

Venous leg ulcers

The session will focus on Venous leg ulcers, how to recognize and diagnose them.

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

65

GUEST SESSION DESCRIPTIONS Every year EWMA invites different organisations to present a guest session at the EWMA Conference. This serves to increase awareness and also to allow Conference participants to learn more about activities relating to, but not necessarily primarily focused on, wound healing and management. It also serves to increase scientific cooperation and networking with organisations active in thematic issues related to wound healing and management.

A number of EWMA partner organisations will be part of the EWMA 2017 programme, in which the following guest sessions will take place:


Session Room E102

World Alliance for Wound & Lymphoedema Care (WAWLC)

Session objectives:


• Wound Care in Haiti After the 2010 earthquake in Haiti, the temporary wound centre

at the airport in Port-au-Prince was established as a permanent clinic at Bernard Mevs Hospital, with the aid of Project Medishare and the University of Miami and under the mentorship of Dr. John Macdonald. This clinic has evolved into a clinic led and staffed by Haitians.

• Experience with Lymphatic Filariasis (LF) in Leogane, Haiti Lymphatic Filariasis (LF) is the leading cause of disability in the

world, and in the western hemisphere Haiti has been hardest hit. Lymphatic filariasis is considered a national disease in Haiti as it is present in 118 of 140 communes, making 88% of the country at risk. In specific hyperendemic zones, nearly 45% of the popula-tion is infected with LF. Estimates suggest up to 5% of the Haitian population suffers from lymphoedema associated with LF. This session will provide a historical overview of elimination efforts as well as the current morbidity plan to manage LF throughout the country.

• The wound management cycle: An approach to Wound Care Recently Wounds Canada (www.woundscanada.ca) published an

update to the Wound Bed Preparation model. Previous models such as the TIME concept focused primarily on local wound care. The new model focuses on a process with the patient at the centre. This session will walk through the five steps of the model with emphasis on implementation in resource limited settings.

66

• Therapies using local resources Traditionally, the use of local resources in wound care has passed

down through the generations via verbal description and demon-strations. Even in low resource communities where natural remedies are regularly used, it is not unusual that the original principles and anecdotal evidence for their use are unknown. This presentation will provide an overview of the evidence supporting the use of a range of local resources in wound care and discuss the process through which the evidence is collated and accessed by practitioners in low resource communities.

• Follow up after 5 yearly courses on modern adapted wound care in Cameroon

Based on six basic principles and low technological means, this knowledge greatly empowers woundcare givers to deliver en-hanced care to their patients

In collaboration with Yaoundé Faculty of Medicine, we set up in 2013, a basic training course based on 3 to 5 days teaching and 4 days practicing in a selected wound care ward (Akonolinga hospital). 95% of the teacher involved were locals.

To date, 137 interdisciplinary students coming from all over the country, mostly doctors and nurses, but also students, pharmacists and physios have been trained.

Some students also came from NGO’s like Médecins sans Frontiers and other countries: Ivory Coast, Senegal and Togo. In these countries, the replication of this course, with the knowhow from Cameroon is going to take place in the coming years.

Some students spontaneously ?? created woundcare courses and concerns in their hospitals.

Six basic principles used are:1. Evaluate and correct: - The specific cause of the wound - The patient’s general condition2. Maintain a moist wound environment3. Protect wound from any additional trauma - Physical, chemical - Protect peri wound skin4. Promote a clean wound bed without infection5. Control the peri wound Lymphoedema6. Prevent or correct any secondary disability

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

67

About WAWLC:WAWLC is a global partnership between health organisations, non-governmental organisations, health professional associations, academic and research institutions, industry, and individuals interest-ed in advancing wound care and lymphoedema management worldwide.

The WAWLC’s mission is to work in partnership with communities worldwide in settings with limited resources to advance the sustain-able prevention and care of wounds and lymphoedema. WAWLC started as a working group in 2007 and was officially launched as global partnership in 2009.

Find more information about WAWLC on www.wawlc.org


Room: Elicium 1

JA-CHRODIS

Session title: Building on JA-CHRODIS, What Can We Do to Reduce the Burden of Chronic Diseases?

Session objectives: JA-CHRODIS is a European Joint Action that brings together over 70 associated and collaborating partners from national and regional departments of health and research institu-tions, from 25 countries. These partners have worked together to address the burden of chronic diseases and to identify, validate, exchange and disseminate good practices on chronic diseases across Europe.

JA-CHRODIS focused on three key areas: health promotion and primary prevention, multimorbidity, and prevention and care of type 2 diabetes. In the frame of the JA-CHRODIS, diabetes is considered a case study on strengthening healthcare for people with chronic diseases.

About JA-CHRODIS JA-CHRODIS is a European collaboration that brings together over 70 associated and collaborating partners from e.g. national and regional departments of health and research institutions, from 25 European countries. These partners work together to identify, validate, exchange and disseminate good practice on chronic diseases across EU Member States and to facilitate its uptake across local, regional and national borders. The focus is health promotion and primary prevention as well as the management of diabetes and multi-morbid chronic conditions.

Find more information about JA-CHRODIS on www.chrodis.eu

68


Session Room E102

Dystrophic Epidermolysis Bullosa Research Association (DEBRA)

Session objectives: The session will focus on the launch of the new Wounds International best practice guidelines: skin and wound care in EB, psychological impact of wounds in EB from a nursing perspec-tive and on itch in EB.

About DEBRA:DEBRA International is a worldwide network of national groups working on behalf of those affected by the genetic skin blistering condition epidermolysis bullosa (EB). DEBRA’s vision is to ensure that people living with EB have access to the best quality support and medical care, while also driving the development of effective treat-ments and cures.

Find more information about DEBRA on www.debra-international.org


Emerald Room

The European Society for Clinical Nutrition and Metabolism (ESPEN)

Session title: Nutrition and Wound Healing

Session objectives: The session will focus on the benefits of nutri-tional support in wound healing and how to improve food intake in older adults.

About ESPENESPEN is dedicated to all issues relevant to the field of clinical nutrition and metabolism and promotes:• Basic and clinical research• Basic and advanced education• The organisation of consensus statements about clinical care and

care quality control • The aims of ESPEN are to encourage the rapid diffusion of

knowledge and its application in the field of Parenteral and Enteral Nutrition or, more broadly, Clinical Nutrition and Meta-bolism.

Find more information about ESPEN on www.espen.org

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

69


Room: Elicium 1

Association of Diabetic Foot Surgeons (A-DFS)

Session objectives: The session will focus on:• The increasing role of surgery in the multidisciplinary manage-

ment of diabetic foot• Surgical debridement of chronic wounds: why, when and how?• Diabetic heel ulcers with calcaneal osteomyelitis: new treatment

options with local antibiotic carriers• Local and regional flaps for soft tissue coverage of diabetic foot

wounds• The foot with wound and deformity: what to treat first?

About A-DFS: The Association of Diabetic Foot Surgeons (A-DFS) is an inter-national not-for-profit organisation open for all foot surgeons with an interest in the diabetic foot: orthopaedic surgeons, podiatry surgeons, vascular surgeons etc.

A-DFS aim to support cooperation between foot surgeons interested in, and working with, the diabetic foot and work to enhance best practice in research, education and clinical interventions.

A-DFS organise meetings and conferences and support the develop-ment of approaches, techniques and medical devices which will facilitate better surgical treatment on the diabetic foot.

Find more information about A-DFS on: www.a-dfs.org

70


Emerald Room

International Lymphoedema Framework (ILF)

About ILF:The success of the UK Lymphoedema Framework in improving the management of this condition in Great Britain has led many inter-national lymphoedema experts to express an interest in the method-ology and spirit of the Framework. This is why Christine Moffatt and her team decided to set up the International Lymphoedema Frame-work (ILF) as a charity. The choice of charitable status is a strong message to the lymphoedema community on the ethos and vision that govern the Framework. It is also a guarantee of the independ-ence of the ILF in the ethical use of its resources and its capacity to actively contribute to the improvement of the management of lymphoedema worldwide, and especially in developing countries.

We believe that:• Patients should always be at the heart of Framework Projects.• Only a collaborative and multidisciplinary partnership between all

stakeholders, recognised as experts, can lead to an improvement in the management of lymphoedema.

• Improving the management of lymphoedema is a dynamic process requiring ongoing research and implementation into practice.

• International collaboration is essential.

What motivates us: “Thanks for your assistance and all the work you have done and are doing to move Lymphoedema forward. As a mom with a young child with lymphedema, you have no idea how much your efforts mean to me.” K.A., Canada

Find more information about ILF on www.lympho.org

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

71


Session Room E102

The European Council of Enterostomal Therapy (ECET)

Session title: Good Clinical Practise in Stomatherapy

Session objectives: Stomatherapy is a wide field of nursing practise.This session picks up three cases with high importance for nurses in the daily work with ostomates.1. Pre-operative stoma-siting is the beginning of the adaption for

ostomates to their life with a stoma. This session gives a summary of the evidence-based recommendations in stoma-siting.

2. The identification and competent management of stoma compli-cations is a question of high impact for ostomates. Nurses should be focused on this to assist patients in the best way.

This session offers an overview of the common complications for ostomates, the special identification and the individual treatment.

3. Accurate documentation is necessary for nurses in all working fields. This session provides the best recommendations to produce high quality photos in stomatherapy.

About ECETThe association is a non-profit organisation with these aims:The development of a professional identity on a European level for all nurse and healthcare professionals concerned with, or active in the area of, stomatherapy, incontinence and/or treatment of wounds.

The main aims are the following:• To establish European recognition for nurses specialised in the

area of stoma care, incontinence care and/or treatment of wounds;

• To bring together health care professionals involved in the care of stoma, incontinence and wound- patients; the association shall ensure the protection and defence of professional interests of its members;

• To promote research and to ensure that knowledge remains up to date;

• To encourage contacts and collaboration with the industry, distributors or official healthcare insurance organisations with the aim of improving the quality of care and the various devices;

• To organise conferences, seminars, and short training courses;• To break down national barriers and to promote European

identity;• To promote the exchange of information between various

European countries by establishing efficient communication systems;

• To develop teaching standards which are generally acceptable;• To promote stoma care according to quality and ethical

standards.

Find more information about ECET on www.ecet-stomacare.eu

72

Friday 5 May 08.00-09.30

Emerald Room

European Pressure Ulcer Advisory Panel (EPUAP)

Session title: The Joint EPUAP-EWMA PU Prevention & Patient Safety Advocacy Project

The topic of patient safety has for some years been high on the European Commission healthcare agenda. At the EU level, as well as at the national levels of most European nations, considerable investments have been made by healthcare authorities to establish organisations and programmes addressing the patient safety agenda. Looking at the patient safety agenda from a wound care perspective, the topic of pressure ulcer (PU) prevention has always been central due to the fact that most PUs are preventable if the patient is managed correctly by healthcare staff. Consequently, both EPUAP and EWMA have separately, over some years, been advocating for the prevention of PUs as a major healthcare and patient safety issue. This project brings together the combined efforts, skills and know-ledge of both EWMA and EPUAP to work together in partnership in a combined effort to raise the awareness of pressure ulcers and patient safety in general, at the European level, as well as at the national level in selected European countries.

Objective of the session: The objective of this session is to provide the participants with a clear understanding of the joint EPUAP- EWMA PU Prevention & Patient Safety Advocacy Project, in addition to inviting participant debate and discussion around the proposed actions.

About EPUAP:The European Pressure Ulcer Advisory Panel was created in London in December 1996 to lead and support all European countries in efforts to prevent and treat pressure ulcers. At its inaugural meeting in London in December 1996, which included experts from many European countries, the group of over 20 delegates agreed on their mission statement and the initial Executive Board and Trustees. The mission statement reads: “To provide the relief of persons suffering from or at risk of pressure ulcers, in particular through research and the education of the public and by influencing pressure ulcer policy in all European countries towards an adequate patient centred and cost effective pressure ulcer care”.

Find more information about EPUAP on www. www.epuap.org

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

73

Friday 5 May 08.00-09.30


European Burns Association (EBA)

Session objectives:The session will focus on:• Importance of psychosocial support in burn care• Possibilities of the use of NPWT in the treatment of burns• Challenges in burn wound care• Organisation of centre to centre and cross-border burn-care in the

Netherlands. Lessons learned from previous mass casualties

About EBA:The European Burns Association was founded in 1981 by leading burn specialists in Europe, in order to encourage co-operation in the field of burn care throughout the continent.

The EBA serves as a forum through which medical specialists, researchers, professions allied to medicine (PAM), and other workers come together to discuss aspects of burn treatment and research. In this way, expertise and knowledge are spread throughout the countries of Europe.

The EBA has been established as a non-profit making organisation for the benefit of the public, to promote burn prevention, to study the prevention of burn injury and all other aspects of burn treatment, and, in particular:• To disseminate knowledge of and to stimulate prevention in the

field of burn injury• To encourage and co-ordinate research into the scientific, clinical,

and social aspects of burn injury• To promote education in all aspects of burns, including first aid,

nursing, and rehabilitation• To co-operate in international disaster planning• To facilitate the exchange of personnel• To co-ordinate and to publicise congresses relating to burn care

throughout Europe

Find more information about EBA on www.euroburn.org

74

Friday 5 May 08.00-09.30


Wounds Australia

The Wounds Australia session will focus on:

– Chronic disease risk factors and chronic wounds: A universal challenge Chronic wounds are closely associated with the most commonly experienced chronic diseases such as cardiovascular disease, diabetes and obesity. Chronic disease can directly cause wounds, compromise healing, and can require treatments that negatively affect the skin. The major risk factors for chronic disease are smoking, physical inactivity, poor nutrition and harmful alcohol use, and these risk factors are universal. This presentation will review local and international research that has addressed the management of these chronic disease risk factors among the chronically wounded and discuss implications for practice and research.

– Projects under Pressure The Department of Diving and Hyperbaric Medicine at The Royal Hobart Hospital in Tasmania, Australia conducts clinical research and patient cantered care.

This presentation will explore some of the current work being undertaken by the multidisciplinary team and focus on the evolving dynamic of caring for patients under pressure.

– Risk factors for wound dehiscence following surgery: a review of the evidence and the clinical challenge Surgical wound dehiscence (SWD) impacts on patient wellbeing, increases the length of hospital stay and health-care costs, particularly in the community nursing setting. Globally, the health-care costs associated with SWD are poorly reported and those reported are frequently associated with surgical site infection (SSI), rather than dehiscence of non-microbial causes. This presentation will review the contemporary evidence for the identifi-cation of risk factors for wound dehiscence and discuss the impact on clinical management of patients in the post-acute care setting.

About Wounds Australia: The objectives of Wounds Australia are to promote increased awareness, knowledge and the application of effective wound management by:• Establishing a network of people with knowledge and expertise in

wound management• Providing current information and resources for health profes-

sionals and the broader community• Developing educational guidelines for health professionals and

the broader community

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

75

• Facilitating and encouraging research that will enhance the quality of wound management strategies

• Being recognised as an authoritative body that consults with, makes representation to and advises government, governing bodies, educators, and health care providers in regard to wound care management strategies based on expert current validated research

• Liaising and co-operating with other national/international associations or groups whose objectives seek to enhance the quality of wound management

• Encourage reciprocal representation with these aforementioned associations/groups

• Publishing a national Journal of Wound Management and any other periodicals, books or educational material

Learn more about Wounds Australia on www.awma.com.au

Friday 5 May 08.00-18.00

Session Room E102

International Compression Club (ICC)

Session title: Oedema and Compression

Session objectives: To present evidence for oedema reduction by different compression modalities including bandages, compression stockings, intermittent pneumatic compression and manual lymph drainage, and to understand the mechanisms of action behind these procedures, including practical implications.

About ICCAlthough the ICC does not have any regulatory power, proposals elaborated by joint working groups of experts from the medical field and the industry will hopefully be able to provide a valuable basis for further improvements of internationally accepted regulations and guidelines. Working groups consisting of medical experts and representatives of the industry are invited to cooperate in the following activities:• Organise meetings, in which several problems of common interest

to both groups can be discussed• Develop and deliver consensus reports and recommendations• Organise teaching courses on CT• Guidance on experimental and clinical trials• Plan and coordinate effective communication and education• Give recommendations for indications and classification of

compression products

Find more information about ICC on www.tagungsmanagement.org

76

Friday 5 May 10.15-11.15


V&VN Wound Expertise

Session title: Who is the Case Manager in Complex Wound Management?

Session objectives: The session will focus on: • Roles of the case manager (Dutch standard)• Limitations of nurse leadership• First and second line differences • How is the management of complex wounds organised in different

countries in Europe? • What are the strengths and weaknesses of nurses being in the

lead?

About V&VN Wound ExpertiseV&VN Wound Expertise’s main goal is to achieve a higher quality of wound care in Dutch hospitals and other health institutions. The exchange of knowledge and to disseminating proper information is of great importance.

Find more information about V&VN Wound Expertise on www.venvn.nl

Friday 5 May 11.30-12.30


Wound Platform Netherlands

Session title: Concept Quality Standard Complex Wound Care in the Netherlands

Session objectives: Information and discussion about quality standard complex wound care. Aimed at Dutch participants in order to discuss the concept version, but the session will also be of interest to other countries to explain how we developed the standard.

About Wound Platform NetherlandsWound Platform Netherlands connects professionals in wound care with the goal to promote the quality of wound care in favour of patients. It tries to achieve this by gathering and sharing knowledge and practice.

Find more information about Wondplatform Nederland on www.wondplatform.nl

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

77

Friday 5 May 14.00-15.30

Room: Elicium 1

European Society for Vascular Surgery (ESVS)

The ESVS strives to relieve sickness and to preserve and protect health by advancing, for the public benefit, the science art and research into vascular disease, including vascular surgery.

Vision & Mission:Our mission is to become a leader in promoting optimal care for patients with vascular disease by:• Supporting high quality research• Providing educational opportunities• Organising meetings, seminars, lectures and conferences• Commissioning and publishing guidelines• Sponsoring the European Journal of Vascular and Endovascular

Surgery• Promoting dialogue with National Societies and others involved in

the treatment of vascular disease• Advising Regulatory Authorities on matters relating to vascular

disease

Find more information about ESVS on www.www.esvs.org

Friday 5 May 14.00-15.30

Emerald Room

European Tissue Repair Society (ETRS)

Session title: Advanced Therapies in Wound Healing

Session objectives: Despite an increasing number of sophisticated wound dressings, impaired wound healing remains a clinical problem with increasing impact on health care systems. Progress in patient outcomes is limited by the extreme complexity of the underlying pathophysiology indicating the necessity for the development of tailor made advanced therapeutic approaches, often based on biological material. In this session we will highlight the need for this kind of treatment and evaluate several of these advanced therapies for treatment of wounds of different aetiologies.

About ETRS:The European Tissue Repair Society, a non-profit organisation founded in 1988, aims to promote knowledge and interchange between scientists, healthcare professionals, industry and other individuals that have an interest in tissue repair of all organs. The Society has an annual meeting and a number of focus meetings each year concentrating on different aspects of tissue repair, ranging from basic science to the clinical aspects of healing.

Find more information about ETRS on www.etrs.org

78

36th annual meeting of the European Bone and Joint Infection Society

Save the date7 - 9 September 2017

Nantes · France · La Cité Nantes Events Center

Important deadlinesAbstract Submission8 May 2017

Early Registration1 July 2017

www.ebjis2017.org

All sessions will have simultaneous translation to French

Visit EWMA on our

Social Media Platforms

Follow us and get the latest updates about the EWMA 2017 Conference

as well as other EWMA activities:

www.facebook.com/EWMA.Wound

www.linkedin.com/company/ european-wound-management-association

Twitter: @ewmatweet

Instagram: @ewmapics

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

79

Friday 5 May 14.00-15.30


European Society of Plastic, Reconstructive and Aesthetic Surgery (ESPRAS)

The National Societies of plastic surgery, from all over the world, are affiliated to the umbrella organisation, International Confederation for Plastic, Reconstructive and Aesthetic Surgery, IPRAS. The aim of this organisation is to promote plastic surgery both scientifically and clinically, to further education, and to encourage friendship between physicians all over the world

Find more information about ESPRAS on www.espras.org

Karel BakkerEWMA Honorary speaker 2017

In 2017, Karel Bakker is awarded EWMA honorary speaker for his lifelong commitment to the development of diabetic foot care and wound care in Europe and globally.

By some he is called the ‘Godfather of the Diabetic Foot’. He is a tireless lecturer on the subject, which has taken him to all continents of the world to create more awareness of the problem of the ‘Diabetic Foot.

Karel Bakker has written dozens of articles and chapters on diabetic foot care, global guideline development on how to improve education, and on the implementation of guidelines processes.

Due to his involvement in the International Working Group of the Diabetic Foot (IWGDF), he is an active promoter of improving diabetic foot care in developing countries.

Karel Bakker has received a number of awards and recognitions from universities and medical societies for his contributions to the management of diabetic foot problems and in 2002 he was knighted in the Order of the Dutch Lion by the Queen of the Netherlands for his national and international achievements in foot care.

Karel Bakker is a specialist in internal medicine, diabetology and endocrinology. He had his medical training in the USA (Madison, Wisconsin), the Dutch Antilles (Curaςao) and the State University Groningen in The Netherlands, where he also received his PhD in endocrinology.

In 1977 he was assigned as specialist in Internal Medicine, Diabetology and Endocrinology at the Spaarne Hospital, Heemstede, The Netherlands. In 1987 he founded the first specialised Diabetic Foot Clinic in the Netherlands in his hospital in Heemstede.

Karel Bakker chaired the Dutch Diabetes Education Study Group for more than 10 years until he retired from his practice in 2002.

80

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

In 1999, the IWGDF launched the International Consensus and Practical Guidelines on the management and prevention of the diabetic foot, with supplements in 2003 and 2007. The consensus document has since been translated into 26 languages. The most recent guideline was published in 2015: IWGDF Guidance on the management and prevention of foot problems in diabetes 2015

In his many years of working with the diabetic foot, Karel Bakker has served as chairman of the very successful International Symposiums on the Diabetic Foot (ISDF) in Noordwijkerhout, The Netherlands. He has been the the chairman of the Dutch Consensus Group on the Diabetic Foot. He is the immediate past-chairman of the IDF Consultative Section on the Diabetic Foot and the International Working Group on the Diabetic Foot (IWGDF). He chaired and was responsible for the World Diabetes Day (WDD) 2005 on Diabetic Foot Care and the global ‘Year of the Diabetic Foot’ campaign.

This is the sixth time an honorary speaker has been appointed by EWMA.

Friday 5 May 11.30-12.30 Room: Forum

( )

81

82


Room: Forum

( )

Change, Opportunities and Challenges – the vision of IWGDF for global diabetic foot care, management and prevention

Session objectives: The International Working Group on the Diabetic Foot existing of two major bodies, the guidelines develop-ment and the implementation & education unit like to share especially on their implementation tasks their global new vision and cooperation with other international partners, reflecting the needs from the 7 cooperative regions. Europe can learn a lot from the other regions, knowing that 80 % of the diabetes patients are living in the low and middle income regions.

Session speakers and topics:• Introduction by chair Kristien Van Acker (Belgium)• When off loading is a high priority in diabetic foot wound

management, but you don’t have the access? A cooperation IWGDF & WHO ties to give global solutions for

the coming years for all power regions worldwide. By Niel Baker (UK, Kuwait)• Diabetic Foot Care in India over the last 15 years: changes,

opportunities and challenges for the Indian DF study group (DFSI) By Milind Ruke, on behalf of DFSI, India• The impact of an IWGDF- Train the Foot Trainer program in the

Western Pacific Region. Reflections from the hosting Country, Thailand. By Gulapar Srisawasdi (Thailand)• Panel discussion

About IWGDF: The International Working Group on the Diabetic Foot (IWGDF) was founded in 1996. In 1999 the IWGDF published for the first time the International Consensus on the Diabetic Foot and Practical Guidelines on the Management and the Prevention of the Diabetic Foot. In order to implement the International Consen-sus, the IWGDF recruited local champions as members of the IWDGF and nowadays these members represent over 140 countries around the world.The IWGDF is instrumental in acting as a consultant for implementation programmes as “the Step by Step, improving diabetic foot care in developing and low income countries”, the “Train-the-Foot-Trainer, how to set up Step by Step programme” (TtFT) programs, “the Diabetic foot care education programme for assistants” (DFCAss) and Post-graduate courses. Today we have two co- chairs: dr Kristien Van Acker (implementation) & dr Nicolaas Shaper (guidance document).

DIABETIC FOOT STREAM

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

83


Room: Forum

( )

Diabetic Foot key session


Diabetic foot ulceration (DFU) is known as one of the most severe complications of diabetes. Revascularisation plays a crucial role in achieving ulcer healing. Non-surgical, minimally invasive, revasculari-sation options for DFU have expanded over the last decade and have become a prominent tool to prevent amputation.

What is the role of endovascular treatment of the DFU nowadays? When should we consider this option, what are the opportunities? Should we look at the location of the ulcer? What is the evidence of the intervention on angiosome-base?

Systemic hyperbaric oxygen therapy (HBOT) has been proposed as a medical treatment for diabetic foot ulcers. The value of HBOT in the treatment of diabetic ulcers is still under debate. Available evidence suggests that HBOT may improve the healing of diabetic ulcers, but it comes from small trials with heterogeneous populations and interventions. As an example, the HODFU study (2010) showed that adjunctive treatment with HBOT facilitates healing of chronic foot ulcers in selected patients with diabetes. The DAMOCLES trial is performed in the Netherlands and it is unique for addressing patients with ischaemic diabetic foot ulcers who may also receive vascular reconstructions. What are the results? How should we use the outcomes? What should be/is the role of HBOT in treating DFU?

A series of multiple mechanisms can contribute to lack of healing in people with DFUs. The association of diabetes with impaired wound healing and other vascular complications is a serious public health issue. For example, Matrix Metalloproteinases (MMPs) play an integral role in wound healing. Their main function is degradation, by removal of damaged extracellular matrix (ECM) during the inflammatory phase, breakdown of the capillary basement mem-brane for angiogenesis and cell migration during the proliferation phase, and contraction and remodeling of tissue in the remodeling phase. For effective healing to occur, all wounds require a certain amount of these enzymes, which on the contrary could be very damaging at high concentrations causing excessive degradation and impaired wound healing. The imbalance in MMPs may increase the chronicity of a wound, a familiar problem seen in diabetic patients. What should we know about the molecular changes leading to stagnation? What are the possible treatment options?

84


Room: Elicium 1

EWMA-FIP-IFP symposium

Care of the diabetic foot by podiatrists: a comparative study on a global scale• Vince Hetheringthon: Experiences from American podiatrists in

the care of the diabetic foot• Christian Jérôme: Experiences from French podiatrists in the care

of the diabetic foot• Ekaterina Kalykakis: Experiences from Greek and Australian

podiatrists in the care of the diabetic foot• Brad Sonnema: Experiences from Canadian podiatrists in the care

of the diabetic foot• Q&A managed by Vince Hetheringthon


Room: Elicium 1

The collaboration between the FIP-IFP and the IWGDF

The session offers a world premier presentation of standardized high level competence packages for dedicated practitioners in the area of diabetic foot care : by Dr. Matthew G. Garoufalis, president of the International Federation of Podiatrists and Dr. Kristien Van Acker chair of the International Working Group of the Diabetic Foot, followed by a panel discussion with members of the Diabetic Foot Commission.


Room: Elicium 1

Podiatry practice on wound management

The session will cover:Teamwork in Healing Diabetic Wounds (Pauline Wilson)Techniques in Wound Debridement (Debbie Wilson)Surgical treat and Salvage of the Diabetic Foot (Lee Murphy)

About The International Federation of Podiatrists – Fédération Internationale des Podologues (FIP-IFP)

The International Federation of Podiatrists – Fédération Inter-nationale des Podologues (FIP-IFP) is an international not-for-profit association focused on global leadership and the development of podiatric medicine around the world. Working together collabora-tively with leaders of the podiatry profession, the federation enhances the podiatric profession through the sharing of knowledge, practice and research among member countries.

Its mission statement is to advance podiatry worldwide through education, advocacy, and strategic alliances for the benefit of those with foot and ankle ailments. www.fip-ifp.org

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

85


Room: Elicium 1


Session objectives: The session will focus on:• The increasing role of surgery in the multidisciplinary manage-

ment of diabetic foot• Surgical debridement of chronic wounds: why, when and how?• Diabetic heel ulcers with calcaneal osteomyelitis: new treatment

options with local antibiotic carriers• Local and regional flaps for soft tissue coverage of diabetic foot

wounds• The foot with wound and deformity: what to treat first?

About A-DFS: The Association of Diabetic Foot Surgeons (A-DFS) is an inter-national not-for-profit organisation open for all foot surgeons with an interest in the diabetic foot: orthopaedic surgeons, podiatry surgeons, vascular surgeons etc.

A-DFS aim to support cooperation between foot surgeons interested in, and working with, the diabetic foot and work to enhance best practice in research, education and clinical interventions.

A-DFS organise meetings and conferences and support the develop-ment of approaches, techniques and medical devices which will facilitate better surgical treatment on the diabetic foot.

Find more information about A-DFS on: www.a-dfs.org

86

This EWMA/BSAC symposium presents a new paper, which is currently in review, written by Rose Cooper and David Leaper. The paper addresses the need for and possible use of non-antibiotic antimicrobials in wound management and is part on the ongoing Anti-microbial Stewardship Programme on which EWMA has a close collaboration with BSAC (British Society for Antimicrobial Chemotherapy).

The second part of the symposium focusses on how to implement antimicrobial stewardship programmes. It presents experiences from two European frontrunners in combatting antibiotic resistance: The Netherlands and the United Kingdom.

Time Title Speaker

10.15 Chair introduction Rose Cooper

10.20 Non-antibiotic antimicrobial interventions in wound care; agents, resistance and beyond!

Rose Cooper

10.50 Non-antibiotic alternatives in clinical practice Jan Stryja

11.10 Discussion

Break 11.15

11.30-11.35 Chair introduction: What can we learn from national approaches to AMS

Philip Howard

11.35-12.00 Euregional AMS strategy: An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID)

Jan-Willem Dik

12.00-12.25 UK strategy for combatting resistance Philip Howard

12.25-12.30 Discussion

Friday 5 May 10.15-11.15 and 11.30-12.30 Room: Elicium 2

( )

ANTIMICROBIAL STEWARDSHIP IN WOUND MANAGEMENT – A JOINT SYMPOSIUM OF EWMA AND BSAC

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

87

INTERNATIONAL PARTNER ORGANISATION SESSION 2017: KOREAN WOUND MANAGEMENT SOCIETY (KWMS)

About the Korean Wound Management Society: The Korean Wound Management Society was established in 2002 with its inaugural meeting, with a vision of integrating all realms of woundcare to become a leader in wound management. It has grown to become the large society it is now, with about 700 diverse members. Medical personnel come from diverse backgrounds; nurses working in acute care hospitals, home care nurses, intensive care unit nurses, wound care nurses, orthopedic surgeons, burn specialists, physicians working in rehabilitation medicine, dermatologists, and emergency department doctors. It conducts annual seminars, holds the Korean Wound Academy, annual pressure sore forums, dressing forums and wound education forums. The Society actively publishes its conference proceedings, and also publishes the Journal of Korean Wound Management Society, a bi-monthly issue that addresses relevant topics. The Society has an outreach programme, and makes charity visits to those in need of wound care.

Learn more about KWMS on www.woundcare.or.kr/eng

About the International Partner Organisation session:The session will focus on the following topics:• Non-surgical methods of managing diabetic foot ulcer• Surgical debridement of ulcers• Microsurgical and covering operations to prevent amputations• Quality of life of diabetic ulcer patients regarding healthcare

The clinical significance of diabetes is increasing with a growing aged population and changes in lifestyle. Among all complications of diabetes mellitus, diabetic ulcers are the most severe and expensive. The lifetime incidence of diabetic foot ulceration is as high as 25%. Ulcers frequently become infected and are associated with the risk of limb amputation and increased mortality and healthcare costs. A specialised multidisciplinary team approach is needed to care for patients with ulceration. In complex wounds, surgical treatment is inevitable. Surgery may involve the decision to preserve the limb from amputation. Reconstruction surgery, including flap surgery, involves preserving the limb with secure coverage. This session reviews the surgical management involved in the limb salvaging process and discusses the quality of life of patients who have diabetic foot ulcer.

Thursday 4 May 10.00-11.00 Emerald Room

88

Wednesday 3 May Thursday 4 May

Friday 5 May12.00-12.30 Conference

exhibition 3C13

EWMA Education lounge in the conference exhibition

This year, a “EWMA Education” lounge with focus on education in wound management has been placed in the conference exhibition.

You will find information about – and get a copy of – EWMA materials available for educational purposes, as well as materials aiming to support the planning of wound management education on various levels. You will also find information about the wound management courses endorsed by EWMA.

Finally, you will be able to meet with members of the EWMA Education Committee on all conference days between 12.00-12.30

We look forward to meeting you there!

Wednesday 3 May 11.45-13.15 Room E103

Teacher Network Meeting

During the EWMA 2017 Conference the members of the EWMA Teacher Network will meet for the 6th time. The network offers an opportunity for teachers of wound management at educational institutions all over Europe to get together and share views, experi-ences, and ideas with peers from different teaching cultures and backgrounds.

The topics on the agenda of the meeting in Amsterdam are

• a survey initiated by the network, “Preregistration Nursing Curriculum in Europe – Upgrading Skin Health and Wound Management”,

• the new EWMA “Wound Curriculum for Nurses – Post-registration qualification Wound Management” (Level 5 and 6 EQF).

If you wish to join the network or the meeting, please contact the EWMA Secretariat: [email protected]

EWMA EDUCATION ACTIVITIES Education has been one of the main focus areas of EWMA since the association was established 25 years ago. Improving education in wound management and wound care is an important element in the realisation of EWMA’s objectives to improve and develop wound management in Europe. The education activities are coordinated by the EWMA Education Committee.

At the EWMA 2017 Conference, the following education related activities will take place:

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

89


Room G106-107

Introduction to wound management for pre-registration nurses

EWMA has invited all Dutch pre-registration nurse students to join the first day of the EWMA 2017 Conference in Amsterdam for an introduction to the field of wound management. The session will include an introduction to the basic principles of assessment and wound management as well as more focused presentations on pressure ulcers and diabetic foot ulcers. The students will also hear about the career opportunities within this field of practice.


Room E105-106


This year’s EWMA Education Session will focus on quality in wound management education and will introduce different quality para-meters as well as current initiatives aiming to ensure a common content and level of knowledge among healthcare professionals across Europe.

SpeakersEdda Johansen: Quality in continuous professional wound education

– what, how and why? Ron Legerstee: Teaching excellence in the Netherlands - how to

bring science into education Andrea Pokorná: Wound curriculum for nurses – post-registration

qualification wound management Christian Münter: Fundamentals in wound healing for physicians

Friday 5 May 8.00-9.30

Room E105-106

EWMA UCM Session: “Therapeutic Patient Education in Wound Care: from theory to practice”

This lecture is open to everyone, but is part of the EWMA University Conference Model (UCM) programme and specifically directed toward university students. This year’s theme is “Therapeutic Patient Education in Wound Care: from theory to practice”, which addresses the challenges of and approaches to patient interaction and education from theoretical and practical perspectives. Due to the educational objective, this session will be characterised by a certain amount of interaction.

The session will be chaired by Madeleine Flanagan and Tiny Coremans.

SpeakersJulie Jordan O’Brien and Véronique Urbaniak

90

EWMA UNIVERSITY CONFERENCE MODEL (UCM)

- in AmsterdamThe EWMA Conference offers a unique setting for learning. To benefit from this, an international group of wound care specialists, studying post-graduate qualifications in wound management, participate in the conference as part of their curriculum. The EWMA UCM programme in Amsterdam offers lectures as well as assignments and workshops arranged specifically for the EWMA UCM participants. Additionally, the participants are offered excellent networking opportunities with current and future wound specialists.

UCM Activities during EWMA 2017

Wednesday 3 May 2017

08.30-09.15 Hello and welcome: Official EWMA UCM Initial gathering• Briefing by the EWMA Education Committee Chair,

Luc Gryson, and official welcome by EWMA President Elect Sue Bale

• Introduction to International Practice Development pt. 1

MEETING ROOM E104

13.45-15.15 Peer-review workshop: “Making sense of the literature” MEETING ROOM E104

17.00-18.00 Social gathering (Drinks & snacks) MEETING ROOM E104

Thursday 4 May 2017

09.45-10.45 Symposia Review MEETING ROOM E104

13.00-14.00 International Practice Development pt. 2 MEETING ROOM E104

Friday 5 May 2017

08.00-09.30 Session: Therapeutic Patient Education in Wound care: from theory to practiceSpeakers: Julie Jordan O’Brien and Véronique Urbaniak


09.30-10.00 Student feedback session SESSION ROOM E105-106

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

91

Bring your students to a whole new level

EWMA strongly encourages teaching institutions and students from all countries to benefit from the possibilities of international networking and access to lectures by many of the most experienced wound management experts in the world.

Visit us in the EWMA Education Lounge, in the EWMA Office at the conference or write us an e-mail at [email protected] if you would like to know more about how you can be a part of the EWMA UCM.

Participation in the EWMA UCM is available to all teaching institutions with wound management courses for health professionals. The initiative has proven to be an immensely successful way for universities to utilise the EWMA conference programme as a supplement to their curriculum.

Participating universities

HESSO Switzerland

Escola Superior de Enfermagem Portugal

Universidade Católica Portuguesa Porto, Portugal

CNPV VZWBelgium

University of applied science Lithuania

Donau UniversitätAustria

University of Hertfordshire United Kingdom

92

Wednesday 3 May Session Chair

11.45-13.45

Screen 1: 12.45-13.45 Diabetic Foot Barbara den BoogertScreen 2: 11.45-13.30 Antimicrobials and Infection Annette HøghScreen 3: 11.45-13.30 Dressings 1 Jan RiceScreen 4: 11.45-13.30 Negative Pressure Wound Therapy Lenka Veverková

15.00-15.30

Screen 1: 15.00-15.30 Pressure Ulcer 1 Tania SantosScreen 2: 15.00-15.30 Leg Ulcer 1 Esther Armans MorenoScreen 3: 15.00-15.30 Burns 1 Anna-Barbara Schlüer

Thursday 4 May Session Chair

9.30-10.00

Screen 1: 9.30-10.00 Wound Assessment 1 Tania SantosScreen 3: 9.30-10.00 Home Care, Pain and Quality of Life Annette Høegh

12.30-14.15

Screen 1: 13.30-14.15 Health Economics and Outcome Jasmina BegicScreen 2: 12.30-14.15 Devices and Intervention Stella AmeszScreen 3: 12.30-14.15 Basic Science Corinne WardScreen 4: 12.30-14.15 Dressings 2 Maarit Ahtiala

15.30-16.00

Screen 1: 15.30-16.00 Burns 2 Wouter BreckelmansScreen 2: 15.30-16.00 Wound Assessment 2 Pedro L. Pancorbo-HidalgoScreen 3: 15.30-16.00 Leg Ulcer 2 Sonja Koller

Friday 5 May Session Chair

9.30-10.15

Screen 1: 9.30-10.15 Acute Wounds Lea PulliainenScreen 2: 9.30-10.15 Prevention Jasmina BegicScreen 3: 9.30-10.15 Pressure Ulcer 2 Tania SantosScreen 4: 9.30-10.15 Education Corinne Ward

EWMA 2017 E-POSTER SESSIONSThe e-Poster sessions take place in the e-Poster area in the exhibition area.

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

93

E-POSTER PRESENTATIONS OVERVIEWUnderlined = Presenting author

SCREEN 1 – WEDNESDAY 3 MAY

12.45-13.45 DIABETIC FOOT

EP001 EXPERIENCE WITH THE MARINE OMEGA-3 WOUND MATRIX IN THE TREATMENT OF COMPLICATED WOUNDS AFTER AMPUTATIONS IN THE LOWER LIMB IN DIABETIC PATIENTSBernhard Dorweiler, Trinh Tong, Dünschede Friedrich, Vahl Christian-Friedrich

EP002 SEVERE ARTHEROSCLEROTIC AND OBSTRUCTIVE DIABETIC FOOT RECONSTRUCTION USING THORACODORSAL ARTERY PERFORATOR FLAP WITH LONG VASCULAR PEDICLEYoun Hwan Kim, Sang Wha Kim

EP004 THE TIME TO HEALING FOR FOREFOOT, MIDFOOT, AND REARFOOT ULCERS TREATED WITH TOTAL CONTACT CASTSJeffrey Lehrman, Luke Vetti

EP005 COMPARISON BETWEEN MR AND SPECIMEN IN DIAGNOSTIC PATH OF OSTEOMYELITIS IN DIABETIC PATIENTSSepideh Torabi Parizi, Claudio Morisi

EP006 EVALUATE THE EFFECTIVENESS OF A NEW WOUND DRESSING TECHNOLOGY IN COMBINATION WITH NEGATIVE PRESSURE IN THE MANAGEMENT OF HARD-TO-HEAL DIABETIC FOOT ULCERSIsabel Negre, Josep Royo Serrando, Anna Cabases

EP007 A TRIAL OF ADVANCED WOUND CARE DRESSING VERSUS TOPICAL ANTIBIOTIC COMBINATION ON DIABETIC FOOT ULCERSYong Cheng Xu, Yemin Cao

EP008 VEGF-A MRNA IMPROVES WOUND CLOSURE AND INCREASE OXYGENATION IN A MOUSE MODEL OF DELAYED DIABETIC WOUND HEALINGKenny Hansson, Shayn M Peirce, Cassandra Fraser, Anthony C. Bruce, Scott A. Seaman, Kenneth R. Chien, Regina Fritsche-Danielson

EP009 TREATMENT OF DIABETIC HEEL ULCERATIONS WITH THE HELP OF POLYMERIC MEMBRANE DRESSINGSCharalambos Agathangelou

EP010 CHALLENGES IN TREATING DIABETIC FOOT ULCERS ON PATIENTS WITH MENTAL HEALTH ISSUESCharalambos Agathangelou

EP011 EARLY RESULTS FROM A TECHNOLOGY ENABLED INTEGRATED DIABETIC FOOT CARE SERVICEFrances Game, Doreen Bunting, Achala Patel, Chris Hart

EP012 NEGATIVE PRESSURE THERAPY IN TREATMENT OF PATIENTS WITH DIABETIC FOOT ULCERMarek Kucharzewski, Katarzyna Wilemska Kucharzewska

EP013 INFLUENCE OF SILVER FOAM DRESSING ON BACTERIA, FLORA ISOLATED IN PATIENT WITH DIABETIC FOOT ULCERMarek Kucharzewski, Katarzyna Wilemska- Kucharzewska, Maciej Sopata, Elżbieta Tomaszewska

EP014 THREE-YEAR MORTALITY AND AMPUTATION RATES IN DIABETIC PATIENTS WITH CRITICAL LIMB ISCHEMIA TREATED BY AUTOLOGOUS CELL THERAPYAndrea Nemcova, Alexandra Jirkovská, Robert Bem, Vladimíra Fejfarová, Veronika Woskova, Anna Pysna, Michal Dubský

EP015 RESULTS OF INTRALESIONAL RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR THERAPY IN 21 PATIENTS WITH DIABETIC FOOT ULCERSÖmer Arda Çetinkaya, Serhat Ozdogan, Hakan Uncu

94

EP016 DIABETIC LIMB SALVAGE: CHALLENGES OF TREATMENT IN THE BRAZILIAN HEALTH CARE SYSTEMDebora Sanches Pinto, David Souza Gomez, Araldo Ayres Monteiro, Rolf Gemperli

EP017 MULTIDISCIPLINARY CARE FOR AUTOAMPUTATION IN PATIENTS WITH NONINFECTIOUS CRITICAL LIMB ISCHEMIAHan Eun jin

EP018 NON INVASIVE DIAGNOSISA OF OSTEOMYELITISI IN DIABETIC FOOT- A COMPARISON WITH HITHOPATHOLOGIC SPECIMENSepideh Torabi Parizi, Claudio Morisi

EP019 TARGETING CURETTAGE DEBRIDEMENT TO REGIONS OF BIOBURDEN IN DIABETIC FOOT ULCERS WITH REAL-TIME BACTERIAL FLUORESCENCE IMAGINGRose Raizman

EP020 A TOTAL CONTACT CAST SYSTEM IN THE MANAGEMENT OF ACUTE DIABETIC FOOT ULCERATION: YOU CAN AFFORD TO OFFER THIS TO YOUR PATIENTSGraham Bowen

15.00-15.30 PRESSURE ULCER 1

EP021 CLINICAL EFFECTS OF COMBINED TREATMENT THAT USES NEGATIVE PRESSURE WOUND THERAPY AND RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR ON PRESSURE SOREHwan Jun Choi

EP022 PRESSURE ULCER RISK ASSESSMENT: RISK FACTORS AND RISK SCREENING IN OLDER PERSONS- A PILOT STUDYAglécia Budri, Zena Moore, Declan Patton, Tom O’Connor

EP023 THE MODIFIED SUPERIOR GLUTEAL ARTERY PERFORATOR FLAP FOR SACRAL SORE RECONSTRUCTIONDong Hye Kang, Kyu Hyung Lee

EP024 INCONTINENCE-ASSOCIATED DERMATITIS IN CRITICALLY ILL PATIENTS OF CHINESE POPULATION WITH FECAL INCONTINENCE: AN OBSERVATIONAL STUDYYuting Bao, Li Wei, Jiaqi Zheng, Weiwei Xu

EP025 SIGNIFICANCE OF HIP FLEXION REGARDING PERFORATOR FLAP IN INTRAOPERATIVE INSETTING FOR RECONSTRUCTION OF ISCHIAL SOREJoo Hyoung Kim, June Seok Choi, Su Bong Nam

EP026 PRESSURE ULCERS: DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE PATIENT KNOWLEDGE OF PRESSURE ULCER PREVENTION INSTRUMENTEmer Shanley, Zena Moore, Declan Patton

EP030 REAL-WORLD EVIDENCE EVALUATING A NOVEL EARLY-DETECTION DEVICE FOR HAPU REDUCTIONRachael Lester

EP031 SIMPLE STRATEGY REDUCES THE RISK OF PRESSURE ULCER WITH 73%Aase Fremmelevholm

EP032 EVIDENCE-BASED ELEARNING MODULE FOR SKIN CHECKSKaren Campbell, Keith Hayes, Jillian Swaine, Marianne Mullane, Luke Brennan, Michael Stacey

SCREEN 1 – THURSDAY 4 MAY

9.30-10.00 WOUND ASSESSMENT 1

EP033 SACS 2.0: A REVIEW OF THE ORIGINAL SACS SCALEMario Antonini, Gaetano Militello, Raimondo Arena, Silvia Manfredda, Stefano Veraldi, Stefano Gasperini

EP034 LEVELS OF MMPS ASSOCIATED TO THE HEALING PROCESS OF PERISTOMAL SKIN DISORDERS Mario Antonini, Gaetano Militello

EP035 THE TORONTO SYMPTOM ASSESSMENT SYSTEM FOR WOUNDS (TSAS-W)Jason Corban, Vincent Maida

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

95

EP036 DEVELOPMENTS TOWARDS A MINIATURIZED SMART SYSTEM FOR LIGHT STIMULATION AND MONITORING OF WOUND HEALING - EU PROJECT MEDILIGHTBouschbacher Marielle, Julien Steinbrunn, David Kallweit, Rolando Ferrini, Anja Becker, Anna Klapczynski, Natalia Kuch, Norbert Gretz, Manuel Steckel, Kyriakos Michaelides, Rhys Waite, Rudolf Frycek, Dyonisos Manessis

EP037 NEW PRACTICAL WOUND CARE GUIDELINEYoung Joon Jun

EP038 THE DRESSING WITH SURFACTANT: A NEW FRONTIER OF TREATMENT OF CHRONIC WOUNDSSara Sandroni, Stefania Fabrizi, Laura Detti

EP039 MEETING THE PRACTICAL AND ECONOMIC CHALLENGES OF MANAGING SKIN AND WOUNDS USING SELF-CARE AS AN OPTION FOR PATIENTS WITH LYMPHEDEMAEllen Kuip

13.30-14.15 HEALTH ECONOMICS & OUTCOME

EP040 NEGATIVE-PRESSURE WOUND THERAPY: A PHARMACOECONOMICS ASSESSMENT REVIEWRui Pereira, Adriana Barbosa, Ana Cláudia Costa, Ângela Ferreira, Ana Rita Rodrigues, João Cainé

EP041 REDUCING COSTS IN COMPLEX WOUNDS MANAGEMENTGustavo Feriani, Carina Salerno

EP042 WOUND OUTCOMES IN PALLIATIVE CAREJason Corban, Vincent Maida

EP043 THE REAL VALUE OF MECHANICAL DEBRIDEMENT IN ASSESSMENT OF CHRONIC WOUNDS: AN ECONOMIC EVALUATIONSara Sandroni, Lara Iannelli, Andrea Sacchetti, Tania Fabbri, Laura Detti, Stefania Fabrizi

EP044 IMPROVING OUTCOMES IN CHRONIC WOUND HEALING BY FOLLOWING A 2 WEEK PATHWAY USING MONOFILAMENT DEBRIDEMENT PAD AND ANTIMICROBIAL REGIMEJohn Timmons, Clare Morris, Neil Sykes, Leanne Calladine

EP045 IMPLEMENTATION OF A WOUND FORMULARY USING AN ONLINE ORDERING SYSTEMDebbie Simon

EP046 THE EXPERIENCE OF EWMA CERTIFICATION IN A AMBULATORIAL WOUND HEALING CENTER OF SESC SAÚDE SÃO FRANCISCO IN BELO HORIZONTE, BRAZILRogério Noronha, Ana Beatriz De Pinho Barroso, Jéssica Leroy, Gisele Avelar, Bárbara Raposo, Rosalia Rodrigues, Bárbara Monteiro, Jailton de Oliveira, Adriana Corrêa, Mislene Persilva

EP047 ORGANIZATION OF WOUND CARE: COOPERATIVE NETWORK IN BELO HORIZONTE, BRAZIL. EXPERIENCE IN A EWMA ENDORSED WOUND HEALING CENTRERogério Noronha, Ana Beatriz De Pinho Barroso, Bruno de Freitas Belezia, Túlio Pinho Navarro, Paulo Roberto da Costa, Sarah de Pinho Coelho, Gisele Avelar, Rosália Rodrigues, Bárbara Raposo, Jailton de Oliveira, Bárbara Monteiro, Mislene Persilva

EP048 VISION AND EXPERIENCE OF NURSES COORDINATING UNITS OF CHRONIC WOUNDSGonzalo Esparza Imas, Adrián Fuentes Agúndez, María Jesús Morales Pasamar, Juan Manuel Nova Rodríguez

EP049 ACELLULAR FISH SKIN GRAFT PERFORMANCE AGAINST PREDICTED OUTCOMES IN DFU AND ITS ECONOMIC MODELINGJohn Lantis

EP050 HEALTH ECONOMICS OF A BIOACTIVE BETA-GLUCAN GELKeith Cutting

EP051 COST EFFECTIVENESS OF SILVER DELIVERY APPROACHES IN THE MANAGEMENT OF PATIENTS WITH SUPERFICIAL AND DEEP-PARTIAL THICKNESS BURNS I.E. SILVER BARRIER DRESSING (SBD)A, SILVER HYDROFIBER DRESSING (SHD)B AND SILVER FOAM DRESSING (SFD)C INCLUDING 1% SILVER SULFADIAZINE (SSD)Leo Nherera, Paul Trueman

EP052 PRESENTATION OF AN INTEGRATED COMPREHENSIVE MULTIDISCIPLINARY WOUND TEAM: THE ISRAELI JERUSALEM BASED MEUHEDET WOUND CENTERAharon Wanszelbaum, Nahum Grinberg, Yoav Kamkaji, Tsvi Levy, Marina Karasik, Jaklin Nusair

EP053 TERRITORIAL ORGANIZATION OF CHRONIC WOUNDS MANAGEMENT IN THE DISTRICT CÔTES D’ARMOR-FRANCEMoisan Cecile

96

15.30-16.00 BURNS 2

EP054 THE USE OF NEW DRESSINGS IN THE TREATMENT OF DONOR SITESBorisov Valery, Kaplunova Mariia

EP055 NEW SKIN SUBSTITUTE IN THE TREATMENT OF DERMAL BURN AFTER DERMABRASIONBorisov Valery, Kaplunova Mariia, Afanasov I.M., Filatov I.Y.

EP056 EFFECTIVENESS OF SILVER SODIUM CARBOXYMETHYLCELLULOSE FIBRES DRESSING IN MANAGEMENT OF PARTIAL-THICKNESS FACIAL BURNS IN CHILDRENMaya Argirova

EP057 KOREA FIREFIGHTER BURN NATIONAL SURVEYGuHyun Kang, Choi HY MD, Kim WH Dr., Jang YS Dr, Kim MJ Miss

EP058 THE EFFECTS OF MUSIC THERAPY ON PAIN CONTROL IN BURN PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSISShu-Fen Lo

EP059 CONTROLLED WOUND HEALING OF SLOUGHY BURNS TREATED WITH A NEW HIGH-ABSORBENT FIBER DRESSINGAnne Guier, Joseph Chateau, Geneviève de Gennaro, Julien Textoris, Fabienne Braye

EP060 CLINICAL EXPERIENCE OF COMBINING A PROTOSAN AND BETADINE SOLUTION WASH WITH AN IONIC SILVER ALGINATE PASTE DRESSING AS TREATMENT FOR CHRONICALLY INFECTED BURN WOUNDS IN A RESOURCE-LIMITED ENVIRONMENT AT IALCH, CENTRAL BURN UNIT, DURBAN, SOUTH AFRICAAlessandro Andreone

SCREEN 1 – FRIDAY 5 MAY

9.30-10.15 ACUTE WOUNDS

EP061 DEBRIDEMENT IN SUBCUTANEOUS HEMATOMAS USING RINGER DRESSINGJoan Ernest Peris Caballero, Federico Palomar Llatas, Begoña Fornes Pujalte, Concepcion Sierra Talamantes, Paula Diez Fornes, David Palomar Albert, Jorge Zamora Ortiz, Elena Garcia Hervas

EP062 NEGATIVE PRESSURE WOUND THERAPY, WOUNDS IN CHILDRENNatusya Barova, Victor Tarakanov, Maxim Stepkin, Ilia Trembach

EP063 THE EXPERIENCE OF WOUND TREATMENT WTH BIOPLASTIC MATERIALS IN CHILDRENNatusya Barova, Victor Tarakanov, Maxim Stepkin, Ivan Pankratov, Artem Onofriychuk, Ilia Trembach

EP064 IMPORTANCE OF INITIAL MANAGEMENT AND SURGICAL TREATMENT AFTER HYDROFLUORIC ACID BURN INJURY OF THE FINGERHyun Ho Han, Jong Won Rhie

EP065 DETERMINATION OF THE ADHESIVE PROPERTIES OF A FIRST AID DRESSING WITH SILICONE ADHESIVE IN COMPARISON TO AN ACRYLATE-BASED ADHESIVEMaike Kuhlmann, Sonja Kristof, Katrin Klensang, Birgit Buck, Felix Krause-Kyora, Rainer Wolber, Elke Grönniger

EP066 RESULTS OF THE COMBINATION OF TWO NATIONAL MULTICENTRE OBSERVATIONAL TRIALS ON ACUTE WOUNDS WITH AN ADHESIVE NEUTRAL FOAM DRESSING WITH TECHNOLOGY LIPIDOCOLLOID MATRIX AND SILICONE BORDERWinfried Keuthage, Patricia Wilken, Udo Moller

EP067 A PLANT DERIVED PRIMARY WOUND DRESSING CONTAINING OILY EXTRACTS OF NEEM AND HYPERICUM FOR THE TREATMENT OF SURGICAL WOUND DEHISCENCESFiorella Carnevali, Stephen Andrew van der Esch, Pierluigi Altavista, Maurizio Palombi, Michela Di Venanzio

EP068 PROSPECTIVE STUDY OF THE EFICIENCY OF COMPLEX SILVER ALGINATE MATRIX IN THE TREATMENT BURNSLuis Simões, Mario Lopes

EP069 RISK OF THE WOUND PROCESS COMPLICATIONS AFTER SURGICAL TREATMENT OF THE SOFT TISSUE SARCOMAS USING CRYOSURGERYMikhail Khanevich, Anton Khazov

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

97

EP070 TRANSLATING COMPLEX WOUND MANAGEMENT WITH “STARS” THERAPY: A SIMPLE REGENERATIVE MEDICINE SOLUTIONSandeep Shrivastava

EP071 THE USE OF TISSUE ENGINEERED TISSUE IN WOUND HEALINGDavid Dae-Hwan Park

EP072 CLOSURE OF COMPLICATED WOUNDS USING A COMBINATION OF RUBBER BANDS WITH NEGATIVE PRESSURE WOUND THERAPYAyman Helmi, Safwat Ibrahim


11.45-13.30 ANTIMICROBIALS AND INFECTION

EP073 THE ANTIMICROBIAL EFFICACY OF THE COMBINATION OF NANO-CRYSTALLINE SILVER DRESSING AND CADEXOMER IODINE POWDER: AN IN VITRO STUDYAdisaputra Ramadhinara

EP074 A NOVEL HYDRO-DESLOUGHING ABSORBENT DRESSING WITH A NON-ADHERENT HEALING MATRIX WITH IONIC SILVER - A CASE SERIES ANALYSISMartin Tadej, Lorraine Grothier

EP075 HIGHER OXIDATIVE STATES OF SILVER EFFECTIVELY DISRUPT WOUND BIOFILMS AND PROMOTE HEALING OF EX VIVO PORCINE BURN WOUNDSHelen Thomason, Charis Saville, Christian Stephenson, Andrew McBain

EP076 THE RISK TO DEVELOP BACTERIAL RESISTANCE AGAINST SILVER IN WOUND CARE - UPDATED EVALUATION OF PUBLISHED DATAJohannes Georg Böttrich, Horst Braunwarth, Joachim Dissemond, Hilt Joerg, Karl-Christian Münter, Patricia Wilken

EP077 A SELECTION OF AFRICAN PLANTS WITH ANTIMICROBIAL ACTIVITIES AGAINST BACTERIAL AND FUNGAL INFECTIONS FREQUENTLY ASSOCIATED WITH NON-HEALING WOUNDSCannan Tawonezvi, Constance Chivengwa, Terence Ruhukwa, Jerneja Vidmar, Constance Chingwaru, Walter Chingwaru

EP078 TETRA SODIUM EDTA: AN ADJUNCTIVE THERAPY THAT ENHANCES THE ANTI-BIOFILM ABILITY OF ANTIMICROBIAL WOUND DRESSINGSSteven Percival, Sonya Taylor, Louise Suleman

EP079 EFFICACY OF A RESPONSIVE NEXT GENERATION ANTI-BIOFILM COMPLEX FOR THE TREATMENT OF BIOFILMS AND INFLAMMATIONSteven Percival, John Hunt, Rui Chen, Louise Suleman

EP080 EFFICACY OF A SILVER RELEASING VERTICAL ABSORPTION POLYURETHANE FOAM WITH PERFORATED SILICONE LAYER COMPARED WITH A SILVER RELEASING VERTICAL ABSORPTION POLYURETHANE FOAM IN INFECTED WOUNDSSara Sandroni

EP081 ANTIMICROBIAL AND TOLERABILITY PROFILE OF A SPRAYABLE ACID-OXIDIZING SOLUTION FOR WOUND CARENadia Giarratana, Giorgio Reiner

EP082 ANTIBACTERIAL AND FUNCTIONAL PROPERTIES OF CAMEROONIAN AND MANUKA HONEY FOR POTENTIAL WOUND HEALINGJoshua Boateng, Keshu Nso Diunase

EP083 EVALUATING THE USE OF ANTI-BIOFILM GEL OR IRRIGATION IN COMBINATION OF A SILVER ALGINATELiezl Naude

EP084 IS REALLY EFFECTIVE A SURFACTANT-BASED ANTIMICROBIAL WOUND DRESSING IN THE MANAGEMENT OF INFECTED LEG ULCERS?Francesco Paolo Palumbo, Giacomo Failla, Simone Serantoni, Luca Gazzabin, Franca Abbritti

EP085 CIPROFLOXACIN LOADED CALCIUM ALGINATE BASED DRESSINGS FOR POTENTIAL HEALING OF CHRONIC DIABETIC FOOT ULCERSAsif Ahmed, Giulia Getti, Joshua Boateng

98

EP086 EVALUATION OF THE EFFECT OF SILVER-, PHMB- AND IODINE-CONTAINING WOUND CARE PRODUCTS ON P. AERUGINOSA BIOFILMS IN A COLONY DRIP FLOW REACTOR WOUND MODELKatie Bourdillon, Craig Delury

EP087 EVALUATION OF A NEW ANTIMICROBIAL DRESSING WITH CLEANING ACTION ACROSS A RANGE OF WOUNDS WITHIN AN INTEGRATED TRUSTElizabeth Merlin-Manton, Elizabeth Thompson

EP088 EVALUATION OF ANTIBACTERIAL AND CYTOTOXIC ACTIVITY OF OPUNTIA COCHENILLIFERA (L.) MILLAndressa Letícia Lopes da Silva, Maria Gabriella Silva Araujo, Regina Veríssimo, Joice Fragoso da Silva Oliveira

EP089 OMEGA-3 RICH FISH SKIN IS A BACTERIAL BARRIER AGAINST S. AUREUS IN VITRO AND P. MIRABILIS IN VIVOHilmar Kjartansson

EP090 EVALUATION OF IN VITRO ANTI-BIOFILM ACTIVITIES OF TWO DRESSINGS WITH POLY-ABSORBENT FIBRES AND A DACC-COATED DRESSINGNicolas Desroche, C. Frin, Odile Mary, Anne-Sophie Danerol, Philippe Janod, Cindy Dropet

EP091 COMPARISON OF IN VITRO ANTI-BIOFILM ACTIVITIES OF A NEW POLY-ABSORBENT DRESSING WITH A SILVER MATRIX AND A SILVER HYDROFIBER DRESSINGNicolas Desroche, C. Frin, Odile Mary, Anne-Sophie Danerol, Philippe Janod, Cindy Dropet

EP092 ALCOHOLIC CHLORHEXIDINE IN CARDIAC SURGERY: IS IT EFFICIENT AND COST EFFECTIVE?Antonio Capo, Claudio Grossi

EP093 A SURFACTANT-BASED DRESSING FOR THE DISRUPTION AND PREVENTION OF BACTERIAL BIOFILMSQingping Yang, Gregory Schultz, Daniel Gibson

EP094 THE USE OF HYPOCHLORITE IN THE ANTISEPSIS OF WOUNDED SKIN: RESULTS OF A SYSTEMATIC OVERVIEW OF THE LITERATUREAngela Peghetti, Lucia Manfredi, Giovanni Pomponio

EP095 RELATIVE EFFICACY OF ANTIBIOTICS AT PLASMA CONCENTRATIONS COMPARED TO THOSE AFTER RELEASE FROM A VOID FILLING DEVICE, USING A NOVEL MODEL OF AN INFECTED DERMISBianca Price, Krishanu Baruah, Curtis Dobson

EP096 BACTERIAL SPECTRUM IN DIABETIC FOOT INFECTIONS AND BIOFILM FORMATION IN SAMPLES ISOLATED FROM CHILEAN PATIENTSMaria Ines Diaz, Claudia Ramirez, Catherina Rodas Krause, Julio Tapia

EP097 NEW APPROACH IN TREATING INFECTION IN COMPLEX WOUNDS WITH A BACTERIOSTATIC DRESSINGKatia Furtado, Joao Crastes

EP098 MANAGEMENT OF INFECTED WOUNDS USING RISK EVALUATION TOOL AND RISK STRATIFICATIONVincent Siaw-Sakyi, Paul Jhass, Phil Bowler

EP099 MANAGEMENT OF INFECTED WOUNDS USING RISK EVALUATION TOOL AND RISK STRATIFICATIONVincent Siaw-Sakyi, Paul Jhass, Phil Bowler

EP100 REMOVING CRITICAL COLONISATION FROM THE WOUND INFECTION CONTINUMMTerry Swanson

EP101 TREATMENT OF MRSA INFECTED WOUNDS: STRATEGY OF SUCCESS WITH ULTRASOUND TECHNOLOGYSara Sandroni, Morena Mascalchi

EP102 BALANCING ANTIMICROBIAL ACTIVITY WITH PROTECTION OF HOST CELLS: A STRATEGY FOR MANAGEMENT OF WOUNDS WITH SUSPECTED BIOFILMKatie Bourdillon, Craig Delury, Breda Cullen

15.00-15.30 LEG ULCER 1

EP103 EFFICIENCY OF SHAVE THERAPY IN COMPLEX TREATMENT OF PATIENTS WITH LOWER LIMBS VENOUS TROPHIC ULSERSMikhail Kushnarchuk, Sergey Katorkin, Mikhail Melnikov

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

99

EP104 A NOVEL THERAPY OF COMBINING ULTRASOUND AND ELECTRICAL STIMULATION AS ADJUVANT TREATMENT FOR RECALCITRANT VENOUS LEG ULCERSDiane Eng, Adisaputra Ramadhinara

EP105 APPLICATION OF MEDICAL MOISTURE RETENTION CREAM (MMRC); A NEW OPTION IN THE TREATMENT OF VENOUS ECZEMAArmand Rondas, Jos Schols

EP106 FEED WOUNDS AND PATIENTS: EFFECTIVENESS OF AMINOACIDS IN THE TREATMENT OF LEG ULCERSRoberto Cassino

EP107 COMPRESSION THERAPY PATHWAY FOR VENOUS AND LYMPHATIC DISEASELorraine Jones

EP108 THE ROLE OF FOAM SCLEROTHERAPY (UGFS) AND THE ENDOVENOUS THERMO-COAGULATION VERSUS SAPHENOUS STRIPPING IN CURING ULCUSCRURISIstvan Rozsos, Gergely Vadasz, Eszter Szőnyi

EP109 COMBINED TREATMENT WITH FOAMING OR ENDOVENOUS ABLATION AND COMPRESSION THERAPY OF RECALCITRANT VENOUS ULCERSDiego Backaert, Speybrouck Sabrina

EP110 PERFORMANCE OF AN INNOVATIVE TECHNOLOGY DRESSING IN THE LOCAL MANAGEMENT OF WOUNDS FROM THEIR DEBRIDEMENT STAGEMichèle Sigal, Azeddine Addala, Vincent Crebassa, Anne Dompmartin, Florent Sala, Serge Bohbot

EP111 SUCCESSFUL TREATMENT OF CHRONIC INFECTED VENOUS ULCERS WITH A 1,470-NM ENDOVENOUS LASERSergey Yakushkin, Alexey Kovylov, Anton Solomahin, Alexey Kipajkin, Alexandr Lebedev


12.30-14.15 DEVICES & INTERVENTION

EP112 THE USE OF PLATELET RICH PLASMA IN ORTHOPAEDIC SURGERY: OUR CLINICAL EXPERIENCEClaudio Manzini, Giovanni Longoni, Roberto De Pamphilis, Pasquale Gifuni, Roberto Pelucchi, Elisabetta Diotti

EP113 GOLD NANOPARTICLES CONJUGATE WITH BACOPA PROCUMBENS EXTRACT IMPROVE WOUND HEALING IN IN VIVO MODELAdriana Martínez, Ma. del Consuelo Gómez Garcia, Virginia Sánchez Monroy, Marlon Rojas López, Raúl .J. Delgado Macuil4, David Guillermo Pérez Ishiwara

EP114 USEFULNESS OF A THERAPY BASED ON BIOPHOTONICS TECHNOLOGY IN THE TREATMENT OF CHRONIC WOUNDS OF THE LOWER LIMBS: CLINICAL APPLICATION IN NURSING CLINICKlarida Hoxha, Sofia Fioravanti, Alice Casadei, Ilaria Succi, Pasquale Longobardi

EP115 THE USE OF COMBINED MODULATED ULTRASOUND AND ELECTRIC FIELD STIMULATION FOR CHRONIC WOUND HEALINGTom O’Connor, Zena Moore, Declan Patton, Pauline Wilson, Corey Gilllen, Mairead Hughes, Aoife Reilly

EP116 EVALUATION OF A MEDICAL DEVICE BASED ON PEG (POLYETHYLENE GLYCOL), ALLANTOIN AND SODIUM HYALURONATE TO TREAT CHRONIC SKIN LESIONSLeonardo Baricordi, Rino Corrarello, Maria Concetta Granatelli

EP117 COLD ATMOSPHERIC PRESSURE PLASMA AS A NOVEL TREATMENT MODALITY IN DIABETIC FOOT ULCERS: A PILOT STUDYRimke Lagrand, Paulien Smits, Guus Pemen, Edgar Peters, Ana Sobota, Bas Zeper, Louise Sabelis

EP118 THE ISRAELI EXPERIENCE WITH COMBINED ULTRASOUND AND ELECTRIC FIELD STIMULATION ON CHRONIC WOUNDSJonathan Rosenblum, Ram Avrahami

EP119 COMBINED ULTRASOUND AND ELECTRIC FIELD STIMULATION CAUSE AN IMMEDIATE WOUND HEALING RESPONSE IN CHRONIC WOUNDSJonathan Rosenblum, Fabrizia Toscanella, Ram Abrahami, Diane Eng

100

EP120 DETERMINATION OF THE EFFECT OF STERILIZATION ON THE DEBRIDEMENT PERFORMANCE OF A MONOFILAMENT DEBRIDER DEVICECornelia Wiegand, Kirsten Reddersen, Martin Abel, Stefanie De Lange, Peter Ruth, W. Harreither, C. Schmalenbach, U.-C. Hipler

EP121 PYODERMA GANGRENOSUM (PG) - USE OF A SYSTEMATIC MANAGEMENT TOOL CONSISTING OF DATA COLLECTION SHEETS CAN PROVIDE A CONTINUOUS OVERVIEW OF THE COMPLEXITY IN CHRONIC WOUND CARE.Jane Thinggaard Knudsen, Jeanette Møller Hansen

EP122 DEBRIDEMENT TO IMPROVE HEALING OUTCOME: THE USE OF MONOFILAMENT PADSKevin Woo, Jeanette Muldoon

EP123 TOPICAL WOUND OXYGEN AS AN ADJUNCT IN HEALING CHRONIC ULCERATIONSMichael Griffiths, Mathew Garoufalis

EP124 PHOTOBIOMODULATION: CONFRONT BETWEEN BIOPHOTONIC AND PHOTODYNAMIC THERAPIESAlessandro Corsi, Ornella Forma, Umberto Cazzarò, Giulia Vidotto, Sara Lupi, Teresita Gaiani

EP125 A MULTI-CENTRE, UK WIDE CASE SERIES OF A NEW MONOFILAMENT FIBRE DEBRIDEMENT LOLLY IN AN ACUTE AND COMMUNITY SETTING FOR THE MANAGEMENT OF CAVITY WOUNDS AND HARD TO REACH AREASClaire Clayton, Jennie Armstrong, Janice Little, Clare Morris

EP126 USE OF PLATELET RICH PLASMA ON NON-HEALING WOUDS: CLINICAL REPORTMari Mustonen, Päivi Mäntyvaara, Leena Berg, Tomi Tervala

EP127 NON-THERMAL AIR PLASMA PROMOTES ACUTE AND CHRONIC WOUND HEALINGŠárka Kubínová, Kristyna Zaviskova, Oleg Lunov, Vitalii Zablotskii, Olexandr Churpita, Alexandr Dejneka

EP128 THE EFFECT OF MECHANICAL DEBRIDEMENT ON WOUND’S BACTERIAL BURDENFranjo Rudman, Srećko Budi, Jasenka Škrlin, Karolina Dobrović, Rudolf Milanović, Zdenko Stanec

EP129 CONTROLLED CASE SERIES EVALUATING THE USE OF NEURO-MUSCULAR ELECTRIC STIMULATION DEVICE ON PATIENTS WITH WOUNDS OF DIFFERING AETIOLOGY IN THE LOWER LIMBNia Jones, Nicola Ivins, Vicky Ebdon, Nia Jones, Susan Hagelstein, Keith Harding

EP130 THERAPEUTIC MAGNETIC RESONANCE FOR PREVENTING SURGICAL SITE INFECTION IN CARDIO-SURGERY WOUNDS: A CONTROLLED PROOF-OF-CONCEPT PILOT STUDYOrnella Forma, Umberto Cazzaro, Teresita Gaiani, Giulia Vidotto, Sara Maria Lupi

EP131 A NON-PATIENT VOLUNTEER STUDY TO DETERMINE THE EFFECT OF SKIN BARRIER CREAMS ON INCONTINENCE PAD ABSORBENCYSarah Bradbury, Peter Dykes

EP132 THE USE OF TOPICAL PORCINE HAEMOGLOBIN IN CHRONIC WOUNDSLiezl Naude

EP133 INTERMITTENT VACUUM THERAPY: APPLYING SPACE TECHNOLOGY TO WOUND CARELiezl Naude, Jacques Swanepoel, Lauren Brown

EP134 TREATMENT WITH ACELLULAR FISH SKIN RESULTS IN LOWER USE OF ANTIBIOTICS: A RETROSPECTIVE STUDY ON 68 CHRONIC WOUNDSBaldur T. Baldursson

EP135 EFFECTS OF EXTRACORPOREAL SHOCK WAVE THERAPY ON WOUND HEALING: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALSZhang Li, FU Xiao-bing, Zhao Zhan-bo

EP136 TESS - TISSUE VIABILTY ELECTRONIC SUPPORT SERVICECilla Page, Jan Hogben

EP137 PREVENTING ULCERS IN BULLOUS ERYSIPELAS - TOPICAL WOUND CARE TREATMENTChausha Weitman Cernica

EP138 ELECTROSPUN NANO-FIBROUS DRESSINGS: A HANDHELD DEVICE FOR PERSONALIZED BEDSIDE WOUND DRESSING CAREJosef Haik, Eyal Gur, Yehuda Ullman, Dean Ad-El, Dana Egozi, Sivan ZIssman, Rachel Kornhaber, Elad Ofir, Moti Harats

EP139 IMPROVEMENT OF SKIN SCAR USING LOW LEVEL LASER THERAPYLuiz Gustavo Balaguer Cruz, Vania Declair Cohen, Rodrigo Labat Marcos, Rachid Rahouad, Rodrigo Alvares Brandao Lopes-Martins, Raquel Dalmaso

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

101

15.30-16.00 WOUND ASSESSMENT 2

EP140 USING HYDROFIBER AG FOAM DRESSING AND HYPERBARIC OXYGEN THERAPY IN TREATMENT OF CHRONIC WOUNDSNera Fumić, Marin Marinović, Davor Jurišić, Boris Reinić, Emmanuela Marucci, Mia Grković, Maja Radić

EP141 POINT-OF-CARE BACTERIAL FLUORESCENCE IMAGING DEVICE GUIDES WOUND CLEANING AND PATIENT EDUCATION IN OBESE WOUND CARE PATIENTSRose Raizman

EP142 USE OF A WOUND ASSESSMENT DEVICE IN MANAGEMENT OF CHRONIC WOUNDS: A CASE REPORTHelena Meally, Janet Woods, Amy Barrett, David Russell

EP143 WOUND MEASUREMENT: A CLINIMETRIC ASSESSMENT ON THE VALIDITY AND RELIABILITY OF THE 3D STRUCTURE SENSOR ON WOUND SURFACE AREA AND WOUND VOLUMEMartijn Doomen, Catherine van Montfrans, Wouter Willems, Paul van Zuijlen

EP144 RELEVANCE OF PH LEVELS AND TEMPERATURE IN WOUND DIAGNOSTICSThomas Eberlein, Thomas Riesinger

EP145 DISPOSABLE TEMPERATURE AND PH SENSORS FOR THE CONTINUOUS MONITORING OF WOUNDSFabio Di Francesco, B. Melai, P. Salvo, N. Calisi, C. Paoletti, A. Kirchhain, F.M. Vivaldi, V. Dini, M. Romanelli, A. Paolicchi

EP146 COMPLEX GROWTH FACTORS IN WOUND HEALING A PROSPECTIVE STUDY WITH 72 PATIENTSLuis Simões, Jose Luis Cabral, Ruben Fernandes

EP147 MICROCIRCULATORY EVALUATION OF LEG ULCERS BY LASER SPECKLEGiacomo Failla, Francesco Paolo Palumbo, Pier Luigi Antignani


9.30-10.15 PREVENTION

EP148 WASH-OFF RESISTANCE OF SKIN BARRIER CREAMSNancy Atwood, Gary Grove, Chuck Zerweck, Debra Thayer, Bruce Ekholm, Stephanie Bernatchez, Paul Bainbridge

EP149 ESTABLISHMENT OF NOVEL MOISTURIZER APPLICATION METHOD FOR DRY SKIN FOCUSED ON CERAMIDE KINETICS-PRELIMINARY TEST ON NORMAL RAT SKINMiku Aoki, Kazuhiro Ogai, Masato Kobayashi, Junko Sugama

EP150 DURABILITY OF INVESTIGATIONAL SKIN PROTECTANT PRODUCT, BASED ON ACRYLATE CHEMISTRY, COMPARED WITH THREE COMMERCIAL PRODUCTSMary Mathisen, Gary Grove, Bruce Ekholm, Paul Bainbridge

EP151 USING REAL-WORLD EVIDENCE TO EVALUATE THE CLINICAL BENEFIT OF INCORPORATING EARLY DETECTION TECHNOLOGY INTO PU PREVENTION PROGRAMSRachael Lester

EP152 A PRE-POST STUDY EVALUATING THE EFFECTIVENESS OF A NEW INITIATIVE, THE ‘PRESSURE BUNDLE’, COMPARED WITH STANDARD CARE IN REDUCING THE INCIDENCE AND PREVALENCE OF SACRAL PRESSURE ULCERS IN CRITICALLY ILL PATIENTS IN AN INTENSIVE CARE UNIT IN RIYADH, SAUDI ARABIAAnas Ahmad, Amin Yousef, Mahmoud Alkurdi, Mohammad Amirah

EP153 USE OF DRESSING TO CONTROL MICROBIAL LOAD IN THE PREVENTION OF INCISIONAL COMPLICATION AFTER GASTROINTESTINAL SURGERY. A MONOCENTRIC RANDOMIZED CONTROL TRIAL PFC01Ornella Forma, Riccardo Rosati, Maria Lemma, Sara Maria Lupi, Ugo Elmore

EP154 PATIENT RISK FACTORS OF PRESSURE INJURY DEVELOPMENT IN AN ACUTE CARE FACILITY IN KOREAKyuwon Baek, Kyoungmin Kwon, Minkyung Kim

102

EP155 AN AUDIT OF INCONTINENCE-ASSOCIATED DERMATITIS PREVALENCE AND SKIN BARRIER PRODUCT USAGE IN NURSING AND RESIDENTIAL HOMES IN A WELSH HEALTH BOARDDelia Keen, Jackie Griffin, Jason Carroll, Sarah Bradbury

EP156 PATIENT TURNING MADE SIMPLESandra Dudziak, McEvan Lisa, Mona Khalek

EP157 DEVELOPMENT OF PREVALENCE OF CHRONIC WOUNDS IN HELSINKI AREA FROM 2008 TO 2016Kirsti Ahmajärvi


11.45-13.30 DRESSINGS 1

EP158 COMPARISON BETWEEN HIGHLY AND EARLY HYDROPHILIC POLYURETHANE FOAM DRESSING IN THE MANAGEMENT OF SKIN GRAFT DONOR SITES IN DIABETIC PATIENTSYe-Na Lee, Seung-Kyu Han

EP159 SECONDARY INTENTION HEALING AFTER SURGICAL EXTERIORIZATION OF HIDRADENITIS SUPPURATIVAKyoung Ae Nam, Kee Yang Chung

EP160 CLINICAL EVALUATION OF A NEW ADVANCED SKIN PROTECTANT FOR THE TREATMENT OF INCONTINENCE ASSOCIATED DERMATITIS (IAD)Bruce Ekholm, Mary Brennan, Catherine T. Milne, Bart Maene

EP161 A SIMPLE AND FAST DRESSING FOR SKIN GRAFTS: COMPARISON WITH TRADITIONAL TECHNIQUESSang Wha Kim, Youn Hwan Kim, Jeong Tae Kim

EP162 EPITHELIAL CELLS DETACHMENT BY WOUND DRESSING REPLACEMENT WILL SLOW WOUND HEALINGHendro Sudjono Yuwono, Boby Eko Nugroho

EP163 FIRST RESULTS - CASE SERIES DEMONSTRATING THE PERFORMANCE AND SAFETY OF A NOVEL SUPERABSORBENT DRESSING IN HIGH EXUDING CHRONIC WOUNDSKarsten Glockemann, Wolber Silke, Scheuenstuhl Yvonne, Stefanie De Lange, Martin Abel

EP164 SILVER ALGINATE MATRIXAna Filipa Martins

EP165 IONIC SILVER POWDER TO CONTROL COMPLICATIONS OF NEOPLASTIC SKIN LESIONSRoberto Cassino

EP166 APPLICATION OF MODERN DRESSING MATERIALS IN THE STAGE TREATMENT OF “SMALL” WOUNDS OF DIFFERENT ETHIOLOGYStanislav Pyatakov, Anatoly Zavrazhnov, Sergey Bogdanov, Igor Lukyanchenko, Aleksandr Soldatov, Svetlana Ralko, Sergey Bardin

EP167 RESULTS OF A NATIONAL MULTICENTRE OBSERVATIONAL TRIAL ON CHRONIC WOUNDS WITH A FOAM DRESSING WITH MATRIX-METALLOPROTEINASES INHIBITOR AND SILICONE BORDERWinfried Keuthage, Dimitrios Tsantilas, Elisa Becker, Patricia Wilken, Udo Möller

EP168 RESULTS OF A NATIONAL MULTICENTRE OBSERVATIONAL TRIAL ON ACUTE WOUNDS WITH AN ADHESIVE NEUTRAL FOAM DRESSING WITH TECHNOLOGY LIPIDOCOLLOID MATRIX AND SILICONE BORDER*Winfried Keuthage, Michael Dietlein, Elisa Becker, Patricia Wilken, Udo Möller

EP169 EXAMINING THE ANTIBIOFILM PROPERTIES OF A NEW PHMB FOAM DRESSINGAlexis Joseph, Emma Bhatt

EP171 THE ANTIBIOFILM PROPERTIES OF A NEW HIGH GELLING, FIBRE WOUND DRESSING WITH SILVERAlexis Joseph, Colin Bradford, Lynne Salmon, Chetan Sharma

EP172 USE ADVANCED DRESSING REDUCE SHEARING AND FRICTION FORCES ON POCKET WOUND CARE EXPERIENCEYu-Chi Wang, Yen Huang, Hsing-Kuang Lai

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

103

EP173 MANAGEMENT OF CHRONIC SKIN WOUNDS WITH TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT A MIXTURE OF POLLEN EXTRACT AND UNSAPONIFIABLES FRACTION OF WHEAT GERM, SOYBEAN AND OLIVE OIL: A THIRTY PATIENT EXPERIENCES ON TWO YEARSAlessandro Ragno, Daniele Marsili, Emanuela Cavallaro, Federica Marmo, Luca Turrini, Antonello Silvestri, Armando Passeri, Angelo Emanuele Catucci

EP174 PERFORMANCE OF DRESSINGS ON DONOR SITE IN BURN PATIENTS: INTEGRATIVE REVIEW OF LITERATUREFernanda Santos, Silvana Prazers, Sandra Leal

EP175 EVALUATION OF THE WEAR TIME AND RE-STICK PERFORMANCE OF A NEW SILICONE FOAM DRESSINGKelsey Hei, Shelley-Ann Walters, Anja Becker

EP176 SILICONE FOAM DRESSINGS: EVALUATING ABSORPTION UNDER COMPRESSION THERAPYJames Sieracki, Anja Becker

EP177 USE ADVANCED POLYMERIC MEMBRANE DRESSING ON ABRASION WOUND CARE EXPERIENCEYu-Chi Wang, Yen Huang, Hsing-Kuang Lai

EP178 AN IN-VITRO EVALUATION OF THE PHYSICAL CHARACTERISTICS OF TWO GELLING FIBER DRESSINGSCraig Delury, Rachel Bolton

EP179 COMPARISON OF THE EFFECT OF NON-ADHERING DRESSINGS AND A DRAINAGE FOIL DURING NPWT IN VITROCornelia Wiegand, Martin Abel, Stefanie De Lange, Peter Ruth, Martin Pohl, U.-C. Hipler

EP180 APPLICATION OF NON-ADHERING DRESSINGS DURING NPWT IN VITROCornelia Wiegand, Martin Abel, Stefanie De Lange, Peter Ruth, Martin Pohl, U.-C. Hipler

EP181 TREATMENT OF HYPERGRANULATION: A REVIEWBabette de Waard, Anne-Margreet van Dishoeck, Ron Legerstee, S.E.R. Hovius

EP182 EVALUATIONS OF THE PERFORMANCE OF A NEW SILICONE ADHESIVE FOAM DRESSING*Thomas Lane, MIchelle Delbono

EP183 THE EXUDATE PATHWAY - HOW TO ACHIEVE PATIENTS BENEFITS WITH COST SAVINGSLorraine Jones

EP184 NON-INFERIORITY RANDOMIZED CLINICAL STUDY: CALCIUM POLYURONATE VS. NEGATIVE PRESSURE WOUND THERAPYRevol Marc, Atlan Michaël, Barthelemy Isabelle, Bertheuil Nicolas, Braye Fabienne, Bruant-Rodier Catherine, Cambon-Binder Adeline, Casanova Dominique, Casoli Vincent, Chignon-Sicard Bérengère, Gorj Mihai, Guerreschi Pierre, Hu Weiguo, Moullot Pierre, Philandrianos Cécile, Pluvy Isabelle, Rousseau Pascal, Sinna Raphael, Stroumza Nathaniel, Watier Eric

EP185 RANDOMISED CROSSOVER CLINICAL TRIAL: FOAM OF NEGATIVE PRESSURE WOUND THERAPY + CALCIUM POLYURONATE INTERFACE VS. FOAM ALONEGayet Louis-Etienne, Abiraad Maroun, Bey Eric, Collet Denis, Paquette Brice, Radu Dana, Regimbeau Jean-Marc, Reibel Nicolas

15.00-15.30 BURNS 1

EP186 ANALYSIS OF THE FACTORS ASSOCIATED WITH THE SEVERITY AND TREATMENT OF PARTIAL THICKNESS BURNS IN BURN PATIENTS ATTENDED AT A REFERENCE PRIVATE E BURN CENTER IN THE CITY OF FLORIANÓPOLIS, BRAZIL.Mauricio Pereima, Andrea Trentin, Dilmar Leonardi, Carolina Cureau, Paula Nascimento

EP187 EXPERIENCE WITH SILVER ALGINATE PASTE ON PARTIAL THICKNESS BURNSEvgeny Zinoviev, Denis Kostyakov, Kamil Osmanov, Ilya Almazov

EP188 IMPROVING METHODS OF SURGICAL TREATMENT IN COMBUSTIOLOGY USING VACUUM THERAPYSergey Bogdanov, Roman Babichev, Denis Marchenko, Anatoliy Zavrazhnov

EP189 FEATURES TREATMENT OF DERMAL BURNS OF THE UPPER EXTREMITIESOlga Kovalenko, Heorhii Kozynets, Anton Kovalenko

104

EP190 THE USE OF STEM CELLS TECHNOLOGY IN THE TREATMENT OF DEEP BURNHeorhii Kozynets, Olga Kovalenko, Volodimir Tsygankov

EP191 PLANNING AND EXECUTION OF TISSUE EXPANSION IN POST BURN SCARS AND DEFECTSVinay Kumar Tiwari, Ankur Tiwari

EP192 SILVER SULFADIAZENE CREAM VS. SUSTAINED RELEASE SILVER DRESSING IN BURN: A SURPRISING RESULTVinay Kumar Tiwari, Ankur Tiwari

EP193 THE METHODS OF RECONSTRUCTION IN ELECTRICAL BURN INJURIES OF SEVERELY TRAUMATIZED CERVICAL REGIONChunyu Xue


9.30-10.00 HOME CARE, PAIN AND QUALITY OF LIFE

EP194 VALIDITY, INTER-RATER AND INTRA-RATER RELIABILITY OF AN ADJUSTABLE COMPRESSION DEVICE APPLICATIONJeanette Muldoon, Sylvie Hampton

EP195 CHALLENGES IN CHANGING HEALTH CARE SYSTEMS: EXPERIENCES WITH LOW FREQUENCY ULTRASOUND USED FOR WOUND DEBRIDEMENT IN HOME CARE SETTINGSBernd Gächter, Sebastian Probst, Stephan Schlunke, Paul Biegger

EP196 HOW CAN VELCRO COMPRESSION WRAP SYSTEMS CONTRIBUTE IN WOUND MANAGEMENTRobert de Klerk

EP197 IMPACT OF PUNCH-GRAFTING ON PAIN IN PATIENTS WITH CHRONIC ULCERSElena Conde Montero, Soledad Guisado Muñoz, Laura Pérez Jerónimo, Alicia Peral Vázquez, Juan Jesús Montoro López, Raquel Carrascosa de Lome, Pablo de la Cueva Dobao

EP198 EFFECTS OF CAPSAICIN 8% PATCH ON DIABETIC PERIPHERAL PAINFUL NEUROPATHY IN REAL LIFEGunilla Larsson, Katarina Fagher, Magnus Löndahl

EP199 LIVING WITH A STOMA: AN INTEGRATIVE REVIEW OF LITERATURE REVIEWSJoao Caine, Paulino Sousa, Isabel Moreira

EP200 A CASE SERIES DEMONSTRATING THE EFFECTIVNESS OF TOPICAL WOUND OXYGEN ON CHALLENGING LOWER EXTREMITY WOUNDS PRESENTING TO A COMMUNITY-BASED OUTPATIENT CLINICMichael Griffiths, Lisa Horn-Stinson

EP201 EPIDERMOLYSIS BULLOSA: THE UAE EXPERIENCEDiana Darweesh

12.30-14.15 BASIC SCIENCE

EP202 ESTABLISHMENT OF EARLY SKIN PRESSURE ULCER MODEL IN MINIATURE PIGS AND THE PATHOLOGICAL ANALYSISZequn Chen, Hao Daifeng, Guang Feng, Wanli Chu, Fan Zhao

EP203 EVALUATION OF THE ANTISEPTICS TOXICITY IN PORCINE SKIN EXPLANTSKristina Nešporová, Vojtěch Pavlík, Veronika Machalová, Vladimir Velebny

EP204 EFFECT OF HUMAN PLACENTAL EXTRACT ON RANDOM PATTERN FLAP SURVIVAL IN RATSSeungeun Hong, So Ra Kang, Bo Young Park

EP205 COMPARISON BETWEEN EFFECTS OF HUMAN UMBILICAL CORD BLOOD-DERIVED MESENCHYMAL STEM CELLS AND HEALTHY FIBROBLASTS ON WOUND HEALING ACTIVITY OF DIABETIC FIBROBLASTSJae-A Jung, Seung-Kyu Han

EP206 EFFECTS OF HUMAN ADIPOSE DERIVES STEM CELLS AND STROMAL VASCULAR FRACTION ON CRYOPRESERVED FAT GRAFTJoo Hyoung Kim, June Seok Choi, Su Bong Nam

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

105

EP207 ANATOMICAL STUDY OF SUPERFICIAL FEMORAL ARTERY AND COLLATERALS; IS IT SAFE TO USE ANTEROLATERAL THIGH FLAP WITHOUT CT ANGIOGRAPHY IN DIABETIC PATIENTSHyun-suk Suh, Joon Pio Hong

EP208 WELL-BEING IN WOUNDS INVENTORY(WOWI):A RELIABILITY AND VALIDITY MEASURE OF WELL-BEING IN CHINESE PEOPLE WITH CHRONIC WOUNDSWeiwei Xu Yuting Bao, Li Wei

EP209 HUMAN DERMAL MESENCHYMAL STROMAL CELLS ASSOCIATED WITH BACTERIAL CELLULOSE MEMBRANES: A NEW TOOL FOR SKIN WOUND TREATMENTAndrea Trentin, Dilmar Leonardi, Rafaela Machado, Talita Jeremias, Diana Heck, Michele Rode, Maiara Silva, Camila Silva, Derce Recouvreux, Mauricio Pereima

EP210 THE EFFECTS OF ADIPOSE DERIVED STEM CELLS ON PERIPHERAL NERVE REGENERATIONYoung Joon Jun

EP211 HONEY REPRESSES VIRULENCE AND VIABILITY IN STAPHYLOCOCCUS AUREUS FROM ATOPIC DERMATITISSuhaila Al Kindi, Rose Cooper, Rowena Jenkins

EP212 A NOVEL RECONSTRUCTION METHOD FOR MAXILLARY DEFECT USING A PATIENT-SPECIFIC 3D PRINTED BIODEGRADABLE SCAFFOLDHyun Ho Han, Jong Won Rhie, Jin Hyung Shim, Won Soo Yun

EP213 EVALUATION OF LAMININ-DERIVED PEPTIDE PROMOTING SCIATIC NERVE REGENERATIONHahn Sol Bae, Sang Wha Kim

EP214 EFFECT OF RETINOIC ACID ON PROLIFERATION OF HUMAN UMBILICAL VEIN ENDOTHELIAL CELLSEunsoo Park, Seung Min Nam, YongBae Kim

EP215 THE EFFECT OF RECIPIENT SITE PRECONDITIONING WITH FRACTIONAL CO2 LASER ON FAT SURVIVAL RATEJun Ho Lee, Jaewon Kim, Sung-Eun Kim

EP216 NEGATIVELY CHARGED MICROSPHERES PROVIDE AN ADDITIONAL SURFACE FOR CELL ATTACHMENT LEADING TO PROLIFERATION, TISSUE REGENERATION AND WOUND HEALINGLuis Guillermo Correa Astorquiza

EP218 THE NEW METHOD FOR MEASUREMENT OF INFLAMMATORY MARKERS IN THE WOUND SECRETIONSLenka Javorska, Lenka Kujovská Krčmová, Lubos Sobotka

EP219 THE EVALUATION OF THE ANTIMICROBIAL, CYTOTOXIC AND ANTIOXIDANT POTENTIAL OF THE CRUDE ETHANOLIC EXTRACTS OF PLUMERIA RUBRA: A PERSPECTIVE FOR WOUND HEALINGRegina Célia Sales Santos Veríssimo, Izabelle Cristina Acioly de Omena, Maria Gabriella Silva Araujo, Andressa Letícia Lopes da Silva, Joice Fragoso da Silva Oliveira, Thaís Honório Lins Bernardo, João Xavier de Araújo Júnior

EP220 EVALUATION OF THE BIOLOGICAL POTENTIAL OF THE CAATINGA SPECIES FOR WOUND HEALINGRegina Célia Sales Santos Veríssimo, Andressa Letícia Lopes da Silva, Maria Gabriella Silva Araujo, Joice Fragoso da Silva Oliveira, Maria Lysete de Assis Bastos, João Xavier de Araújo Júnior

EP221 EFFICACY OF THE ETHANOLIC EXTRACT OF MELIA DUBIA ON CUTANEOUS WOUND HEALING IN RATSLonchin Suguna, Pratima Pathak, Ponrasu Thangavel, Iyappan Kuttalam, Vinaya Subramani Gayathri, Sangeethapriya Vilvanathan

EP222 EXPERT-BASED RECOMMENDATIONS AIMED TO IMPROVE THE QUALITY OF CLINICAL RESEARCH ON THE TREATMENT OF WOUND INFECTIONSSilvia Tedesco, Giovanni Pomponio, Angela Peghetti, Tommaso Bianchi, Sara Rowan, Alessandro Greco, Keith Cutting, Patricia Price, Zena Moore, Randall Wolcott

EP223 FISH SKIN SUPPORTS 3D CELL INGROWTH OF ADIPOSE DERIVED MESENCHYMAL STEM CELLS FOR 21 DAYS IN VITROPAM 2017Skuli Magnusson, David M. Burmeister, Robert J. Christy, Matthew K. McIntyre, Baldur T. Baldursson, Hilmar Kjartansson, Fertram Sigurjonsson

EP224 FISH SKIN GRAFTS PROMOTES SUPERIOR CELL INGROWTH COMPARED TO AMNION ALLOGRAFTS, HUMAN CADAVER SKIN AND MAMMALIAN CTPSJohn Lantis

EP225 OXIDATIVE DAMAGE PERSISTS AFTER EPITHELIZATION OF VENOUS LEG ULCERSVojtěch Pavlík, Lubos Sobotka, Vladimir Velebny

106

EP226 THE EFFECT OF ADIPOSE-DERIVED STEM CELLS FOR WOUND HEALING: COMPARISON OF APPLICATION METHOD Hyeonwoo Kim, Sang Wha Kim

15.30-16.00 LEG ULCER 2

EP227 THE COMPARISON OF EFFECT OF HYALUROINAN-OCTENIDINE BASED AND SILVER BASED WOUND DRESSINGS ON BIOFILM FORMATIONLubos Sobotka, Vladimira Adamkova, Jitka Borkovcova

EP228 EVLT ABLATIO TREATMENT OF PATIENTS WITH A VENOUS LEG ULCER, WHAT DOES EVIDENCE TELL USCarla van Dijk

EP229 PATIENT INVOLVEMENT IN IMPROVING LEG ULCER MANAGEMENTClair Priestly, Elizabeth Merlin-Manton

EP230 A NEW METHOD OF CLOSING LARGE LEG ULCERSMarcin Malka

EP231 USING CONSERVATIVE AND SURGICAL TREATMENT FOR PERSISTENT CHRONIC VASCULAR ULCER MANAGEMENTInga Guogiene, Agne Andriuskeviciute, Augustina Grigaite, Darius Bagdanavicius, Rytis Rimdeika

EP232 ZINC BASED VS. FOUR COMPONENT COMPRESSIONAllison O’Connor, Eri Fukaya, Andreas Nilsson, Torbjörn Lundh

EP233 INTEGRATING AN INNOVATIVE ACID-OXIDIZING SOLUTION INTERACTING WITH THE WOUND MICROENVIRONMENT IN THE MANAGEMENT OF CHRONIC WOUNDS: INTERIM ANALYSIS OF OBSERVATIONAL EVIDENCESVeronica Fessia, Elia Ricci

EP234 AN AUDIT OF THE USE OF COMPRESSION HOSIERY KITS AS FIRST LINE TREATMENT OF PATIENTS WITH LEG ULCERATION IN LEG ULCER CLINICSClare Lazelle, Becky Joyce

EP235 THE COMBINED USE OF LYMPHOTAPING AND ANTIMICROBIAL DRESSING TO REDUCE PAIN IN PATIENTS WITH LOWER LIMB CHRONIC WOUNDSOrnella Forma, Giulia Vidotto, Umberto Cazzaro, Teresita Gaiani, Sara Maria Lupi


9.30-10.15 PRESSURE ULCER 2

EP027 TREATMENT OF PRESSURE CUTANEOUS ULCER CAUSED BY PACEMAKER IMPLANTATIONHongwei Liu

EP028 PRESSURE ULCER RISK ASSESSMENT AND PREVENTION: IMPLEMENTATION OF EVIDENCE-BASED NURSING PRACTICEAsuncion Merino, Ana Mateo, Teresa Garcia, Lourdes Alvira, Maria Jose Lasheras, Ana Izco

EP029 A FORMAL EVALUATION USING AN ACTIVE THERAPY MATTRESS SYSTEM FOR PRESSURE ULCER PREVENTION IN AN ACUTE CARE SETTINGHelen Strapp, Sinead Roche

EP236 EVALUATION OF A POWERED HYBRID MATTRESS WITHIN A BUSY CLINICAL ASSESSMENT WARD AND MEDICAL WARD SETTING: A PRACTICAL ADVANTAGEKaren Whelan

EP238 CLINICAL EFFICACY OF SKIN PROTECTANT IN PREVENTION PRESSURE INJURY AND MOISTURE ASSOCIATED SKIN DAMAGE IN ACUTE CAREKyuwon Baek, Minkyung Kim, Kyoungmin Kwon

EP239 DEBRIDEMENT METHODS EFFICACY FOR THE SECOND STAGE PRESSURE ULCERS TREATMENT IN OUTPATIENT DEPARTMENTErnest Zacharevskij, Valdone Kolaityte, Gytis Baranauskas, Karolina Venslauskaite, Rytis Rimdeika

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

107

EP240 HANDHELD DEVICE TO DECREASE HOSPITAL ACQUIRED PRESSURE INJURIES: FROM THEORY TO PRACTICERose Raizman, Minette MacNeil

EP241 INCIDENCE OF PRESSURE INJURY IN PEDIATRIC INTENSIVE CARE UNIT IN BRAZILMaria Lucia Barbosa Maia dos Santos, Juliana Caires de Oliveira Achili Ferreira, Marcia Aparecida de souza, Solange Mignoni Guimarães, Hida Yogui

EP242 CARDIOPULMONARY RESUSCITATION (CPR) FUNCTION OF AIR MATRESSES IS USELESSEsa Soppi, Ansa Iivanainen, Leila Sikanen, Elina Jouppila-Kupiainen

EP243 DECUBITUS IS STILL A PROBELM IN THE 21 CENTURYLenka Veverkova, Alena Gerslova, Katerina Krejsova, Petr Vlcek, Jan Žák, Michal Reška, Jan Konecny

EP244 THE 24H, LOW FLOW RATE OF OXYGEN SUPPLY COMBINED WITH MOIST THERAPY IN THE TREATMENT OF PRESSURE ULCER STAGE 3,4Yingpei Zeng, Miaoli Wu, Shumin He

EP245 PREVENTION AND REDUCTION OF PRESSURE ULCERS/MOISTURE INJURYYvonne Bouten - Siebers

EP246 CLINICAL AUDIT AS STRATEGY FOR THE EVALUATION OFTHE ATTENTION TO THE PATIENT IN A PRESSURE ULCERS’ PREVENTION PROGRAM IN ANUNIVERSITY HOSPITALFrancesco Uccelli, Marilena Pradal, Monica Scateni, Marco Romanelli

EP247 INVESTIGATING SKIN BARRIER FUNCTION AND THE RISK OF PRESSURE ULCERATION - FROM CONCEPTUALIZATION TO RECRUITMENTJimmy Choo, Steven Ersser


11.45-13.30 NEGATIVE PRESSURE WOUND THERAPY

EP248 VACUUM THERAPY FOR BURNS AND WOUNDS OF DIFFERENT ETIOLOGYAliaksei Chasnoits

EP249 CURATIVE EFFECTS PF PLATELET-RICH PLASMA COMBINED WITH NEGATIVE PRESSURE WOUND THERAPY ON STERNAL OSTEOMYELITIS AND SINUS TRACT AFTER THORACTOMYHao Daifeng, Guang Feng, Tao Li, Wanli Chu, Zequn Chen, Shanyou Li, Xinjian Zhang, Jingfeng Zhao, Fan Zhao

EP250 THE EFFECT OF POSTOPERATIVE NEGATIVE PRESSURE WOUND THERAPY ON THE INCIDENCE ON WOUND DEHISCENCE IN HIGH RISK PATIENTSEmmy Sloof, Erik de Laat, D.J.O. Ulrich, Pèdrou D. Westland

EP251 NEGATIVE PRESSURE WOUND THERAPY POSITIONING RISK INDEX: A PILOT STUDYMario Antonini, Gaetano Militello, Francesco Loru

EP252 APPLICATION OF NEGATIVE PRESSURE WOUND THERAPY IN MYLTIMODAL TREATMENT OF DIFFUSE PERITONITIS IN CANCER PATIENTS (PRELIMINARY EVALUATION)Roman Murashko, Ivan Uvarov, David Sichinava

EP253 WOUND MANAGEMENT WITH VARIABLE INTERMITTENT AND CONTINUOUS NEGATIVE PRESSURE WOUND THERAPY (NPWT): INTERIM RESULTS FROM A RANDOMISED CONTROLLED TRIALMartin Forlee, Judith Horner, Alan Rossington, John Cockwill, Jenny Smith

EP254 NEGATIVE PRESSURE WOUND THERAPY FOR MANAGEMENT OF COMPLICATED WOUND AT ECMO (EXTRACORPOREAL MEMBRANE OXYGEN SYSTEM) SITEYeseul Eom, Kyong-ge Woo Woo, Jai-Kyong Pyon

EP255 ENDOLUMINAL VACUUM FOR ESOPHAGEAL PERFORATION TREATMENTSirota Alexander, Aleksey Kovalenko, Artur Akobyan

EP256 THE USAGE OF AN ULTRAPORTABLE SIMPLIFIED CANISTERLESS NPWT DEVICE IN PATIENTS WITH PILONIDAL DISEASEMikhail Egorkin, Ilya Gorbunov, Sergey Goryunov, Valery Vechorko, Eteri Bolkvadze

EP257 COST MINIMIZATION ANALYSIS WITH CONTROLLED NEGATIVE PRESSURE THERAPYClara Lourenço, Sandra Lourenço, Jacinto Costa, Óscar Lourenço

108

EP258 REAL-TIME FLUORESCENCE IMAGING OF BACTERIA GUIDES TREATMENT SELECTION AND TIMING OF DRESSING CHANGES IN INPATIENTS UNDERGOING NEGATIVE PRESSURE WOUND THERAPYRose Raizman

EP259 NEGATIVE PRESSURE THERAPY FOR STERNAL WOUND INFECTION IN CHILDREN AFTER CONGENITAL HEART SURGERYAlexey Voitov, Ilya Soynov, Alexey Zubritskiy, Yuriy Gorbatykh, Artem Gorbatykh, Nataliay Nichay, Yuriy Kulaybin, Alexander Bogachev-Prokophiev, Alexander Karaskov

EP260 USE OF NEGATIVE PRESSURE WOUND THERAPY IN THORACO-ABDOMINAL SURGERY: OUR 7-YEARS EXPERIENCEStefano Sanna, Jury Brandolini, Marta Mengozzi, Desideria Argnani, Natascia Valentini, Dario Bettini, Piergiorgio Solli

EP261 THE USE OF NEGATIVE PRESSURE WOUND THERAPHY IN CHRONIC AND TRAUMATIC WOUNDS: WHAT HAS CHANGED IN OUR CLINICAL PRACTICE? OUR EXPERIENCE OF 15 YEARSAmedeo Strano, Giuseppe Amadeo, Gabriele Delia, Francesco Stagno d`Alcontres

EP262 EVALUATION OF A NEW NEGATIVE PRESSURE WOUND THERAPY SYSTEM INCORPORATING A HYDROFIBER DRESSINGEmma Sharp, Constance Traynor

EP263 THE FIRST DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY DEVICE WITH HYDROFIBER DRESSING TECHNOLOGY; A MULTI-SITE CLINICAL EVALUATIONRachel Torkington-Stokes

EP264 A NEW SYSTEM WHICH COMBINES NEGATIVE PRESSURE WOUND THERAPY WITH HYDROFIBER TECHNOLOGYJudith Barnard

EP265 NEGATIVE PRESSURE WOUND THERAPY IN TREATMENT OF INFECTED WOUNDS IN PEDIATRIC SPINE SURGERYNikita Khusainov, Belyanchikov Sergey, Murashko Vladislav, Kartavenko Kirill, Kokushin Dmitry, Vissarionov Sergey, Alexey Baindurashvili

EP266 NPWT FOR COMPLICATED WOUNDS AFTER LOWER LIMP SURGERY IN CHILDRENVladimir Kenis, Sapogovskiy Andrey

EP267 SINGLE-USE NEGATIVE PRESS ION WOUND THERAPY: AN EXTRA HELP IN TREATING SURGICAL INCISION COMPLICATIONSDomitilla Foghetti

EP268 CAN NEGATIVE PRESSURE WOUND THERAPY REDUCE THE INTRAABDOMINAL ADHESIONS IN PATIENTS TREATED WITH OPEN ABDOMEN TECHNIQUETomasz Banasiewicz, Adam Bobkiewicz, Aleidis Caro, Bartosz Cybułka, Salomone Di Saverio, Marco Fraccalvieri, Martin Hutan, Minna Kääriäinen, Tomasz Kasprzyk, Kirien Kjossev, Mike Laukoetter, Nadia Lehwald-Tywuschik, Craig McBride, Ventsislaw Mutafchyiski, Giuseppe Novelli, Olona Carles, Georgi Popivanov, Zoran Stojcev, Marek Szczepkowski, Zoltan Szeberin, Alberto Tavares de La Paz Luis, Csaba Toth, Gregorio Tugnoli, Arnulf Gregor Willms, Lenka Veverkowa, Fahri Yetisir, Marek Zawadzki, Maciej Zielinski, Zsolt Zsenkeresti, Zbigniew Lorenc

EP269 IMPACT ON THE TISSUE EPITHELIALIZATION OF A COMBINED USE OF NPWT AND EQUINE COLLAGEN: OBSERVATIONAL ANALYSISBattistino Paggi, Ornella Forma, Umberto Cazzaro’, Teresita Gaiani, Giulia Vidotto, Sara Maria Lupi


12.30-14.15 DRESSINGS 2

EP270 A NEW MODALITY OF WOUND CARE TREATMENT IN PNI WITH AN ACTIVE MEDICATION: A PILOT STUDYClaudio Morisi

EP271 THE ART OF DRESSING SELECTION: A CONSENSUS STATEMENT ON SKIN TEARS AND BEST PRACTICEKimberly LeBlanc, Karen Campbell, Samantha Holloway, Ann Williams, Mary Gloeckner, Dawn Christensen, Diane Langemo, Kevin Woo, Sharon Baranoski

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

109

EP272 A NEW MODALITY OF WOUND CARE TREATMENT IN PNI WITH AN ACTIVE MEDICATION: A PILOT STUDYClaudio Morisi

EP273 ANTI-BIOFILM EFFICIENCY OF DIFFERENTLY DESIGNED ELECTROSPUN DRUG-LOADED FIBROUS DRESSINGS FOR THE LOCAL TREATMENT OF INFECTED WOUNDSLiis Saks, Andres Meos, Ivo Laidmäe, Tavo Romann, Marta Putrins, Tanel Tenson, Karin Kogermann

EP274 CLINICAL ASSESSMENT OF A NOVEL RECOMBINANT HUMAN COLLAGEN FLOWABLE MATRIX FOR WOUND MANAGEMENTEyal Shapira, Eran Tamir, Elad Keren, Tal Amzel, Hannah Kaufmanh

EP275 IN VITRO EVALUATIONS OF A NEW SILICONE ADHESIVE FOAM DRESSING IN APPLICATIONS WHERE SHEAR FORCE AND PRESSURE ARE PRESENTThomas Lane, Daniel Parker

EP276 A 100% CHITOSAN DRESSING FOR RAPID HAEMOSTASIS AND ANTIBIOTIC DELIVERY TO TRAUMATIC WOUNDS: A NOVEL APPROACH TO MANAGE SEVERE TRAUMA INJURIESLeo Mavely, Kiran Sonaje

EP277 COMPARISON OF ABSORBENTS DRESSINGS: RELATIONSHIP BETWEEN CLINICAL EVIDENCE AND PATIENT SATISFACTIONAlessandro Corsi

EP278 TOPICALITY OF BACTERIAL BINDING ANTIMICROBIAL DRESSING 10 YEARS FROM THE APPEARANCE ON THE MARKET: COMPARISON WITH A PREVIOUS COMPARATIVE STUDYAlessandro Corsi, Simone Baldacci

EP279 AN ASSESSMENT OF ANTIMICROBIAL WOUND DRESSINGS WHICH INCORPORATE ONE PIECE REMOVAL TECHNOLOGIESAlexander Waite, Craig Delury, Daniel Parker

EP280 EVALUATION OF ADHESION ON SKIN WITH A NEW HYDROPHILIC FOAM DRESSING WITH A SOFT SILICONE ADHESIVESebastian Zimmermann, Klaus-Peter Wilhelm, Marianne Brandt, Iryna Kruse

EP281 IN VITRO EXUDATE MANAGEMENT PERFORMANCE OF A NEW HYDROPHILIC FOAM DRESSING RANGESebastian Zimmermann

EP282 DESIGN ATTRIBUTES OF A HYDROPOLYMER ADHESIVE DRESSINGLeanna Poole, Clinton Hill

EP283 COMPARISON OF CADEXOMER IODINE AND AN ANTI-BIOFILM DRESSING IN AN IN VITRO SIMULATED CHRONIC WOUND BIOFILM MODELRuth Scully, Mike Walker, Jan Hobot, Dan Metcalf, Philip Bowler, David Parsons

EP284 CLINICAL RESULTS WITH USE OF POLYURETHANE FOAM DRESSING ON AN ENDORSED WOUND HEALING CENTRE IN SESC SAÚDE SÃO FRANCISCO, BELO HORIZONTE, BRAZILAna Beatriz De Pinho Barroso, Rogério Noronha, Rosália Rodrigues, Bárbara Raposo, Bárbara Monteiro, Mislene Persilva, Jailton de Oliveira, Gisele Avelar, Suelen de Souza, Jéssica Leroy

EP285 COLLAGEN-HONEY FILMS: A NOVEL COMBINATION FOR THE MANAGEMENT OF HARD-TO-HEAL WOUNDSAnnalisa Neri, Arash Moavenian, Eduardo Saiz

EP286 REDUCING HEALING TIMES USING AN INNOVATIVE NEW PRODUCTEbony Ryan

EP288 PRE-CLINICAL CHARACTERIZATION OF WOUND BED MICROENVIRONMENT MODULATION BY AN INNOVATIVE ACID-OXIDIZING SOLUTIONNadia Giarratana, Jeff Hart

EP289 THE USE OF A NEW, ACTIVE TREATMENT OPTION TO HEAL 10 STALLED WOUNDSBrenda King

EP290 THE COMPARIAON OF THE SKIN GRAFT DONOR SITE BETWEEN THE TREATMENT WITH REMNANT SKIN AND THE TREATMENT WITH FOAM DRESSINGSae Hwi Ki

EP291 AN 8-WEEK OPEN-LABEL, NON-COMPARATIVE, MULTICENTRE EVALUATION OF THE PERFORMANCE OF A TECHNOLOGY LIPID-COLLOID NANO-OLIGOSACCHARIDE FACTOR WOUND DRESSINGKatie Adolphus, Louise Toner, Jackie Stephen-Haynes, Michelle Deeth

110

EP292 CLINICAL EFFECTIVENESS OF HAEMOGLOBIN SPRAY AS ADJUNCT THERAPY - META-ANALYSIS BY WOUND TYPE ACROSS THREE REAL WORLD, RETROSPECTIVE COHORT CONTROLLED EVALUATIONSFredrik Elg, Sharon Dawn Hunt

EP293 A 2-WEEK OPEN-LABEL, NON-COMPARATIVE, MULTICENTRE EVALUATION OF THE PERFORMANCE OF A HYDRO-DESLOUGHING ABSORBENT TECHNOLOGY LIPIDO-COLLOID SILVER WOUND DRESSINGKatie Adolphus, Louise Toner, Jackie Stephen-Haynes, Michelle Deeth

EP294 STIMULATION OF THE WOUND BED IN MID-SECRETING LESIONS: AN INNOVATIVE DRESSINGAlessandro Corsi

EP295 FISH SKIN ACELLULAR DERMAL MATRIX FOR TREATMENT OF CHRONIC WOUNDS IN DIABETICSHolger Diener, E. Sebastian Debus

EP296 THE USE OF MEDICAL GRADE HONEY IN THE SOUTH AFRICAN WOUND CARE ENVIRONMENTLiezl Naude


9.30-10.15 EDUCATION

EP297 DEVELOPMENT OF CLINICAL PRACTICE GUIDELINE BY ADAPTATION: DIABETIC FOOT CAREIhn Sook Jeong, Park Kyung Hee

EP298 BUILDING EVIDENCE-BASED PRACTICE: AN OVERVIEW OF SYSTEMATIC REVIEWS RELATED WITH ADVANCED CARE IN WOUNDSRui Pereira, Joao Caine, Maria Rito

EP299 TRAINING DEVICE FOR A BETTER MANAGEMENT OF VENOUS LEG ULCERS WITH COMPRESSION THERAPY, IN HOME CAREStéphane Coffre, Catherine Busnel, Sebastian Probst

EP300 TRAINING AND EDUCATION TO PROMOTE WOUND MANAGEMENT: EXPERIENCE ON ASUR MARCHE AV 3Martina Tesei, Battistino Paggi

EP301 THE JOURNEY TO A ONE STOP WOUND CARE SHOPNicky Griffith

EP302 DEVELOPING AND IMPLEMENTING A LEG ULCER PATHWAY TO IMPROVE WOUND HEALING OUTCOMESJulie Mullings, Elizabeth Merlin-Manton

EP303 DEVELOPING A COMPETENCY FRAMEWORK FOR CHRONIC OEDEMAJanice Bianchi, Madeleine Flanagan, Susan Knight, Ray Norris

EP304 USE MONITOR-SCALE SYSTEM ON NEGATIVE PRESSURE WOUND THERAPY EXPERIENCEYu-Chi Wang, Yen Huang, Hsing-Kuang Lai

EP305 EPIDERMOLYSIS BULLOSA: A CHALLENGE FOR THE (OVER) LIFESilvana Prazers, SANDRA Leal

EP306 KNOWLEDGE OF WOUND CONSULTANT NURSES IN PRESSURE ULCERS PREVENTION IN THE CZECH AND SLOVAK REPUBLICAndrea Pokorna, Jana Dvořáková

EP307 REAL-TIME BACTERIAL FLUORESCENCE IMAGING GUIDES WOUND CLEANING AND FACILITATES PATIENT EDUCATION IN PILONIDAL SINUS WOUND CARE PATIENTSRose Raizman

EP308 IMPACT OF A TRAINING INTERVENTION IN STUDENTS ON TWO ACRONYMS FOR THE EVALUATION OF CHRONIC WOUNDSAdrián Fuentes Agúndez, Gonzalo Esparza Imas, María Jesús Morales Pasamar, Juan Manuel Nova Rodríguez, Lucía Crespo Villazán

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

111

www.ewma.org

EP309 EFFECTIVELY BRIDGING THE THEORY PRACTICE GAP THROUGH COLLABORATIVE EDUCATIONKaren Ousey, Leanne Atkin, Jeanette Milne, Val Henderson

112

E-POSTERS (NOT IN E-POSTER SESSION)

EP310 SECONDARY INTENTION HEALING AFTER SURGICAL EXTERIORIZATION OF HIDRADENITIS SUPPURATIVAKyoung Ae Nam, Kee Yang ChungAcute Wounds

EP311 THE EFFICACY OF A HAEMOGLOBIN OXYGEN SPRAY ON BIOFILMSSteven Percival, Sonya Taylor, Lousie SulemanAntimicrobials

EP312 AN INNOVATIVE WOUND IRRIGATING SOLUTION FOR CONTROLLING BIOFILMSSteven Percival, Sonya Taylor, Louise SulemanAntimicrobials

EP313 EFFICACY OF NEXT GENERATION ANTI-BIOFILM WOUND DRESSINGSSteven Percival, Sonya Taylor, Rui Chen, John Hunt, Louise SulemanAntimicrobials

EP314 DETERMINATION OF THE BIOBURDEN LEVEL OF SPOOLS OF SURGICAL TAPES IN DIFFERENT MEDICAL INSTITUTIONSBirgit Struensee, Thorben Nehrdich, Verena Deing, Victoria YuAntimicrobials

EP315 IN VIVO EFFICACY OF WOUND IRRIGATION SOLUTIONSGerhard Kammerlander, Claudia Geyrhofer, Gerlinde Luch, Thomas EberleinAntimicrobials

EP316 SCAR REMODELING EFFECT OF ALGINATE GEL-ENCAPSULATED DECOY WNT RECEPTOR (SLRP6E1E2)-EXPRESSING ADENOVIRUS IN A PIG MODELChae Eun Yang, Hsien Pin Chang, Hyo Min Ahn, Chae Ok Yun, Won Jai LeeBasic Science

EP317 IDENTIFICATION OF FIBROCYTE-LIKE CELLS IN WOUND BIOPSIES FROM EQUINE EXPERIMENTAL WOUNDSLouise Bundgaard, Henrik Elvang Jensen, Bent Aasted, Mette Aamand Sørensen, Stine JacobsenBasic Science

EP318 PROTECTIVE EFFECT OF TELOMERASE-BASED 16-MER PEPTIDE VACCINE (GV1001) ON SUPERFICIAL INFERIOR EPIGASTRIC ISLAND SKIN FLAP SURVIVABILITY IN ISCHEMIA-REPERFUSION INJURY RAT MODELYung ki Lee, Tae Joon Choi, Young Hun ChungBasic Science

EP319 THE USE OF A NOVEL WOUND MODEL TO STUDY BIOFILM DEVELOPMENT AND EFFICACY OF WOUND DRESSINGS AND ANTIMICROBIALSLouise Suleman, Sonya Taylor, Steven PercivalBasic Science

EP320 MECHANICAL INJURY INCREASES THE RADIORESISTANCE OF NORMAL SKIN FIBROBLASTS BUT NOT TUMOR CELLSShi ChunmengBasic Science

EP321 TREATMENT OF WOUNDS BY HERBAL HEALERS IN A CAPITAL CITY IN THE NORTHEAST OF BRAZILRegina Célia Sales Santos Veríssimo, Maria Willianne Alves do Nascimento, Thaís Honório Lins Bernardo, Maria Lysete de Assis BastosBasic Science

EP322 ANTIBACTERIAL AND CYTOTOXIC ACTIVITY OF ARGEMONE MEXICANA LINN ROOT EXTRACT: PERSPECTIVE FOR THE TREATMENT OF INFECTED WOUNDSMaria Gabriella Silva Araujo, Wanderlei Barbosa dos Santos, Diolyne da Silva Barros, Bárbara do Nascimento Lopes Pessoa, João Xavier de Araújo Júnior, Regina Célia Sales Santos VeríssimoBasic Science

EP323 ANTIOXIDANT ACTIVITY OF PULLULAN HELPS HEALING OF DIABETIC WOUNDSSangeethapriya Vilvanathan, Iyappan Kuttalam, Vinaya Subramani GayathriBasic Science

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

113

EP324 THE USE OF THE MOLECULIGHT BACTERIAL CAMERA IN THE MANAGEMENT OF BACTERIAL LOAD IN BURN PATIENTSSteven JefferyBurns

EP325 EVALUATION OF A SURFACTANT-BASED PRODUCT IN THE MANAGEMENT OF SECOND DEGREE BURNSFrans MeuleneireBurns

EP326 PREVENTION OF POST-BURN SCARRING USING HYALURONIDASE PREPARATIONSAndrey Alekseev, Natalya MalutinaBurns

EP327 APPLICATION OF HISTOEQUIVALENT-BIOPLASTIC MATERIAL FOR TREATMENT OF BURN WOUNDSNatalya Malutina, Andrey Alekseev, Yryi TurnikovBurns

EP328 INVESTIGATION OF EFFECTIVENESS OF TEMPORARY SKIN SUSTITUTES IN TREATMENT OF BURN WOUNDSAleksandr Bobrovnikov, Andrey Alekseev, Natalya Malutina, Sergey PopovBurns

EP329 EFFECTIVENESS OF ACELLULAR DERMAL MATRIX ON AUTOLOGOUS SPLIT-THICKNESS SKIN GRAFT IN TREATMENT OF DEEL TISSUE DEFECT: DOES COGRAFT AFFECT OUTCOMES?Hee Joung Kim, Su Hyun JangDevices & Intervention

EP330 FREE FLAP TRANSFER FOR COVERAGE OF TRANSMETATARSL AMPUTATION STUMP TO PRESERVE RESIDUAL FOOT LENGTHSu Hyun Jang, Hee Joung KimDevices & Intervention

EP331 PROSPECTIVE EVALUATION OF A COLLAGEN REGENERATION MATRIX IN TERMS OF SAFETY AND EFFICACY FOR THIRD-DEGREE BURNS TREATMENT AND RECONSTRUCTIVE SURGERY IN THE UNIVERSITY HOSPITAL OF BORDEAUXVincent Casoli, Romain Weigert, Jean Christophe Lepivert, Tiphaine Menez, Audrey Michot, Emilie DesnouveauxDevices & Intervention

EP332 ANALYSIS OF MULTIPLE RISK FACTORS AFFECTING THE RESULT OF FREE FLAP TRANSFER FOR NECROTISING SOFT TISSUE DEFECTS OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUSYung Ki Lee, Baek Kyu Kim, Chang Sik PakDiabetic Foot

EP333 INJECTABLE SKIN SUBSTITUTES WITH ADIPOSE-DERIVED STEM CELLS ENHANCE DIABETIC WOUND HEALINGYixiao Dong, Sacha Khong, Sigen A, Melanie Rodrigues, Nina Kosaric, Elizabeth Brett, Wenxin Wang, Geoffrey GurtnerDiabetic Foot

EP334 HYDROTHERAPY A NEW TREATMENT APPROACH TO TREATING DIABETIC FOOT ULCERSPaul Chadwick, Samantha HaycocksDiabetic Foot

EP335 CHANGES IN BACTERIAL FLORA IN DIABETIC FOOT ULCERS DURING HYPERBARIC OXYGEN THERAPYElzbieta Arlukowicz, Roman Nowicki, Ewa LenkiewiczDiabetic Foot

EP336 IN VIVO METHODS TO EVALUATE A NEW SKIN PROTECTANT FOR LOSS OF SKIN INTEGRITYRaha A. Been, Stéphanie F. Bernatchez, Deena M. Conrad-Vlasak, Robert A. Asmus, Bruce P. Ekholm, Patrick J. Parks, Alexandra DreuwDressings

EP337 COMPARATIVE ASSESSMENT OF A NOVEL THIN POLYURETHANE FOAM DRESSINGAnder BugedoDressings

114

EP338 COMPOSITE MULTI-FUNCTIONAL DRESSINGS FOR SIMULTANEOUS DELIVERY OF LIDOCAINE AND SILVER NANOPARTICLES TO CHRONIC LEG ULCERSJoshua Boateng, Ovidio CatanzanoDressings

EP339 THE AIM OF THIS STUDY WAS TO EVALUATE A MALTODEXTRIN/ASCORBIC ACID DRESSING FOR TREATING CHRONIC AND ACUTE WOUNDS OF VARIOUS ETIOLOGYAlita Jaspar, Jonathan CayceDressings

EP340 EFFICACY OF A SURFACTANT-BASED WOUND DRESSING IN BIOFILM PREVENTION AND CONTROLSteven Percival, Sonya Taylor, Louise SulemanDressings

EP341 EFFICACY OF A SURFACTANT BASED WOUND DRESSING ON THE SEQUESTRATION OF MICROBES AND BIOFILMSLouise Suleman, Sonya Taylor, Steven PercivalDressings

EP342 EFFICACY OF SURFACTANT-BASED WOUND DRESSINGS ON BIOFILM PREVENTION AND CONTROL IN A 3D SKIN MODELLouise Suleman, Sonya Taylor, Steven PercivalDressings

EP343 COMPARISON OF HYALURONIC ACID CONTAINING PRODUCTS WITH WET DRESSING FOR SEVERE DECUBITUS ULCERSAsu Ozgultekin, Semih Güner, Onur Şahin Ozyol, Tuna Karahan, Osman EkinciDressings

EP344 AN IN VITRO SIMULATED CHRONIC WOUND MODEL TO ASSESS THE PERFORMANCE OF SILVER WOUND DRESSINGS AGAINST BIOFILM FORMATIONRuth Scully, Dan Metcalf, Jan Hobot, Mike Walker, Philip Bowler, David ParsonsDressings

EP345 MODERN DRESSINGS: EVALUATION OF THE PRACTICES ON THE USE AND DEVELOPMENT OF A PROTOCOLSara Mahfoudhi, Nessrine Kalboussi, Amel Hassairi, Kallel MohamedEducation

EP346 POSITIVELY IMPACTING SKIN HEALTH IN THE AGED - CLINICAL TRANSLATION OF WOUND RESEARCH OUTCOMES IN AUSTRALIATabatha Rando, Anthony DyerEducation

EP347 USING OUTCOMES TO IMPROVE WOUNDCARE IN THE WHOLE CARE CHAINKarin Creemers, Rens Van LiereHealth Economics & Outcome

EP348 THE EFFECTIVENESS OF WECHAT-BASED TRANSITIONAL CARE IN PATIENTS WITH ENTEROSTOMY COMPLICATIONSFengqing Lu, Yahong Zhao, Xinming Zhao, Yanan Shen, Ping ZhangHome Care

EP349 BURN PATIENTS BETTER OFF AT HOMEKarin Timm, Rob van KomenHome Care

EP350 NURSING TOPCAREJintiene ZeilstraHome Care

EP351 EARLY ABLATION OF REFLUX IN PATIENTS WITH ULCUS CRURIS VENOSUMSimon JulínekLeg Ulcer

EP352 PRESSURE AND SLIPPAGE DURING 48 HOURS OF COMPRESSION THERAPY: A STUDY ON HEALTHY VOLUNTEERSJoseph Tucker, Lynn Peterson, Diane Rauch, Shelley-Ann Walters, Jens BichelLeg Ulcer

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

115

EP353 FROM CONCEPTION TO DELIVERY: THE DEVELOPMENT OF A NEWLY COMMISSIONED LOWER LIMB THERAPY SERVICETracey McKenzieLeg Ulcer

EP354 MICROSCOPY DETECTION OF BACTERIA IN CHRONIC WOUND FLUIDElzbieta Arlukowicz, Roman Nowicki, Magdalena SidorowiczLeg Ulcer

EP355 ЕXPERIENCE IN APPLICATION OF VACUUM-DRAINAGE SYSTEMS IN THE WOUND TREATMENT OF DIFFERENT ETIOLOGY IN MULTY-SPECIALITY HOSPITALS OF KRASNODAR REGIONStanislav Pyatakov, Anatoly Zavrazhnov, Sergey Bogdanov, Aleksandr Shevchenko, Igor Lukyanchenko, Aleksandr Soldatov, Vladimir Basov, Svetlana RalkoNegative Pressure Wound Therapy

EP356 NEGATIVE PRESSURE WOUND THERAPY (NPWT) FOR THE MANAGEMENT OF OPEN ABDOMENSergey Shcherbak, Andrew Singayevsky, Dmitrii Gladyshev, Nikolay Wrublevski, Dmitrii OstapenkoNegative Pressure Wound Therapy

EP357 MULTILAYERED PROPHYLACTIC DRESSINGS ARE BIOMECHANICALLY EFFECTIVE PROVIDED THAT THEY ARE ADEQUATELY DESIGNEDAmit GefenPressure Ulcer

EP358 AN AIR-CELL-BASED CUSHION TECHNOLOGY IS EFFECTIVE IN PROTECTING BONY CLIENTSAyelet Levy, David Brienza, Kara Kopplin, Amit GefenPressure Ulcer

EP359 REDUCING INCIDENCE OF HOSPITAL ACQUIRED PRESSURE ULCERS BY ADDRESSING SPECIFIC PATIENT POPULATIONS AT A FACILITY LOCATED IN SOUTHWEST UNITED STATESDenise Betcher, Edward LewPressure Ulcer

EP360 EVALUATION OF AN INNOVATIVE NEW THERAPEUTIC MATTRESS SYSTEM WITHIN PREVENTION STRATEGIES FOR AN ACUTE ORTHOPAEDIC UNITKatrina McGownPressure Ulcer

EP361 OPERATIVE DEBRIDEMENT OF SACRAL PRESSURE ULCERS AND REVIEW OF 30-DAY POST-OPERATIVE COMPLICATIONSSusan Wozniak, Catherine Florecki, JoAnne Coleman, Vanita AhujaPressure Ulcer

EP362 PRESSURE ULCER PREVENTING PROGRAM AMONG PAEDIATRIC ECMO POPULATION - QUANTITIES STUDYOlga Gokhshtein, Olga RosensteinPressure Ulcer

EP363 IMPROVING PRESSURE ULCER PREVENTION IN CARE HOMESMichael Clark, Sue Haglestein, Nicola IvinsPrevention

EP364 QUALITY OF LIFE IN PATIENT WITH NON-HEALING WOUNDLenka Krupová, Andrea PokornaQuality of life

EP365 HYPERSPECTRAL IMAGING AS POSSIBLE NON-INVASIVE TECHNIQUE TO MONITOR TISSUE INJURY AND WOUND HEALING PROGRESSManuela Besser, Mirwaes Wahabzada, Milad Khosravani, Matheus Kuska, Mahlein Anne-Katrin, Ewa Klara StürmerWound Assessment

116

CASE STUDIES AND PROFESSIONAL COMMUNICATION (NOT IN ORAL E-POSTER SESSION)

EP366 PILOT OF A WOUND E-CLINIC USING TELEMEDICINE CONCEPTSJeanette Timmins

EP367 DERMATOLOGICAL NURSING. DESING OF EDITORIAL AND SCIENTIFIC IMPROVEMENT (2007-2015)Federico Palomar Llatas, Luis Aranton Areosa, Jose Maria Rumbo Prieto, Begoña Fornes Pujalte, Elena Castellano Rioja, Joan Ernest Peris Caballero

EP368 EDITORIAL INDEPENDENCE AND CONFLICT OF INTEREST IN CLINICAL PRACTICE GUIDELINES ON CARE OF ULCERS AND CHRONIC WOUNDSFederico Palomar Llatas, Luis Aranton Areosa, José Maria Rumbo Prieto, Begoña Fornes Pujalte, Elena Castellano Rioja, Joan Ernest Peris Caballero

EP369 DEVELOPING A ‘SILVER STANDARD’ PATHWAY TO IMPROVE LEG ULCER MANAGEMENT IN CARE HOMESMartin Tadej, Mohamud Luxmi

EP370 PATIENT SATISFACTION WITH AN INTERPROFESSIONAL APPROACH TO WOUND CARE IN QATARShaikha Ali Al-Qahtani, Kim Critchley, Emmanuel Ngwakongnwi

EP371 PERIWOUND SKIN APPROACH AS A STEP TOWARDS CHRONIC WOUND HEALINGAna Rita Alves Rodrigues, Joana Filipa Gonçalves Vicente, João Paulo Cabrita Guerreiro Inácio Correia, Ana Rita Batista Cavaco, Ana Lúcia Cardoso Barreto, Alexandra Carvalho

EP372 QUALITY IMPROVEMENT; IMPLEMENTATION OF ADAPTED SSKIN BUNDLE CARE ROUND DOCUMENTATIONHester Dunne

EP373 TWO LESSONS ONE CASE OF PYODERMA GANGRENOSUM CAN TEACH USNee Ling Wong

EP374 AUTOLOGOUS PLATELET RICH PLASMA IN TREATMENT OF DEEP STERNAL WOUND INFECTION: CASE SERIES AND LITERATURE REVIEWWanli Chu, Hao Daifeng, Jingfeng Zhao

EP375 PROSTHESIS INFECTIONS AFTER HIP REPLACEMENT - NON-SURGICAL TREATMENTBorisav Mandic, Mirjana Nikic, Olga Hadzic

EP376 PVP-I POLYURETHANE FOAM DRESSING IN THE TREATMENT OF CASES OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSISJung Yoon Kim

EP377 EFFECTIVENESS OF POLYHEXAMETHYLENE BIGUANIDE ON VIRTUALLY INFECTED ULCERCorrado Giunta, Giorgio Cavallo, Alessia Almoni

EP378 HOME CARE IN LOMBARDYCorrado Giunta, Giorgio Cavallo

EP379 TREATMENT OF CHRONIC VENOUS ULCER IN RURAL AREA - RESISTANCE, MISTREATMENT OR INCOMPLIANCE - A CASE REPORTIvica Jendrašic

EP380 REGENERATING THE SKIN IN ULCERS AND WOUNDSJose Puentes Sanchez, José David Puentes Pardo, Jesús Pérez Pardo, Carmen Maria Pardo González, María Belén Pardo González

EP381 INTERDISCIPLINARY APPROACH OF A PATIENT AFFECTED BY VENOUS LEG ULCERS AND LYMPHEDEMA WITH DACC AND COLLAGEN DRESSINGS IN A LONG TERM SETTINGMªJosé Pujalte Gil, Nuria Maestro, Elisenda Romano, MªCristina Mayordomo Lacambra

EP382 EVALUATION OF A NEW NATIVE COLLAGEN MATRIX IN THE TREATMENT OF A HARD-TO-HEAL VENOUS LEG ULCERLaura Carrasco Cortijo, José Aurelio Sarralde Aguayo, Ana Maria Arnaiz García

EP383 EROSIVE PUSTULAR DERMATOSIS OF THE LEGJanet Doolan

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

117

EP384 WHEN THE HEALING IS INTERRUPTED BY THE INTERACTION OF BACTERIAJose Puentes Sanchez, José David Puentes Pardo, Jesús Pérez Pardo, Carmen Maria Pardo González, María Belén Pardo González

EP385 MANAGEMENT OF VENOUS LEG ULCER COMBINING A NEW NATIVE COLLAGEN DRESSING AND COMPRESSION THERAPYLaura Carrasco Cortijo, Alejandro Ponton Cortina, Marta Fernandez Sampedro

EP386 A NEW APPROACH TO THE THIN AUTOLOGOUS SKIN GRAFTThierry Coppin, Marion Desplanques

EP387 WOUND DRESSINGS FOR MB. HAILEY-HAILEY: CASE REPORTTanja Planinšek Ručigaj, Tomi Bremec, Jana Bremec

EP388 DEMARCATIVE NECROSIS ALONG PREVIOUS LACERATION LINE AFTER FILLER INJECTIONJin Yong Shin

EP389 FIRST RESULTS OF ANTIMICROBIAL FOAM DRESSING IN PRACTICEWiester Martin, Stefanie De Lange, Martin Abel

EP390 RAPID DEBRIDEMENT OF STAGE III PRESSURE ULCER OVER ISCHIAL TUBEROSITY WITH A HYDRO-DESLOUGHING ABSORBENT DRESSING AS PART OF TREATMENT PROTOCOL - A CASE STUDYMartin Tadej, Lindsay Young

EP391 A LIPIDO-COLLOID DRESSING, SHOULD IT BE A TREATMENT OF CHOICE OR THE LAST RESORT? A CASE STUDY ANALYSISMartin Tadej, Sharon Butler

EP392 MULTIDISCIPLINARY PLANTAR DEEP FOOT TREATMENT IN PATIENT WITH TYPE II DIABETES/ CASE REPORTPatricia Garacisi, Paulo Guimaraes, Pablo Santana, Rosana C.C. Pinto, Camila Siqueira, Marisa T.H Salle

EP393 INCISIONAL NEGATIVE PRESSURE WOUND THERAPY FOR TREATMENT OF POSTOPERATIVE PERINEAL SURGICAL SITE INFECTION AFTER APRMario Antonini, Gaetano Militello, Vincenzo Dinolfo

EP394 TARGETED USE OF PROTEASE MODULATING DRESSINGS IN THE PERISTOMAL PYODERMA GANGRENOSUM MANAGEMENTMario Antonini, Gaetano Militello

EP395 HETEROTROPHIC OSSIFICATION IN A DIABETIC FOOT: A CASE REPORTJeffrey Lehrman, Prashant Bhoola

EP396 TRADITIONAL TOTAL CONTACT CASTING VERSUS A ROLL-ON ALTERNATIVEJeffrey Lehrman, Sarah Shipley

EP397 FIRST METATARSOCUNEIFORM JOINT FUSION WITH DORSIFLEXORY WEDGE OSTEOTOMY FOR THE TREATMENT OF CHRONIC SUBMETATARSAL HEAD ONE ULCERATIONSJeffrey Lehrman, Christopher Hood

EP398 TOPICAL MEDICAL CANNABIS (TMC)-A NOVEL THERAPY FOR PYODERMA GANGRENOSUMJason Corban

EP399 THERAPY OF A DEFECT IN AREA AFFECTED BY CHRONIC RADIODERMATITISHana Zelenkova, Jurkaninova Romana

EP400 METHODS BURN SURGERY FOR INFANTS WITH CONGENITAL ICHTHYOSIFORM ERYTHRODERMAOlga Kovalenko, Heorhii Kozynets, Sergey Smyrniy

EP401 EFFECTIVENESS OF A KERATIN GEL IN A WOUND LEFT AFTER BASAL CELL CARCINOMA TREATMENT AND SKIN GRAFTING FAILURE: A CASE REPORT IN AN ELDERLY PATIENTAharon Wanszelbaum, Marina Karasik, Jaklin Nusair

EP402 THE SUCTION EFFECT OF NEGATIVE PRESSURE THERAPY HIGHLIGHTED BY A CASE REPORT OF A NEW NEGATIVE PRESSURE DRESSING DEVICEAharon Wanszelbaum, Nahum Grinberg, Tsvi Levy, Marina Karasik, Jaklin Nusair

EP403 USING A BACTERIA AND FUNGI BINDING DRESSING TO MANAGE A CHRONIC LEG ULCER WITH UNDERLYING PSEUDOMONAS AERUGINOSA INFECTIONMeagan Shannon

EP404 EVALUATION OF AUTOLOGOUS EPIDERMAL GRAFTS IN THE TREATMENT OF COMPLEX WOUNDS IN A DUTCH PERIPHERAL HOSPITAL: A CASE SERIESEddy Koopman

118

EP405 LIMB SALVAGE UTILIZING INNOVATIVE DERMAL REGENERATION TEMPLATEGemma Davies, Kate Merriman

EP406 THE MANAGEMENT OF A NEUROPATHIC DIABETIC FOOT ULCER USING PHMB FOAMDonna Welch, Rebecca Forder

EP407 USE OF SILVER-TLC MATRIX ASSOCIATED WITH COMPRESSIVE THERAPY IN THE TREATMENT OF REFRACTORY VENOUS ULCER: EXPERIENCE REPORTRosangela Aparecida de Oliveria, Mariana Bandeira, Clodine Pepes

EP408 EVALUATION OF ENZYME ALGINOGEL ON A COMPLEX DIHISCED NEONATAL SURGICAL WOUNDDelilah Rooney

EP409 CIRCUMFERENTIAL VENOUS LEG ULCER - COMBINED TREATMENTMarin Marinovic, Jadranka Kovačević

EP410 MOVING TOWARDS BIO-PSYCHO-SOCIAL CARE MODEL: CASE STUDIES OF MANAGING POST TOE-AMPUTATION WOUND IN PATIENTS WITH DIABETES IN PRIMARY HEALTHCAREXiaoli Zhu, Xiuhong Wang, Lili Wan

EP411 GOOD DEBRIDEMENT ENABLES VISUALISATION AND CORRECT ASSESSMENT OF THE WOUNDRia van Dam, Van Berlo Patricia

EP412 COMPLICATED POST-OPERATIVE WOUNDS IN CHILDREN, CAUSES, METHODS OF TREATMENT - ANALYSIS OF CLINICAL CASESTatiana Prudnikova, Elena Dyakonova, Evgenii Okulov, Alexey Gusev, Alexander Bekin

EP413 CONTROLLING INFECTION IN A COMPLEX BURNED PATIENT WITH BETAINE-POLYHEXANIDE IN GEL: AN ALTERNATIVE WOUND BED PREPARATION METHOD FOR GRAFTSAdriana Alzate Rodas, Diego Quispe, Francisco Jofré, Cristian Arriagada

EP414 BEYOND INFECTION CONTROLLuisa Albuquerque

EP415 DIABETIC LIMB SALVAGE: CHALLENGES OF TREATMENT AND THE BRAZILIAN HEALTH CARE SYSTEMDebora Sanches-Pinto, Flavio Duarte, David Souza Gomez, Rolf Gemperli

EP416 EFFECTIVE REMOVAL OF OCCUPATIONAL TRAUMATIC SKIN TATTOO WITH A MONOFILAMENT FIBRE DEBRIDEMENT PADLars Hofmann, Claas Roes, Cornelia Erfurt-Berge

EP417 AMBULATORY TREATMENT OF PYODERMA GANGRAENOSUM WITH A MINIMAL INVASIVE EPIDERMAL HARVESTING SYSTEMDominik Luedi

EP418 THE ROLE OF HYPERBARIC OXYGEN IN CHRONIC NONHEALING ULCERS IN PATIENTS SUFFERING BY SYSTEMIC AUTOIMMUNE DISEASES: FOUR CASE REPORTSLuigi Santarella, Giorgios Vertsonis, Chiara Campomori, Nadia Franchini, Ferruccio Di Donato

EP419 COLD ATMOSPHERIC PLASMA: TREATMENT OPTION FOR CRITICAL ILL PATIENTS WITH AN INFECTED PACEMAKER POCKETHeinrich Rotering

EP420 STIMULATE WOUND HEALING IN CHRONIC AND SECONDARY HEALING WOUNDS: AN INNOVATIVE HYDROPOLYMER TECHNOLOGYErlgard van Kol, Jolanda Alblas, Alexandra Janssen

EP421 UNUSUAL INDICATION NPWT: CASE STUDYLenka Veverkova, Katerina Krejsova, Petr Vlček, Jan Žák

EP422 EDEMA MANAGEMENT AND ITS IMPACT ON FUNCTIONAL MOBILITYSuzie Ehmann

EP423 WHEN FISH SKIN ACCELERATES HEALING OF HARD TO HEAL WOUNDS - A NEW APPROACH TO ADVANCED WOUND TREATMENTMichaela Kaiser, Alex Ochsner

EP424 THE USAGE OF A SINGLE USE NPWT SYSTEM AFTER THE TREATMENT WITH IODINE CADEXOMERMichele Vernaci

EP425 A CLINICAL EVALUATION OF A PHMB AND BETAINE WOUND CLEANSING SOLUTION AND GEL WITHIN THE ORTOPEDIC WARDS IN A LARGE ACUTE TRUSTBernadette Harwood

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

119

EP426 EFFECTIVENESS OF BETAINE-POLIHEXANIDE TO CONTROL DEEP INCISIONAL SURGICAL INFECTIONFernando Rivas, Cindy Ayala

EP427 THE USE OF A NEW SILICONE FOAM DRESSING ON A CATEGORY 4 PRESSURE ULCER TO THE OUTER RIGHT KNEERebecca Forder, Carolynne Sinclair

EP428 THE USE OF A NEW PHMB FOAM DRESSING ON A NONHEALING SURGICAL WOUND.Rebecca Forder, Joanne Overfield, Simon Barrett

EP429 THE USE OF A NEW PHMB FOAM ON A LEG ULCER WOUNDRebecca Forder, Joanne Overfield, Simon Barrett

EP430 COMBINATION OF FOAM SCLEROTHERAPY AND SPECIAL DRESSINGS - THE EFFECTIVE WAY HOW TO TREAT NON-HEALING WOUNDS OF VENOUS ETIOLOGYJúlia Černohorská

EP431 TREATMENT OF CHRONIC WOUND USING HYPOCHLOROUS ACID AND HYDROFIBER SILVER DRESSING: A CASE REPORTMarin Marinovic, Nera Fumic, Stanislava Laginja, Bore Bakota, Boris Reinić, Igor Barković, Mario Franolic

EP432 YARA YÖNETIMI INTRAVENÖZ INFÜZYON NEDEN: TPN YANIKHanife Inç

EP433 ENHANCING THE WOUND HEALING PROCESS IN VENOUS ULCER WITH BETAINE-POLYHEXANIDE IN GELJennifer Venegas

EP434 STUDENTS´ SELF-ASSESSMENT OF EXPERTISE IN WOUND CARESalla Seppänen, Maija Alahuhta, Ansa Iivanainen, Tiina Pennanen, Kaisa Friman

EP435 THE USE OF A RAPID CAPILLARY ACTION DRESSING TO CONTROL THE HYPERGRANULATING WOUND BEDLucy Twyman, Muholan Kanapathy, Nadine Hachach-Haram, Afshin Mosahebi

EP436 NPWT AND INSULATING DRESSSING “BREECHES” AS METHODS OF LARGE POSTOPERATIVE PERINEUM WOUNDS TREATMENT IN PATIENTS WITH FOURNIER GANGRENE AND ANAEROBIC ABSCESSMikhail Egorkin, Sergey Goryunov, Ilya Gorbunov, Valery Vechorko, Eteri Bolkvadze, Dmitry Kozhin

EP437 CHARCOT FOOT - A MULTIDISCIPLINARY APPROACH TOWARDS SAVING A LIMB AND IMPROVING QUALITY OF LIFELiezl Naude, Chris Grabe, Jacques Swanepoel, Conrad Barnard

EP438 EVIDENCE OF THE CLINICAL PROGRESSION OF A DIABETIC FOOT ULCER GRADE II ACCORDING TO SAN ELIAN WOUND SCORE SYSTEMAlfredo Antonio Reyes Sanchez, Josue Carlos Campos Rivera, Francisco Javier Sandoval Flores, Dora Zenaida Arevalo de Reyes

EP439 EVALUATION OF THE EFFECT OF A SURFACTANT-BASED PRODUCT ON STAGNATING CHRONIC ULCERSFrans Meuleneire

EP440 APPLICATION OF THE SILVER ALGINATE WOUND PASTE IN FOURNIER GANGRENEMagdalena Bugaj

EP441 COMBINATION THERAPY (NPWT, DEBRIDEMENT, ALGINATE) IN SEVERE INFECTION WITH NECROSIS OF THE SOFT TISSUE AND BONE OF THE SKULL WITH EXPOSED DURA MATERTomasz Banasiewicz, Bartosz Sokół, KInga Zastawna, Adam Bobkiewicz, Włodziemierz Liebert, Bartosz Mańkowski

EP442 EVALUATION OF VELCRO COMPRESSION WRAP CHARACTERISTICS: A CASE SERIESSuzie Ehmann, Karen Bock

EP443 A SKIN ULCERATION COMPLICATED BY ALCALIGENES XYLOSOXIDANS INFECTIONSunghoon Choi, Seungje Sung, Hahyun Yu, Youngjoon Kim, Sanghyun Nam, Youngwoong Choi

EP444 THE CAPACITY OF A 2MM COLLAGEN-ELASTIN MATRIX AS A DERMAL SUBSTITUTE IN SINGLE-STAGE SKIN GRAFTINGChangryul Yi, Seungje Sung, Hahyun Yu, Youngjoon Kim, Hoon Kim, Sanghyun Nam, Youngwoong Choi

EP445 MANAGEMENT OF CONGENITAL ICHTHYOSIS IN NEW BORNSVania Declair Cohen, Luiz Gustavo Balaguer Cruz

120

EP446 EXPERIENCE WITH COLLOIDAL SILVER RINSING SOLUTION ON VENOUS LEG ULCERS WITH IMPAIRED WOUND HEALINGCristina Quintana, Haydee Lasso, Mario Tuñon

EP447 FRACTIONAL EPIDERMAL SKIN GRAFTING IN VENOUS AND ATYPICAL WOUNDSAgata Janowska, Valentina Dini, Simona Sbolci, Francesca Papadia, Michela Macchia, Marco Romanelli

EP448 PYODERMA GANGRENOSUM AND SKIN GRAFTS: CLINICAL EXPERIENCE IN THE WOUND HEALING RESEARCH UNIT OF PISAAgata Janowska, Simona Sbolci, Valentina Dini, Michela Macchia, Teresa Oranges, Marco Romanelli

EP449 CLINICAL EFFECTIVENESS OF AN EXTRA CELLULAR MATRIX BASED DRESSING TO HEAL RECALCITRANT ULCERS: A CASE SERIESAdisaputra Ramadhinara, Diane Eng

EP450 EXPERIENCE OF A RANGE OF WOUND DRESSINGS ADAPTED TO EACH STAGE OF CHRONIC WOUNDS IN ELDERLY PATIENTS WITH MULTIPLE PATHOLOGIESCarole Dewitte-Valtille

EP451 APPLICATION BENEFITS OF A BIGUANIDE POLIHEXANIDE AND BETAINE GEL IN RADIOTHERAPY SKIN INDUCTED REACTIONS AND SKIN DONOR SITESHelena Vicente, Dora Lisa Rocha Franco

EP452 MANAGEMENT OF WOUND DUE TO INTRAVENOUS INFUSION: TPN BURNHanife Inç

EP453 THE IMPORTANCE OF WOUND CAREZeynep Şahin

EP454 THE USE OF A NEW PHMB FOAM ON A LEG ULCER WOUNDRebecca Forder, Joanne Overfield

EP455 SURGICAL TACTICS OF TREATING POST BURN DEFECTS OF DORSUM OF HANDSPavel Sarygin, Sergey Popov

EP456 METASTATIC POROCARCINOMAEnikő Wenczl, Edit Babarczi

EP457 SURGICAL DEBRIDEMENT IS NOT ALWAYS NECESSARY FOR THE TREATMENT OF DEEP BURNSBernd Gächter, Jennifer Frieda Gächer-Angehrn, Stephan Schlunke, Sebastian Probst, Paul Biegger

EP458 EXPERIENCE WITH A HIGHLY-ABSORBENT FIBER DRESSING IN PERINEAL RECONSTRUCTIVE SURGERYValerie Skiba, Sophie Vercleyen, Marc Marie, Maryline Farys

EP459 A POST FASCIOTOMY FOREARM AND THENAR WOUNDS TREATED WITH ACELLULAR FISH SKINRytis Rimdeika, Goda Astrauskaite, Adas Čepas

EP460 ABOUT TWO CASES OF NECROTIZING FASCIITIS TREATED LOCALLY AFTER SURGERY WITH A NEW HIGH-ABSORBENT FIBER DRESSINGJean-Robert Nzamushe Leplan Mabla, Eric Martin, Marc Marie, Maryline Farys

EP461 USING A SILICONE COATED MEDICAL ADHESIVE TAPE FOR PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBE PLACEMENTTim Tepelmann, Victoria Yu

EP462 UTILIZING A UNIQUE BURN AND WOUND DRESSING IN PEDIATRIC PATIENTS TO FACILITATE A MOIST WOUND ENVIRONMENT FOR AUTOLYTIC DEBRIDEMENTRene Amaya

EP463 A POST-BURN SKIN AND SOFT TISSUE DEFECT OF FOREARM TREATED WITH FREE LATERAL BRACHIAL FASCIOCUTANEOUS FLAPDarius Bagdanavicius, Domantas Rainys, Adas Čepas, Inga Guogienė, Jamil Hayek, Rytis Rimdeika

EP464 CYANOACRYLATE NO-STING LIQUID SKIN PROTECTANT FOR THE PROTECTION OF NEONATAL SKIN OF VARIOUS GESTATIONAL AGESRene Amaya

EP465 THE ROLE OF NUTRITIONAL MANAGEMENT IN THE WOUND HEALING PROCESSBarbara Kuczynska, Tomasz Banasiewicz

EP466 USE OF A BIOCELLULOSE DRESSING WITH PHMB-SURFACTANT COMPLEX TO MANAGE COMPLICATED DIABETIC FOOT ULCERSSarah Bradbury, Zoe Boulton

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

121

EP467 CLINICAL EVALUATION OF A SKIN PROTECTANT OINTMENT &AMP; CLEANSER FOR MANAGING INCONTINENCE-RELATED SKIN DAMAGE IN AN ACUTE TRUSTSarah Bradbury, Joanne Gaffing, Kieron McCracken

EP468 LIMB SALVAGE USING NEGATIVE PRESSURE WOUND THERAPYGustavo Feriani, Carina Salerno

EP469 THE BEESWAX WOUND HEALING VERTU: A CASE REPORT AND A REVUE OF LITERATUREAmina Bereksi Reguig, Loudjedi Salim, Fandi Bassim

EP470 DESCRIBE THE UTILITY AND APPLICABILITY OF NEGATIVE PRESSURE WOUND THERAPY IN TROPICAL DISEASES (SNAKE BITES, STINGRAY´S STING, LEISHMANIASIS)Gustavo Feriani, Carina Salerno

EP471 MANAGEMENTOF NECROTISING LEUKOCYTOCLASTIC VASCULITIS USING A NEW ANTIMICROBIAL DRESSINGWITH CLEANING ACTIONChristopher Webb, Jeanette King

EP472 THE MANAGEMENT OF GUNSHOT INJURY TO THE MANDIBLE AND FACIAL SOFT-TISSUES WITH A FREE OSTEOMYOCUTANEOUS DCIAP FLAP: A CASE REPORTDonatas Samsanavičius, Darius Bagdanavičius, Mantas Kievišas, Adas Čepas, Inga Guogienė, Rytis Rimdeika

EP473 CONSERVATIVE AND SURGICAL TREATMENT APPROACH TO ARTERIAL ORIGIN TROPHIC ULCERInga Guogiene, Augustina Grigaite, Agne Andriuskeviciute, Darius Bagdanavicius, Rytis Rimdeika

EP474 APPLICATIONOF A TWO-LAYER COMPRESSION BANDAGE SYSTEM USED DIRECTLY ONTO A SPLIT THICKNESSSKIN GRAFT IMMEDIATELY IN THE OPERATING THEATRE TO OPTIMIZE WOUND HEALING - ACHANGE IN PRACTICEGeraldine Byford, Beverley Schofield, Christopher Webb

EP475 HYPERBARIC OXYGEN TREATMENT IN THALASSEMIA INTERMEDIATE PATIENTS LEG ULCERIrem Tezer, Christian Fabricius

EP476 THE EFFECTIVENESS OF HYPER OXYGENATED FATTY ACIDS IN THE PREVENTION AND TREATMENT OF VENOUS LEG ULCERSCarlos Alves

EP477 REAL-TIME VISUALIZATION OF BACTERIA WITH A FLUORESCENCE IMAGING DEVICE GUIDES IMMEDIATE INTRAOPERATIVE TREATMENT PLANS BASED ON BACTERIAL LOCATIONHeinrich Rotering

EP478 THE REVOLUTIONARY TECHNOLOGY IN THE TREATMENT OF DIFFICULT, NO-HEALING WOUNDS: THE NANOTECHNOLOGY NANOFLEX A BASIS OF PHEMA (POLY-2-HYDROXYETHYL METHACRYLATE), PHPMA (POLY-2-HYDROXYPROPYL) AND SODIUM DEOXYCHOLATE: CASE REPORTSonia Silvestrini, Antonella Leto

EP479 AN INNOVATIVE TREATMENT OF A SEVERE CASE OF HIDRADENITIS SUPPURATIVE: 5 YEARS OF FOLLOW-UP WITHOUT RECURRENCELuiz Gustavo Balaguer Cruz, Vania Declair Cohen

EP480 MANAGEMENT OF BIOFILM AND HEALING OF CHRONIC WOUNDS WITH ABLATIVE ERBIUM LASER TREATMENTCraig Fortier, Randall Wolcott

EP482 THE IMPLEMENTATION OF IONIC SILVER DRESSINGS IN THE MANAGEMENT OF INFECTED WOUNDS AND PARTIAL THICKNESS BURNSNichola Nangle

EP483 CHALLENGES IN THE CLOSURE OF COMPLEX ONCOLOGICAL SURGICAL WOUND: THE ROLE OF NEGATIVE PRESSURE THERAPYHelena Vicente, Dora Lisa Rocha Franco

EP484 TREATMENT AND CARE OF A POST-TRAUMATIC WOUNDInga Guogiene, Augustina Grigaite, Rytis Rimdeika, Darius Bagdanavičius

EP485 INITIAL KNOWLEDGE ABOUT WOUND CARE AMONG NURSING STUDENTSMirna Žulec, Zrinka Puharić, Ksenija Eljuga, Tamara Salaj, Goranka Rafaj, Đurđica Grabovac

EP486 MONOFILAMENT DEBRIDEMENT: A SYNERGISTIC METHOD FOR RAPID REMOVAL OF DEVITALIZED TISSUETraci Brackin, Heath Tunnell

EP487 EVALUATION OF A LIQUID ALGINATE ON A COMPLEX NEONATAL DEHISCED SURGICAL WOUNDDelilah Rooney

EPUAP2017

One Voice for Pressure UlcerPrevention and Treatment

The 19th Annual Meeting of theEuropean Pressure Ulcer Advisory Panel

20 – 22 September 2017Belfast, Northern Ireland

www.epuap2017.org

Challenges and Opportunitiesfor Practice, Research and Education

Conference venue: Belfast Waterfront

Abstract submission deadline: 10 May 2017

Early registration deadline: 15 June 2017

Welcome reception: 20 September at Belfast City Hall

Conference dinner: 21 September at Titanic Museum

EPUAP 2017 will be organised by the European Pressure Ulcer Advisory Panel in partnership with the Tissue ViabilityNurse Network (Northern Ireland) and the WoundManagement Association of Ireland.

EPUAP Business [email protected] | Tel.: +420 251 019 379

Management of the Diabetic Foot9th Course · 4-7 October 2017 · Pisa · Italy

Welcome to PisaThis 4-day theoretical course and practical training gives participants a thorough intro-duction to all aspects of diagnosis, manage-ment and treatment of the diabetic foot.

Lectures will be combined with practical sessions held in the afternoon at the diabetic foot clinic at the Pisa University Hospital.

Lectures will be in agreement with the Inter-national Consensus on the Diabetic Foot and Practical Guideline on the Management and Prevention on the Diabetic Foot.

Pisa International Diabetic Foot Course

www.diabeticfootcourses.org

The course is endorsed by EWMA

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

123

Management of the Diabetic Foot9th Course · 4-7 October 2017 · Pisa · Italy

Welcome to PisaThis 4-day theoretical course and practical training gives participants a thorough intro-duction to all aspects of diagnosis, manage-ment and treatment of the diabetic foot.

Lectures will be combined with practical sessions held in the afternoon at the diabetic foot clinic at the Pisa University Hospital.

Lectures will be in agreement with the Inter-national Consensus on the Diabetic Foot and Practical Guideline on the Management and Prevention on the Diabetic Foot.

Pisa International Diabetic Foot Course

www.diabeticfootcourses.org

The course is endorsed by EWMA

EP488 ACCELERATED HEALING INSPIRED BY NURTURING NATURELesley Robinson, Jane Todhunter

EP489 HEMOSTATIC PROPERTIES OF ACELLULAR FISH SKIN GRAFT AND A GELATIN SPONGE EVALUATED IN AN ACUTE PORCINE LIVER SQUARE LESION MODELHilmar Kjartansson

EP490 ACELLULAR FISH SKIN AS A BONE AND TENDON COVERING: A CASE REPORTChristopher Winters

EP491 ACELLULAR FISH SKIN GRAFT TO PREVENT RE-INFECTION AND AMPUTATION IN EXPOSED BONE LOWER EXTREMITY WOUNDS WITH HISTORY OF MRSA AND CHRONIC OSTEOMYELITISChristopher Winters

EP492 TIME MANAGEMENT IN GRANULATION TISSUE FORMATION-PLATELET RICH FIBRIN APPLICATIONSErcan Cihandide, Deniz Yahci, Oguz Kayiran

EP493 MINCED SKIN GRAFTS FOR LOWER LIMB ULCERSDebora Sanches Pinto, David Souza Gomez, Araldo Ayres Monteiro, Rolf Gemperli, Elof Eriksson

EP494 MANAGEMENT OF LIFE-THREATENING POST SURGICAL WOUND IN NEWBORN INTENSIVE CARE UNIT: A CASE REPORTErcan Cihandide, Deniz Yahci, Yeşim Coşkun, Oguz Kayiran

EP495 DEBRIDEMENT OVER BOWEL USING A MONOFILAMENT FIBRE LOLLYRommel Orig

EP496 TREATMENT OF DIABETIC FOOT ULCER WITH PRF (PLATELET RICH FIBRIN): A CASE STUDYAli Barutcu

EP497 A CLINICAL EVALUATION OF A BIOACTIVE BETA-GLUCAN GEL IN THE MANAGEMENT OF NON INFECTED DIABETIC FOOT ULCERATIONSDonna Welch

EP498 IMPACT OF A BIOACTIVE BETA-GLUCAN GEL IN FIVE WOUNDS WHERE HEALING WAS STALLEDKeith Cutting

EP499 TWO CASE STUDIES TO DEMONSTRATE THE USE OF AN INNOVATIVE BIOACTIVE BETA-GLUCAN PRODUCT FOR THE TREATMENT OF STALLED WOUNDSBrenda King, Lynne Hepworth

EP500 A 16 MONTH OLD LEG ULCER WAS REDUCED IN SIZE BY 84% IN 4 WEEKS BY USING A BIOACTIVE BETA-GLUCAN GELKerstin Goldbach, Alexandra Müller

EP501 CLINICAL EXPERIENCE WITH THE USE DACC COATED WOUND CONTACT LAYER IN COMBINATION WITH NPWT WHEN TREATING PATIENS WITH SEVERE SOFT TISSUE INFECTIONHubert Terseglav, Andrej Kunstelj

EP502 EDUCATION OF SELF-MANAGEMENT CARE OF PRESSURE ULCER AT HOME ACCORDING TO ICWMehdi Akbarzadeh, Jayran Zabardast

EP503 THE MANAGEMENT CARE OF DIABETIC FOOT ULCER AT HOME ACCORDING TO ICWMehdi Akbarzadeh, Jayran Zabardast

124

EWMA PUBLICATIONS

New EWMA document:Negative pressure wound therapy – Overview, challenges and perspectives

Published March 2017

This document provides an overview of the evidence base for the use of negative pressure wound therapy (NPWT) in wound treatment and covers all three types of NPWT: On open wounds, with instillation and over closed incisions. The document also focuses on the organisational and health economical aspects of NPWT.

The document is published as an online supplement to the Journal of Wound Care.

NPWT will be covered in a key session during the EWMA 2017 Conference: Thursday 4 May 14.30-15.30

New EWMA document:Use of oxygen therapies in wound healing– With focus on topical and hyperbaric oxygen treatment

Published May 2017

The document provides practice-oriented guidance on the use of various forms of oxygen therapies for wound treatment. It will include an overview of treatment options available and an assessment of the best available evidence for use. In addition, the document will detail specific aspects and current discussions connected with the use of oxygen in wound healing.

The document is published as an online supplement to the Journal of Wound Care.

The document will be launched in a key session during the EWMA 2017 Conference: Wednesday 3 May 16.45-18.00

New publications in 2017

125

For download or more information aboutthe above publications and initiatives,please visit www.ewma.org or contact

the EWMA Secretariat: [email protected]

Antimicrobial stewardship in wound care:Non-antibiotic antimicrobial interventions

Expected publication: Spring 2017

In collaboration with the British Society for Antimicrobial Chemotherapy, EWMA seeks to promote the judicious use of all antimicrobials in wound management. This paper aims to review the possible threat of the emergence of non-antimicrobial resistance and to investigate opportunities for developing alternative remedies for wound infection.

The paper will be presented in the BSAC/EWMA Symposium at the EWMA 2017 Conference: Friday 5 May 2017 10.15-12.30

126

AEEVHSpanish Association of Vascular Nursing and Woundswww.aeevh.es

AFIScep.beFrench Nurses’ Association in Stoma Therapy, Wound Healing and Woundswww.afiscep.be

AISLeC Italian Nurses’ Cutaneous Wounds Associationwww.aislec.it

AIUCItalian Association for the study of Cutaneous Ulcerswww.aiuc.it

AMP RomaniaWound Management Association Romaniawww.ampromania.ro

APTFeridasPortuguese Association for the Treatment of Woundswww.aptferidas.com

AWTVNFAll Wales Tissue Viability Nurse Forumwww.welshwoundnetwork.org

AWAAustrian Wound Associationwww.a-w-a.at

BEFEWOBelgian Federation of Woundcarewww.befewo.org

BWABulgarian Wound Associationwww.woundbulgaria.org

CNCClinical Nursing Consulting – Wondzorgwww.wondzorg.be

CSLRCzech Wound Management Societywww.cslr.cz

Cooperating Organisations

CWACroatian Wound Associationwww.huzr.hr

DGfWGerman Wound Healing Societywww.dgfw.de

DSFSDanish Wound Healing Societywww.saar.dk

ELCOSPortuguese Wound Societywww.sociedadeferidas.pt

FWCSFinnish Wound Care Societywww.shhy.fi

GAIF Associated Group of Research in Woundswww.gaif.net

GNEAUPPNational Advisory Group for the Study of Pressure Ulcers and Chronic Woundswww.gneaupp.org

HSWH Hellenic Society of Wound Healing and Chronic Ulcers www.hswh.gr

ICWChronic Wounds Initiativewww.icwunden.de

LBAALatvian Wound Treating Organisation

LUFThe Leg Ulcer Forumwww.legulcerforum.org

LWMALithuanian Wound Management Associationwww.lzga.lt

MASCMaltese Association of Skin and Wound Carewww.mwcf.madv.org.mt/

MSKTHungarian Wound Care Societywww.euuzlet.hu/mskt/

D A N I S H WOUND HEALING S O C I E T Y

127

MWMAMacedonian Wound Management Association

NATVNSNational Association of Tissue Viability Nurses, Scotland

NIFSNorwegian Wound Healing Associationwww.nifs-saar.no

NOVWDutch Organisation of Wound Care Nurseswww.novw.org

PWMAPolish Wound Management Associationwww.ptlr.org.pl

SAfWSwiss Association for Wound Care (German section)www.safw.ch

SAfWSwiss Association for Wound Care (French section)www.safw-romande.ch

SAWMASerbian Advanced Wound Management Associationwww.lecenjerana.com

SEBINKOHungarian Association for the Improvement in Care of Chronic Wounds and Incontinentiawww.sebinko.hu

SEHERThe Spanish Society of Woundswww.sociedadespanolaheridas.es

SFFPCThe French and Francophone Society f Wounds and Wound Healingwww.sffpc.org

SSiSSwedish Wound Care Nurses Associationwww.sarsjukskoterskor.se

SSOORSlovak Wound Care Associationwww.ssoor.sk

SSPLRThe Slovak Wound Healing Society www.ssplr.sk/en

STW BelarusSociety for the Treatment of Wounds (Gomel, Belarus)www.burnplast.gomel.by

SUMSIcelandic Wound Healing Societywww.sums.is

SWHS Serbian Wound Healing Societywww.lecenjerana.com

SWHSSwedish Wound Healing Societywww.sarlakning.se

TVSTissue Viability Societywww.tvs.org.uk

URuBiHAssociation for Wound Management of Bosnia and Herzegovinawww.urubih.ba

UWTOUkrainian Wound Treatment Organisationwww.uwto.org.ua

V&VNDecubitus and Wound Consultants, Netherlandswww.venvn.nl

WCSKnowledge Center Woundcarewww.wcs.nl

WMAIWound Management Association of Irelandwww.wmai.ie

WMAKWound Management Association of Kosova

WMASWound Management Association Slovenia www.dors.si

WMATWound Management Association Turkeywww.yaradernegi.net

128

Alliance of Wound Care Stakeholders www.woundcarestakeholders.org/

AAWCAssociation for the Advancement of Wound Carewww.aawconline.org

Wounds Australia Wounds Australiawww.awma.com.au

Wounds Canadahttps://www.woundscanada.ca/

Debra InternationalDystrophic Epidermolysis Bullosa Research Associationwww.debra.org.uk

EFORT European Federation of National Associations of Orthopaedics and Traumatologywww.efort.org

ETRSEuropean Tissue Repair Societywww.etrs.org

CTRS(Chinese Tissue Repair Society)www.chinese-trs.com/en

FIP-IFPInternational Federation of Podiatrists, Fédération Internationale des Podologueshttp://www.fip-ifp.org/

IWII Int. Wound Infection Institutewww.woundinfection-institute.com

ILFInternational Lymphoedema Frameworkwww.lympho.org

KWMSKorean Wound Management Societywww.woundcare.or.kr/eng

International Partner Organisations

NZWCSNew Zealand Wound Care Societywww.nzwcs.org.nz

SILAUHEIberolatinoamerican Society of Ulcers and Woundswww.silauhe.org

SOBENFeEBrazilian Wound Management Association www.sobenfee.org.br

WAWLCWorld Alliance for Wound and Lymphedema Carewww.wawlc.org

DFSGDiabetic Foot Study Groupwww.dfsg.org

EADVEuropean Academy of Dermatology and Venereologywww.eadv.org

EBAEuropean Burns Associationwww.euroburn.org

ECETEuropean Council of Enterostomal Therapywww.ecet-stomacare.eu

ESPENThe European Society for Clinical Nutrition and Metabolismwww.espen.org

ESPRASEuropean Society of Plastic, Reconstructive and Aesthetic Surgerywww.espras.org

ESVSEuropean Society for Vascular Surgerywww.esvs.org

EPUAPEuropean Pressure Ulcer Advisory Panelwww.epuap.org

Other Collaborators

129

Media Partner

Associated Organisations

Leg ClubLindsay Leg Club Foundationwww.legclub.org

LSNThe Lymphoedema Support Networkwww.lymphoedema.org/lsn

For more information about EWMA’s Cooperating Organisations please visit www.ewma.org

JWCJournal of Wound Carewww.magonlinelibrary.com

PPCPractical Patient Care

EucomedEucomed Advanced Wound Care Sector Groupwww.eucomed.org

HomeCare Europe

www.homecareeurope.org

ICCInternational Compression Clubwww.icc-compressionclub.com

MSFMédecins Sans Frontièreswww.msf.org

WUWHSThe World Union of Wound Healing Societieswww.wuwhs.org

Volume 13Number 2

Published byEuropeanWound ManagementAssociation

October 2013

Volume 13Number 1April 2013


EWMA FOCUS ON ANTIMICROBIALS AND DEBRIDEMENT

Submit your paper to EWMA Journal

Editorial Board

Sebastian Probst, Editor Sue Bale, Editor in Chief Vickie R Driver

Georgina GethinSalla Seppänen Hubert Vuagnat

Published by

EUROPEANWOUND MANAGEMENTASSOCIATION

www.ewma.org

A PATIENT, PROFESSIONAL, PROVIDER AND PAYER PERSPECTIVE

R f

d C

1234567890+´

qwertyuiopå¨

asdfghjklæø’

<zxcvbnm,.-

§!”#€%&/()=?`

QWERTYUIOPÅ^

ASDFGHJKLÆØ*

>ZXCVBNM;:_

WOUND CARE– SHAPING THE FUTURE

Volume 14Number 2October 2014


ON THE ROAD TO BETTER

PATIENT sAfETy




Published byEuropean Wound ManagementAssociation

Volume 14Number 1


May 2014

INNOVATION,KNOW-HOWANDTECHNOLOGY INWOUND CARE





Journal_220317_7k.indd 76 10/04/2017 11.23

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

131

GENERAL INFORMATION

SPONSORS AND EXHIBITORS

AMSTERDAM, THE NETHERLANDS3 - 5 MAY 2017

PRO

GR

AM

ME

IN COOPERATION WITH WCS KNOWLEDGE CENTRE WOUND CARE

EWMA 201727TH CONFERENCE OF THE EUROPEAN WOUND MANAGEMENT ASSOCIATION

W W W.EWM A 2017.ORG

W W W.EWM A .ORG

W W W.WCS.NL

CHANGE, OPPORTUNITIES AND CHALLENGES– WOUND MANAGEMENT IN CHANGING HEALTHCARE SYSTEMS

Volume 13Number 2


October 2013



EWMA FOCUS ON ANTIMICROBIALS AND DEBRIDEMENT

Submit your paper to EWMA Journal

Editorial Board

Sebastian Probst, Editor Sue Bale, Editor in Chief Vickie R Driver

Georgina GethinSalla Seppänen Hubert Vuagnat

Published by

EUROPEANWOUND MANAGEMENTASSOCIATION

www.ewma.org

A PATIENT, PROFESSIONAL, PROVIDER AND PAYER PERSPECTIVE

R f

d C

1234567890+´

qwertyuiopå¨

asdfghjklæø’

<zxcvbnm,.-

§!”#€%&/()=?`

QWERTYUIOPÅ^

ASDFGHJKLÆØ*

>ZXCVBNM;:_

WOUND CARE– SHAPING THE FUTURE



ON THE ROAD TO BETTER

PATIENT sAfETy





Volume 14Number 1


May 2014

INNOVATION,KNOW-HOWANDTECHNOLOGY INWOUND CARE





Journal_220317_7k.indd 76 10/04/2017 11.23

GENERAL INFORMATION

CONTACTEWMA Secretariat Nordre Fasanvej 113DK-2000 [email protected].: +45 70200305

DISABLED ACCESSRAI Amsterdam is accessible for people using a wheelchair. The aisles at the show floor are spacious and the surface is flat. Elevators and disability toilets are available. Visitors with an official ‘disability card’ can follow route 7 to P7-parking garage. With a disability card, parking costs € 18.00 per 24 hours.

CONFERENCE SECRETARIATThe EWMA Organisers Office is located in the registration area. Please see signs and overview map for exact location. The conference telephone and e-mail will be answered between 08.00 and 20.00 every day during the conference. Tel.: +45 7020 0305 E-mail: [email protected]

CONFERENCE HOURS

Tuesday 2 May15.00-18.00 Registration opens:

You can collect your badge and bag in the Registration Area, Entrance G at the venue Amsterdam RAI.

Wednesday 3 May07.30-18.30 Registration09.15-10.00 Opening ceremony10.00-18.00 Plenary & scientific sessions10.30-18.00 Commercial exhibition18.00-23.00 Get-Together event in the

Auditorium Lounge at the Conference Venue Amsterdam RAI

Thursday 4 May07.00-18.00 Registration08.00-18.30 Scientific sessions09.00-16.30 Commercial exhibition

Friday 5 May07.30-14.00 Registration08.00-15.30 Scientific sessions09.00-14.30 Commercial exhibition 15.35-16.00 Closing ceremony

CONFERENCE VENUEAmsterdam RAIEuropaplein 22NL 1078 GZ AmsterdamThe NetherlandsWeb: http://www.rai.nl/en/

132

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

CONFERENCE APP FOR SMART PHONES AND TABLETSThe EWMA 2017 mobile app is an inter-active, digital guide designed specifically for the conference. The app is available for download in App Store or through Google Play.

TRANSPORT TO RAI AMSTERDAMBY PLANEAmsterdam Airport Schiphol is located a mere 15 minutes from RAI Amsterdam whether you travel by car, train, taxi or bus. The easiest route from the Amsterdam Airport Schiphol is the NS Sprinter train from Schiphol Airport Railway station to Amsterdam RAI Railway station. The train ride is 10 minutes long. Get on the NS Sprinter driving towards Hilversum. Get off at the Amsterdam RAI Railway station. When you leave the station follow the signs for RAI Amsterdam.

BY TRAINThe RAI has its ‘own’ station, Railway station RAI Amsterdam, which is located a short distance from the RAI complex and is easy to reach from anywhere in the Nether-lands. When you leave the station follow the signs for RAI Amsterdam. For further information consult the NS [Dutch railways] travel planner by visiting: www.ns.nl/en.

BY TRAM, METRO OR BUSTram 4 runs between the RAI (Europaplein stop), Amsterdam’s city centre and Amster-dam Central Station. You can reach the RAI from the Amstel railway station by taking Metro 51 and Bus 65. Metro 51 also runs to Amsterdam Central Station. Metro 50 runs regularly between the Amsterdam Sloterdijk and Gein stations and stops at the RAI Amsterdam station.

BY CARThe RAI is immediately signposted on roads signs on the ring road drivers end up on after approaching Amsterdam from the A1 motorway (Amersfoort/Amsterdam), the A2 (Utrecht/Amsterdam) or the A4 (Den Haag [The Hague]/Amsterdam). RAI Amsterdam is situated right next to the ring road (Exit 9). The RAI’s car parks are signposted immediately after leaving the ring road.

TAXISTaxis can drive right to the entrance G. Taxi companies:Taxi – TCA 0031 (0)20 777 77 77Receptionist can call the Taxi company.The price for a taxi from RAI Amsterdam:• to Schiphol Airport approx. € 35.00• to the city centre approx. € 18.00• to the Central Station approx. € 22.00

PUBLIC PARKINGThe parking rate at RAI Amsterdam is € 18 per 24 hours. RAI Amsterdam has plenty of parking facilities at and near the exhibition centre. They also offer around 30 electric charging stations.

BADGESAll participants and exhibitors should wear the name badge in the conference area at all times. The badge must be visible.

BANKING/ATMAn ATM can be found at two of entrances (C and K) of the RAI building. The informa-tion desks at various entrances can give you directions to their exact locations.

GENERAL CERTIFICATES OF ATTENDANCEYou are able to print your general certificate after 14.00 hours on your last day of attendance.

133

CLOAKROOMThe cloakroom is located by the Entrance G and costs €2,- for a coat and €3,- for suitcase.

CME (EWMA EUROPEAN CME) – EUROPEAN CONTINUED MEDICAL EDUCATION CREDITSThe conference is accredited by the Europe-an Accreditation Council for Continuing Medical Education (EACCME). For further information on the EACCME please see: www.uems.net

EWMA 2017 is designated for a maximum of up to 14 credits. In order to obtain the CME credits please log your attendance each day before 14.00 hours by scanning your badge at the logging stations in the registration area. You are able to print out your certifi-cate after 14.00 hours on your last day of attendance.

CURRENCYEURO

ENTITLEMENTSFinal programme, conference bag, admission to the full conference programme including all special sessions.

EMERGENCY & FIRST AIDParamedics are present throughout the opening hours. Emergency phone number is +31 (0)20 549 1234.

LUNCH AND COFFEE Lunch and coffee can be purchased in the cafés and restaurants located throughout the venue.

SPEAKER INFORMATION (Oral presentations)Please bring your presentation to the Speakers Upload Center at least 2 hours before your presentation.

The Speakers Upload Center is located in the registration area. Please see overview map for exact location.

The Speakers Upload Center opening hours are:Tuesday 2 May 15.00-18.00Wednesday 3 May 07.30-18.00Thursday 4 May 07.00-18.00Friday 5 May 07.00-14.00

A technician will assist you in transferring the presentation to a central conference server. When the transfer is complete, the technician performs a quick run of the presentation in order for you to check whether the presentation runs correctly and that all parts of the presentation are copied.

Photo: iAmsterdam

134

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

We do not allow the use of personal laptops for presentations. Please bring your presentation on CD, DVD or memory stick. The format of your slides should be 16:9, landscape. Unless otherwise agreed all presentations will be deleted in order to secure that no copyright issues will arise at the end of the conference.

INTERNET AND WIFIFree access to the WIFI at RAI Amsterdam is provided.Wireless network name: EWMA2017Security key: amsterdam

MOBILE PHONESAll mobile phones must be on silent mode during the sessions.

LANGUAGESThe languages for the EWMA 2017 confer-ence are English and Dutch.

LOST AND FOUNDFound items should be returned to the reception entrance G. If you lose something, please report to this reception desk.

NO SMOKING POLICYSmoking is prohibited in all the exhibition halls and at RAI Amsterdam. There are dedicated outdoor smoking areas available.

ELECTRONIC POSTERS (E-POSTERS)E-Posters are on display during all confer-ence days on touch screens situated in the e-poster area in the exhibition. All e-posters are available on all screens.E-Posters should be uploaded online before the conference.

E-Poster sessions: E-poster sessions are held at the screens placed in the e-Poster area in the exhibition.

Photo: iAmsterdam

135

Each e-Posters will be displayed for 3 minutes (guided by a chair), where you are kindly asked to be present and discuss your e-Poster with other participants. Please check programme book for specific time and place of each e-Poster session.

PRESENTER AWARDSEWMA First time presenter prize: This award is designed to encourage people who have not previously presented their work at an international conference. To be eligible for this prize you must have submitted your abstract to EWMA and you must be a “novice presenter”. That is, you should not have presented previously at an internation-al conference. The value of the prize is 450 EURO.

E-POSTER PRIZESThe e-Poster awards are designed to reward the considerable work that goes into preparing an e-Poster for presentation at the conference. To be eligible for consideration you must have a paper accepted for e-Poster presentation at the EWMA 2017 conference.

E-Posters that have been submitted/presented elsewhere are not eligible for an e-Poster prize. A panel of judges will attend the poster sessions, and authors are strongly encouraged to be present at these sessions in order to answer questions concerning their work. The panel will award 3-5 e-Poster prizes. The value of each e-Poster prize is 200 EURO. Your accepted e-Poster will automatically be considered for this award, provided that it has not previous-ly been submitted elsewhere (all categories except Case Studies and Professional Communication).

Photo: iAmsterdam

136

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

SOCIAL EVENTS

GET-TOGETHER EVENING!

Date: Wednesday 3 May 2017 Time: 18.00. The event is expected to end around 23.00.Place: At the conference venue RAI Amsterdam in the Auditorium Lounge.

Use the opportunity to network with fellow delegates.

Tickets bought in advance at 25 EUR per person incl. VAT. Limited number of tickets sold on-site during the day from the Registration counter.

Rustic-style standing snacks/food and drinks (and cash bar after that) with live music and the possibility to dance later on.

© www.shakyground.nl/

137

138

REFERENCE

1. Waite A, Delury C, Regan S, An in vitro evaluation of the physical properties of a new gelling fibre dressing, Presented at EWMA 2016; May 11-13, 2016; Bremen, Germany.

NOTE: Specific indications, contraindications, warnings, precautions and safety information may exist for Systagenix products.Please consult a healthcare provider and product instructions for use prior to application.

Copyright 2016, 2017 Systagenix Wound Management, Limited. All rights reserved. All trademarks designated herein are proprietary to Systagenix Wound Management, Limited, its affiliates and/or licensors. PRA000614-R0-EMEA, EN (04/17). M-74452.

Come and visit us at Acelity™ stand #2B 12. Ask for a demo of BIOSORB™ Gelling Fibre Dressing.

See for yourself how BIOSORB™ Gelling Fibre Dressing can outperform other dressings.

GELLING FIBRE DRESSINGBIOSORB™

Gentle on patients.Strong on removal.

43%greater absorbency than leading gelling fibre dressing. In vitro data1

BIOSORB™ Gelling Fibre Dressing

BIOSORB™ Gelling Fibre Dressing is a soft and conformable non-woven dressing made from sodium carboxymethyl cellulose and strengthening cellulose fibres. Designed to stay intact on removal and make dressing changes less painful.

Come and visit us at Stand #2B 12

BIOSORB_EWMA_Journal_and_programme_advert__OUS__74452_2.indd 2 07/04/2017 16:03

139

REFERENCE

1. Waite A, Delury C, Regan S, An in vitro evaluation of the physical properties of a new gelling fibre dressing, Presented at EWMA 2016; May 11-13, 2016; Bremen, Germany.

NOTE: Specific indications, contraindications, warnings, precautions and safety information may exist for Systagenix products.Please consult a healthcare provider and product instructions for use prior to application.

Copyright 2016, 2017 Systagenix Wound Management, Limited. All rights reserved. All trademarks designated herein are proprietary to Systagenix Wound Management, Limited, its affiliates and/or licensors. PRA000614-R0-EMEA, EN (04/17). M-74452.

Come and visit us at Acelity™ stand #2B 12. Ask for a demo of BIOSORB™ Gelling Fibre Dressing.

See for yourself how BIOSORB™ Gelling Fibre Dressing can outperform other dressings.

GELLING FIBRE DRESSINGBIOSORB™

Gentle on patients.Strong on removal.

43%greater absorbency than leading gelling fibre dressing. In vitro data1

BIOSORB™ Gelling Fibre Dressing

BIOSORB™ Gelling Fibre Dressing is a soft and conformable non-woven dressing made from sodium carboxymethyl cellulose and strengthening cellulose fibres. Designed to stay intact on removal and make dressing changes less painful.

Come and visit us at Stand #2B 12

BIOSORB_EWMA_Journal_and_programme_advert__OUS__74452_2.indd 2 07/04/2017 16:03

Introducing a new Aliphatic Wound Care

Foam with Superior Fluid Handling Properties.

The absorption and retention rates of the

Foam allied to its strength, fast rate of absorption,

processability and softness make this the ideal material

for Wound Care applications.

Foam is available as a high performing foam

or incorporating a class leading high MVTR film.

Visit our stand here at EWMA, Booth 2A26 so we can

introduce you to the range of products!

www.atdemolda.com/woundcare

140

SATELLITE SYMPOSIATIME ELICIUM 2 ELICIUM 1 FORUM EMERALD

ROOMSESSION

ROOM G106-107

SESSION ROOM E102

SESSION ROOM

E105-106

WEDNESDAY 3 MAY12.30-13.30

BSN Chronic Venous Disease – Approaches for Effective Oedema and Wound Management

( )

Smith & NephewReducing the burden of challenging wounds for patients, practitioners and providers

( )15.30-16.30

URGODiscover the 4 Dimensions That Decrease Leg Ulcer Healing Time

Lohmann & RauscherMaking the day-to-day wound management simple

MölnlyckePressure Injury Prevention: Clinical Outcomes Explained by Robust Scientific Evidence

Klox TechnologiesA New Effective Treatment Option for Hard-to-Heal Wounds: KLOX LumiHeal™

Smith & NephewPICO* Negative pressure, positive outcome

WoulganBoost Your Treatment Plans: Harness the Power of Macrophages in Wound Healing

LifeNet HealthDermacell: Human Acellular Dermal Matrix for Advanced Wound Management

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

141

WEDNESDAY 3 MAY

12.30-13.30 Elicium 2

( )

BSN Chronic Venous Disease – Approaches for Effective Oedema and Wound Management Chair: Matthias Augustin

Speakers:Chronic Venous Disease Management - Outcome Measures and Health EconomicsMatthias Augustin

Oedema Prevention as Anti-Wound Strategy in an Expert Center for Wound and Compression CareRobert Damstra

Lively Legs: Increased Physical Activity and Reduced Wound Days in Leg Ulcer PatientsMaud Heinen

Following the symposium we kindly invite you to meet our experts at our stand 3B02 in Hall 3.

12.30-13.30 Forum

( )

Smith & Nephew Reducing the burden of challenging wounds for patients, practitioners and providers Chair: Caroline Dowsett

Speakers:Reducing the burden of challenging wounds Caroline Dowsett

The current and future burden of woundsJulian F Guest

The importance of effective wound bed preparation and the role of biofilms in challenging woundsMatthew Malone

Kick-starting healing in challenging wounds with PICO* NPWTJane Hampton

142

15.30-16.30 Elicium 2

URGO Discover the 4 Dimensions That Decrease Leg Ulcer Healing Time Chair: Karl-Christian Münter

Speakers:Diagnose the Leg Ulcer Burden Karl-Christian Münter

Improve Your Dialog and Partnership with Your Patient Christine Moffatt

Achieve Dynamic Healing with the Right Treatment Protocol Sylvie Meaume

Decreased Healing Time in Clinical Elena Conde

15.30-16.30 Elicium 1

Lohmann & Rauscher Making the day-to-day wound management simple Chair: Susan Lemson

Speakers:Best Practice Statement Holistic Management of Venous Leg Ulceration Alison Hopkins

Best Practice Statement Making the day-to-day management of biofilm simple Kathryn Vowden

Current and future care – how can we improve care of hard-to-heal / chronic wounds? - Practical solutions for everyday use – Susan Lemson

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

143

15.30-16.30 Forum

Mölnlycke Pressure Injury Prevention: Clinical Outcomes Explained by Robust Scientific Evidence Host: Paulo Alves

Discussion: Nick Santamaria Amit Gefen

Introduction Paulo Alves

Driving pressure injury prevention through hospital management Sue Creehan

Role of positioners in the prevention of pressure injury Sue Creehan

Role of turning and positioning systems in the prevention of pressure injury Chenel Trevellini

Discussion and wrap-up Paulo Alves

15.30-16.30 Emerald Room

Klox Technologies A New Effective Treatment Option for Hard-to-Heal Wounds: KLOX LumiHeal™ Chair: Luc Teot

Speakers:Unmet Needs in Wound Healing Luc Teot

Wound Healing: “Very Intimate Process”. The Science Behind LumiHeal™ Giovanni Scapagnini

EUREKA ITALIA. The Evaluation of Real Life Use of KLOX BioPhotonic System in Chronic Wounds Management: A Reproducibility Study. Final Results Marco Romanelli

144

15.30-16.30 Room

G106-107

Smith & Nephew PICO* Negative pressure, positive outcome Chair: Robin Martin

Speakers:Negative Pressure Wound Therapy mode of action on closed incisions and open wounds Hanne Birke Sørensen

Protocols and NPWT bundles for complicated post-surgical wounds Theresa Hurd

Closed incision and open wound evidence for PICO Robin Martin

15.30-16.30 Room E102

Woulgan Boost Your Treatment Plans: Harness the Power of Macrophages in Wound Healing Chair: Matthias Augustin

Speakers:The Local Impact of Non-Healing Wounds Matthias Augustin

The Central Role of Macrophages in Wound Healing and their Activa-tion by Bioactive Beta-Glucan to Restart Healing Ron Legerstee

Bioactive Beta-Glucan in Clinical Practice: Case Reviews and Proposed Treatment Plans Brenda King

15.30-16.30 Room

E105-106

LifeNet Health Dermacell: Human Acellular Dermal Matrix for Advanced Wound Management Chair: Giampietro Bertasi

Speakers:Recent Randomized, Controlled Data Supporting Dermacell as a “One and Done” Solution in Advanced Wound Management Tyler Trapani

Clinical Experience with Dermacell in Advanced Wound Management Giampietro Bertasi

Health Economic Assessment of Currently Available Skin Substitutes for Advanced Wound Management Frederic Peycelon

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

145

TIME ELICIUM 2 ELICIUM 1 FORUM SESSION ROOM

G104-105

SESSION ROOM

G106-107

SESSION ROOM E102

THURSDAY 4 MAY11.15-12.15

Lohmann & RauscherDebridement in daily practice – our options

( )( )

ColoplastThe Triangle of Wound Assessment: Implementing a Simple and Systematic Approach to Wound Management

ConvaTecCombining Hydrofiber® Technology with Negative Pressure Wound Therapy: Presenting the New Avelle™ NPWT System and Recent Clinical Experiences

( )13.15-14.15

MölnlyckeNo Compromise on Quality: Is “Good Enough” Really Good Enough?

( )

FerrisThe Role of Inflammation in Wound Healing

( )

16.00-17.00

ConvaTecBiofilm: From Understanding the Problem to Developing Solutions

MiMedxThe Dynamic Impact of EpiFix® Dehydrated Human Amnion / Chorion Membrane Allograft – Defining the New Standard for Bioactive Healing

3MEnd IAD Today, Prevent it Tomorrow

Söring Clinical Experiences Around the Globe with Ultrasonic-Assisted Wound Debridement (UAW)

Bauerfeind Compression Therapy in the Treatment of the Ulcer Cruris

PraxisPolyHeal Micro: the 1st Micro-technology that accelerates wound healing

146

THURSDAY 4 MAY

11.15-12.15 Elicium 2

( ) ( )

Lohmann & Rauscher Debridement in daily practice – our options Chair: Susan Lemson

Speakers:Debridement in daily practice – our options Susan Lemson

The management of chronic wound biofilm with a debridement pathway: survey of nearly 2,000 nurses and their patients Richard Shorney

Debridement for deep wounds and invasive surgery procedures: Experience in daily practice on 170 patients Gunnar Riepe

The real value of mechanical debridement in assessment of chronic wounds: an economic evaluation Sara Sandroni

11.15-12.15 Elicium 1

Coloplast The Triangle of Wound Assessment: Implementing a Simple and Systematic Approach to Wound Management Chair: Tracey McKenzie

Speakers:Using the Framework in Cases Going from Wound Assessment to Product Choice Emmy Muller

How Can the Framework Be Implemented - Education of Generalists and Junior Nurses to Increase Wound Care Knowledge e.g. Medical Education Module Tracey McKenzie

How to Engage Healthcare Professionals to Use the Framework through Education Ulla Bjerre-Christensen

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

147

11.15-12.15 Forum

( )

ConvaTec Combining Hydrofiber® Technology with Negative Pressure Wound Therapy: Presenting the New Avelle™ NPWT System and Recent Clinical Experiences Chair: Kath Vowden

Speakers:Innovation in Hydrofiber® Technology: The development of a New Disposable NPWT System Stephen Bishop

Old and New Concepts in Negative Pressure Wound Therapy: What’s the Latest and Why? Roberto Brambilla

Clinical Experiences with the Avelle™ NPWT System Rachel Torkington-Stokes

13.15-14.15 Elicium 2

( )

Mölnlycke No Compromise on Quality: Is “Good Enough” Really Good Enough? Chair: Jacqui Fletcher

Speakers:Introduction Jacqui Fletcher

Championing value-based health care Louise Reuterhagen

Managing the fallout from ‘Un-Quality’ Leena Berg

Reaping the benefits of quality dressing selection in post-operative wound care Karen Ousey

Discussion and wrap-up Jacqui Fletcher

13.15-14.15 Forum

( )

Ferris The Role of Inflammation in Wound Healing Chair: Keith F. Cutting

Speakers:Acute Inflammation and Wound Healing Steven Jeffery

Chronic Inflammation and Wound Healing Keith F Cutting

Evaluation of a Multifunctional Dressing at a Norwegian Wound Care Clinic Bodo Gunther

148

16.00-17.00 Elicium 2

ConvaTec Biofilm: From Understanding the Problem to Developing Solutions Chair: Ron Legerstee

Speakers:Practical Identification of Wound Biofilm Jennifer Hurlow

Enhancing Dressing Performance for Anti-Biofilm Effectiveness David Parsons

Clinical Impact of Using AQUACEL® Ag+ Dressings in Practice Leanne Atkin

16.00-17.00 Elicium 1

MiMedx The Dynamic Impact of EpiFix® Dehydrated Human Amnion / Chorion Membrane Allograft – Defining the New Standard for Bioactive Healing Chair: Severin Läuchli

Speakers:Application Techniques and Therapeutic Approaches Using EpiFix Amniotic Allografts for Wound Healing and Surgical Procedures Matthew Garoufalis

The Swiss Experience with EpiFix Severin Läuchli

16.00-17.00 Forum

3M End IAD Today, Prevent it Tomorrow Chair: Lisette Schoonhoven

Speakers:Why should we care about IAD? Dimitri Beeckman

Effect of mixed incontinence on (aging) skin. Jan Kottner

3M Science Applied to Life: Cavilon Advanced Skin Protectant. Debra Thayer

Science in reality: Experiences of Cavilon Advanced Skin Protectant from the US. Mary Brennan

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

149

16.00-17.00 Room

G104-105

Söring Clinical Experiences Around the Globe with Ultrasonic-Assisted Wound Debridement (UAW) Chair: Terry Swanson

Speakers:Wound Bed Preparation with UAW as an Integral Part of Wound Treatment in Australia Terry Swanson

Preliminary Study Results in a Specialized Surgical Clinic in Germany: Opportunities Derived from Using UAW to Prepare the Wound Bed of Post-Surgical Wounds with Healing Chris Braumann

Changing Current Wound Treatment Practice for Patient´s Benefit: The Swiss Experience Using UAW in an Outpatient Setting Bernd Gächter

16.00-17.00 Room

G106-107

Bauerfeind Compression Therapy in the Treatment of the Ulcer Cruris

Speakers:Michael Jünger Tim Wentel

16.00-17.00 Room E102

Praxis PolyHeal Micro: the 1st Micro-technology that accelerates wound healing Chair: Ralf Peter

Speakers:Evaluation in clinical practice of Negatively Charged Microspheres for wound healing Aharon Wanszelbaum

Reawakening the most hard to heal chronic wounds: Long term outcomes of a RCT with NCM technology Hanna Kaufman

Cost-Effectiveness of PolyHeal in treating chronic wounds with Exposed Bones and Tendons and Post-Operative chronic wounds Julian F. Guest

150

FRIDAY 13 MAY

12.45-13.45 Emerald Room

3M Pressure Ulcer Prevention and Management: Do We All Agree? Chair: Dimitri Beeckman

Speakers:Jacqui FletcherLisette SchoonhovenJan Kottner

12.45-13.45 Room

G104-105

Fidia HAVE HEALING: Hyaluronic Acid in wound management Chair: Sybille Masi

Speakers:Why Low Molecular Weight HA in wound healing? Alberto Passi

Hyalo4 Regen (Eq, Collagen + Hyaluronic acid) in DFUs: protocol of use & clinical results Carlo Caravaggi

Hyalo4 product line in ostomy wound management: protocol for peristomal lesions Stefano Gasperini

TIME EMERALD ROOM SESSION ROOM G104-105 SESSION ROOM G106-107

FRIDAY 5 MAY12.45-13.45 3M

Pressure Ulcer Prevention and Management: Do We All Agree?

FidiaHAVE HEALING: Hyaluronic Acid in wound management

BSNOvercoming Obstacles in Wound Infection Management and Prevention

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

151

12.45-13.45 Room

G106-107

BSN Overcoming Obstacles in Wound Infection Management and Prevention Chair: Sharon Hunt

Speakers:Wound Infection Prevention and Management in the light of Developing Resistance Jeffrey Lehrman

Prevention of Surgical Site Infections by Using DACC Coated Dressings George Smith

Early Detection of Wound Infection in the Context of Self-Care and Health Economics Sharon Hunt

Following the symposium we kindly invite you to meet our experts at our stand 3B02 in Hall 3.

152

New therapy option

for chronic wounds

Y

The O2TopiCare Woundsystem® (wound management system)

The O2-TopiCare® Wound System provides localisedoxygen treatment for arms, legs and feet. Angiogenesis plays a central role in wound healing. Among many known growth factors, vascular endothelial growth factor (VEGF) is believed to be the most prevalent, efficacious and long-term signal that is known to stimulate angiogenesis in wounds.By placing a sterile bag of the 02 TopiCare Woundsystem around the leg/wound, the bag can be filled directly with oxygen from a concentrator (or another oxygen source), for example an Everflo. An Everflo creates a pressure system of about 50 mbar that is perfect for allowing the highest amount of oxygen to be absorbed by the blood with topical application.

To stimulate the return of venous blood to the leg, the cuff can be adaptedto an A-V Impulse System® that simulates walking, helping the natural transfer of the venous blood.

Very good results with the O2 TopiCare wound management system

Wound condition at therapy commencement

After 10 months TopiCare therapy

Even if all other therapy possibilities have been exhausted, chronic wounds can begin to heal through the oxygen application of the O2 TopiCare wound management system.

In the case illustrated here all other therapies had failed. Wound healing was stimulated however through the O2 TopiCare wound management system.

OXYCARE GmbH · Holzweide 6 · 28307 Bremen / GermanyFON +49(0)421-48 996-6 · FAX +49(0)421-48 996-99 · E-MAIL [email protected]

Shop price

from 13,50 €

Applicable at:• ulcus cruris• slow-healing wounds• diabetic foot lesions

The 02 TopiCare Woundsystem includes:

4 pcs. O2-TopiCare® woundcuff4 pcs. cuff for A-V-Impulse1 pcs. oxygen concentrator „Everflo“1 pcs. A-V-Impulse system 1 pcs. nasal cannula

Approved as medical device with CE 0197

Fingerpulse oxymeter OXY310 35,00 €

LIMBO waterproof protectorsWide range of adult and child sizes Easy to use durable productEnables comfortable bathing or showering

advert14_24EWMA.indd 1 10.04.2017 14:42:33

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

153

COMPANY WORKSHOPSWEDNESDAY 3 MAY

MEETING ROOM G109

BSN Ulcus Cruris Venosum: meer dan wondzorg en compressie! Workshop leefstijlbegeleiding: Lively Legs

Speaker: Irene van de Glind

10.30-11.30&14.15-15.15

THURSDAY 4 MAY

MEETING ROOM E108

APR WOUND CLEANSING: Which solution? Practical demonstration through clinical cases with Nexodyn AcidOxidizing Solution (AOS)

Speaker: Beyond compression in venous ulcers: a clinical case Sebastian Probst

Speaker: Cleansing as a valuable add-on in the therapeutic approach of a DFU patient: a clinical case Enrico Brocco

11.15-12.15&14.30-15.30

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

155

EXHIBITORS

3MTel.: +31 157 822 [email protected]

3M Science provides unique innovations to protect patient skin and optimally manage wound care using proprietary technologies and supporting clinical education through our 3M healthcare academy.

3D16

ABIGO Medical ABTel.: +46 317 484 [email protected]

ABIGO Medical is the Swedish owner and manufacturer of Sorbact® wound dressings. Sorbact® Right from the start - Prevents and treats wound infections by lowering the bioburden. Meet us at booth 2D12.

2D12

Acelity™Tel.: +1 800 275 4524 [email protected]

Acelity™ is a global wound care and regenerative medicine company. Deliver value through cutting-edge therapies and innovative products and lead the industry in quality, safety and customer experi-ence. For more information, please visit Acelity.com

2B12

Adhesives ResearchTel.: +353 613 003 00 [email protected] www.adhesivesresearch.com

AR is a leader in the development & manufacture of high-performance pressure-sensitive adhesives & coated products. We specialise in bespoke products with critical factors such as ease of use, comfort, wear-time (hours to 14 days+) & biocompatibility.

3D09

Adtec HealthcareTel.: +44 208 737 [email protected]

Adtec Healthcare SteriPlas Wound management technology utilizes gas plasma to reduce the microbial load in wounds regardless of the type or its resistance to antibiotics. Adtec SteriPlas 2 minute treatment showed marked improvement in wound healing.

2A28

ADVAMEDICA INCTel.: +1 973 718 [email protected] www.axiostat.com

Axiostat is an award winning CE-approved 100% chitosan haemostatic dressing that stops severe arterial bleeding within minutes. Axio an ISO 13485 m edical device m anufacturing company develops has brought Axiostat to global market.

2E10

Advanced Oxygen Therapy Inc. (AOTI) Tel.: +353 91 660 310Tel.: +1 760 431 [email protected]

AOTI provides range of patented Topical Wound Oxygen (TWO2) Therapy devices for the treatment of chronic wounds, such as; diabetic, venous & pressure ulcers. TWO2 comes in single-use & reusable versions & can be applied at the patient’s home or in facilities.

2A22

156

Advancis MedicalTel.: +44 162 375 1500 [email protected]

Continuing to innovate in the design, manufacture and delivery of cost effective Advanced Wound Care products, assisting the healthcare professional in the healing of chronic and acute wounds, whilst maintaining a focus on patient comfort.

2C04

Anatomi Metrix Inc.Tel.: +1 514 882 [email protected]

Anatomi Metrix is an innovative Canadian start-up company based in Montréal that develops technologies and software to improve the capture of the anatomical dimensions of the hand.

2E09

MA

DE I N T H E U

SA

Andover Healthcare, Inc.Tel.: +1 978 465 [email protected]

Andover Healthcare provides the most innovative and complete line of Two Layer Compression products available today including Coflex TLC, TLC Lite, TLC XL, TLC Zinc and TLC Calamine.

3B14

APR Applied Pharma Research s.a.Tel.: +41 916 957 [email protected]

Applied Pharma Research is a private, international corporation headquartered in Switzerland and focused on the development and licenses of innovative healthcare products in niche or rare therapeutic areas.

3C04

ARANZ MedicalTel.: +64 337 461 [email protected]

ARANZ Medical’s Silhouette system improves productivity and accuracy in the management of wound assessment for clinical practice and research. It offers 3D wound measurement, imaging, and documentation from multiple sites, integrated with EMR systems

2A30

Argentum Medical LLCTel.: +31 610 624 [email protected]

The Silverlon® bactericidal wound range is different and delivers thehighest Ag ion release only above the MIC’s on a safe, strong and simple way, no chemical residuals or discoloration in situ and very cost effective .

3A20

ArionTel.: +31 464 113 [email protected]

Arion is the innovative company and manufacturer of Swash®, the product behind the revolutionary concept of Bathing 21®. Bathing 21® sets the standards for daily bathing and personal hygiene of the 21st century.

3D13

Association of Diabetic Foot Surgeons (A-DFS)Tel.: +45 702 003 [email protected]

The Association of Diabetic Foot Surgeons (A-DFS) is a not-for-profit international organisation for surgeons working with the diabetic foot syndrome. They work is to support cooperation and best practice in research, education and clinical interventions between foot surgeons working with or having an interest in the diabetic foot.

2A16

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

157

ATD emoldaTel.: +353 182 515 [email protected]

ATD emolda manufactures products for the medical device and pharmaceutical industries. Our new range of aliphatic polyurethane foams has excellent fluid handling properties (absorption and retention) and is manufactured under our ISO 13485 standard.

2A26

ATGmed - AT Technologies GmbH Tel.: +49 219 688 [email protected]

ATG offers NEXODYN as antiseptic solution, Hyalogran for debriding and Hyalofill for conditioning of the chronic wound. Hyalosafe and Hyalomatrix, for epidermal and dermal skin substitutes, INTEGRO as NPWT incl. instillation and oxygen therapy option.

2E30

Avita MedicalTel.: +44 208 947 [email protected]

Avita Medical’s ReGenerCell is a unique technology which delivers a Regenerative Epithelial Suspension (RES) that is applied directly to a wound. RES promotes healing in unresponsive and hard to heal wounds.

3E06

B. Braun MedicalTel.: +41 582 585 [email protected]/woundmanagement

B. Braun wound management supports each phase in the healing process. Provid-ing innovations to remove and prevent Biofilm as Prontosan®, treat infections with Askina® Calgitrol® and clearing the way for the Askina® advanced wound dressings.

2D14

BAP Medical BVTel.: +31 553 552 [email protected]

BAP Medical: Privately owned Dutch company. Specialized in non-invasive scar treatment and medical skincare. Products have been scientifically and clinically proven and offered with and without UV-protection.

2E02

Bauerfeind AG Tel.: +49 366 286 610 [email protected]

Bauerfeind AG is one of the leading manufacturers of medical aids such as supports, orthoses, compression stockings, and foot orthoses. The high- quality products, “Made in Germany”, make an important contribution to maintaining and restoring health.

2E06

BDKTel.: +44 473 659 [email protected]

BDK is an innovative, technical and highly experienced healthcare convertor, a confidential partner to many leading healthcare organisations providing a complete project management service for prototyping, volume manufacture and pouching.

3C15

158

Beier Drawtex HealthcareTel.: +27 317 100 [email protected]

Beier Drawtex Healthcare manufactures Drawtex Hydroconductive Wound dressings in South Africa, and distributes them around the globe. Drawtex combines 3 unique mechanisms of action, to create an innovative method of Wound Bed Preparation.

3B12

BenQ MateerialsTel.: +88 603 374 [email protected]

BenQ Material is established in Taiwan since 1998. With leading core-technology in material science, we focus on biomaterials development. Our products: Chitosan Hemostatic Dressing, PVA sponge, scar reduction Silicone stick and Hydrocolloid dressing.

2D42

Bfactory Health Products B.V Tel.: +31 317 769 005 [email protected]

Bfactory develops a professional portfolio for advanced wound care, i.e. Revamil®. The Revamil® portfolio consists of high-enzyme honey-based products for various stages of the wound.

3D14

Bio Compression Systems, IncTel.: +1 800 888 [email protected]

Bio Compression Systems, Inc. is the leading manufacturer of pneumatic compression devices for the treatment of lymphedema, venous insufficiency, wound care, arterial disease, DVT prophylaxis, post-op edema and sports injuries. Stop by our booth 3E20 to see our full line of products. For more information please visit our website at www.biocompression.com.

3E20

Det Sundhedsvidenskabelige Fakultet INST Faculty of Health and Medical Sciences DEPT

d e pa rt m e n t n a m eu n i v e r s i t y o f c o pe n h ag e n

b i o f i l m t e s t fac i l i t yu n i v e r s i t y o f c o pe n h ag e n

i n s t i t u t n av nkø b e n h av n s u n i v e r s i t e t

b i o f i l m t e s t fac i l i t yu n i v e r s i t y o f c o pe n h ag e n



0/0/0/70

Principopsætning på publikationer

Principopsætning til andre formål end publikationer

Lodret variant med navnetræk placeret under logostregen.

Vandret variant med logo til venstre

Placement of logo on publications

Use of logo for other purposes

Vertical version with logotype under the logo line

Horizontal version with logo to the right

Logo: CMYK C

100/90/0/35

100/100/0/28

Logo: CMYK ULogotype: CMYK U/C

d e pa rt m e n t n a m e2 n d l i n eu n i v e r s i t y o f c o pe n h ag e n

i n s t i t u t n av n2 . l i n j ekø b e n h av n s u n i v e r s i t e t

d e pa rt m e n t n a m e2 n d l i n eu n i v e r s i t y o f c o pe n h ag e n

i n s t i t u t n av n2 . l i n j ekø b e n h av n s u n i v e r s i t e t

Det Sundhedsvidenskabelige Fakultet (FAK version) Faculty of Health and Medical Sciences (FACULTY version)

fac u lt y o f h e a lt h a n d m e d i c a l s c i e n c e su n i v e r s i t y o f c o pe n h ag e n

d e t s u n d h e d s v i d e n s k a b e l i g e fa k u lt e tkø b e n h av n s u n i v e r s i t e t





Principopsætning på publikationer

Principopsætning til andre formål end publikationer

Lodret variant med navnetræk placeret under logostregen.

Vandret variant med logo til venstre

Placement of logo on publications

Use of logo for other purposes

Vertical version with logotype under the logo line

Horizontal version with logo to the right

0/0/0/70

Logo: CMYK C

100/90/0/35

100/100/0/28

Logo: CMYK ULogotype: CMYK U/C

Biofilm Test FacilityTel.: +45 353 373 [email protected]

Research-based microbiology testing of industry products and settings.We test and visualize compounds, coatings, dressings, etc. in relevant models for biofilm killing and inhibition. We engage all projects from single preliminary tests to large preclinical trials.

2A09

BiologiQ InternationalTel.: +31 553 684 [email protected]

BiologiQ is an independent Dutch Medical Company, specialized in marketing, sales and distribution of safe and effective Bio-active and Biotech products and therapies for Wound Healing.

3D14

BioMonde GmbHTel.: +49 406 710 [email protected]

BioMonde specialise in the manufacture and distribution of larval debridement therapy (also known as maggot therapy) products for use in chronic and hard to heal wounds.

2E01

Bioskinco GmBHTel.: +49 931 780 996 [email protected]

Bioskinco introduces epicite-hydro, a wound coverage with exceptionally high water content of up to 99%. It protects the wound against drying, enhances healing and guarantees pain-free removal.

3E45

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

159

BRH MedicalTel.: +97 254 805 [email protected]

Non-invasive portable device combining therapeutic ultrasound and electro-stimulation to promote healing of chronic ulcers. Reduces lesion size, lowers wound pain, and accelerates tissue regrowth.

3E43

BSN Medical GmbHTel.: +49 404 909 909www.bsnmedical.comwww.cutimed.com

BSN medical is a global leader in wound care & related vascular diseases, lymphology and non-invasive orthopaedic products. The company aims to provide an integrated therapy-driven approach – grounded in a broad product portfolio.

3B02

ChemvironTel.: +44 191 582 [email protected]

Manufacturer of the Zorflex direct contact wound dressing. Naturally antimicrobial without putting anything into the body, it is also conductive and manages odour while accelerating healing safely.

2B28

Cica Biomedical LtdTel.: +44 142 379 [email protected]

Cica Biomedical Ltd is an independent UK-based company that provides contract pre-clinical and clinical research services to the wound management / tissue viability sector.

2E20

CINOGY GmbHTel.: +49 552 784 837 [email protected]

CINOGY GmbH is the innovation leader in plasma medicine. CINOGY has globally declared its conformity with EU Guideline 93/42/EEC for its PlasmaDerm® product family after passing the necessary conformity assessment procedures.

2D20

ColoplastTel.: +45 491 111 [email protected]

Coloplast want to make life easier for patients with wounds and simplify wound care for people who care for them.Together we achieve fewer days with wounds.

2C02

COLUXIA LABORATOIRESTel.: +33 438 553 [email protected]

Gergonne Industrie / Laboratoires Coluxia offer high performance components designed for advanced woundcare applications: high MVTR PU films, skin-friendly adhesives and wound contact layers, as well as a clean room conversion and packaging service.

2C10

Contipro a.s.Tel.: +42 465 519 [email protected]

Biotechnology company focused on research and development of wound care products actively supporting healing process.

3C08

ConvaTecTel.: +44 800 289 738www.convatec.com

ConvaTec is a leading developer of innovative medical technologies in Advanced Wound Care, Ostomy Care, Continence and Critical Care and Infusion Devices that have helped improve the lives of millions worldwide.

2B04

160

CovaleoTel.: +1 210 800 [email protected]

COVALEO International is developing and marketing globally Bismuth based antimicrobial and hemostatic wound care products. The latest developments are the antimicrobial, non-adherent, primary wound dressing XERONET and the CACIPLIQ20 spray which replaces heparan sulfate in the extracellular matrix to enable tissue and wound regeneration.

3D03

Covalon Technologies Ltd.Tel.: +1 905 568 [email protected]

Covalon researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon’s technologies are used to prevent, detect and manage medical conditions in the areas of wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.

2A04

Coveris Advanced CoatingsTel.: +44 197 866 [email protected]

Our medical components are designed to bring high performance to moist wound dressings for the professional & consumer market. inspire® includes polyurethane films, foams, conductive films & pattern adhesive coatings.

2C11

Covestro Deutschland AGTel.: +49 214 600 920 [email protected]

Covestro (formerly Bayer Material-Science), one of the world’s largest polymer companies, focused on the manufacture of high-tech polymer materials, offers raw materials for wound dressings/incision films: high performance films, foams and adhesives.

2A14

Crawford HealthcareTel.: +44 156 565 [email protected]

Crawford Healthcare has a range of woundcare solutions for skin protection, wound cleansing, exudate management (with Exu-Safe™ technology) and wound infection (with patented Ag Oxysalts™).

3C09

curasonix GmbHTel.: +49 451 989 005 [email protected]

curasonix GmbH is dedicated to advanced wound cleaning through unparalleled ultrasonic technology for healthcare professionals combining decades of expertise and excellence in medicine and sciences.

2C31

curea medical GmbHTel.: +49 360 719 009 [email protected]

Curea medical develops and manufac-tures wound dressings for all types of exudating wounds as well as highly absorbent products for the medical sector.

2C25

DAEWOONG PHARMATel.: +82 196 928 [email protected]

Daewoong has collaborated with our partners to make a win-win result by localizing our healthcare solutions, and contributes their countries by supplying our best products with reasonable prices.

3B25

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

161

Dale Medical Products Inc.Tel.: +1 800 343 [email protected]

Dale Medical Products, Inc. develops and manufacturers innovative post-surgical care products for the acute, sub-acute and long-term care markets,

2E04

DARCO (Europe) GmbHTel.: +49 887 922 [email protected]

DARCO is dedicated to being one of the leading providers of post op, trauma and wound care solutions to the global foot and ankle community.

2B10

Datt MedicalTel.: +91 114 719 [email protected]

Manufacturer Exporter of Medical Disposables/Gauze Products/ Bandages /Dressing/Advanced Wound Care Products to companies in Europe, U.S.A, Australia, Japan, New Zealand, Middle & Far East and South Africa.

3A08

Working for a life free of pain.

DEBRA InternationalTel.: +44 134 475 2708www.debra-international.org

DEBRA International’s vision is to ensure that people living with the painful genetic skin blistering condition EB have access to the best quality support and care, and to drive the development of effective treatments and cures.

3B28

Deka mela srlTel.: +39 055 882 [email protected]

Deka is a world-class leader in the design and manufacture of lasers and light sources for applications in the medical field with 30 years experience.

3D18

DermaSciencesTel.: +44 162 862 [email protected] www.outside-us.dermasciences.com

Derma Sciences, Inc.: Advanced wound - care company offering the MEDIHONEY® line of Active Leptospermum Honey, XTRASORB®, ALGICELL® Ag and TCC-EZ®, a unique roll-on and quick to apply, off-loading system to treat DFU.

2C21

DeRoyalTel.: +1 865 362 [email protected]

DeRoyal’s affordable and advanced products treat all stages of acute, chronic, or burn wounds and are uniquely constructed with the latest technology.

2D06

Diabetic Foot Study Group (DFSG)Tel.: +45 702 003 [email protected]

The DFSG Meeting is a unique event within the area of the diabetic foot because it is a true interdisciplinary collaboration between diabetologists, podiatrists, specialist nurses, orthopaedic and vascular surgeons, as well as all other specialists with an interest in diabetic patients with foot problems.

2A16

DM Systems’ HeeliftTel.: +1 847 328 [email protected]

Avoid amputation, heal chronic wounds & prevent heel pressure ulcers. See published clinical evidence, request a sample. The Heelift® Suspension Boot.

2B10

162

Don & LowTel.: +44 130 745 2200will.campbell@donlow.co.ukwww.donlow.co.ukwww.thracegroup.com

Don & Low are a UK based, and internationally renowned, manufacturer of innovative, high performance medical nonwovens from polypropylene, polyethylene and thermoplastic polyure-thane.

2D26

Ehob IncTel.: +31 650 815 [email protected]

EHOB is a leading company in Pressure Area Care with more than 30 Years experience. EHOB is specialized in Static Air solutions that are highly cost efficient and have a proven track record.

3E41

European Council of Enterostomal Therapy (ECET)Tel.: +45 702 003 [email protected]

The European Council of Enterostomal Therapy is a professional nursing society, which supports its members by promoting educational, clinical and research opportunities to advance the practice and guide the delivery of expert health care with ostomies, incontinence and wounds.

2A16

European Pressure Ulcer Advisory Panel (EPUAP) Tel.: +420 251 019 [email protected]

The European Pressure Ulcer Advisory Panel works to provide the relief of those suffering from or at risk of pressure ulcers through research, education and influencing pressure ulcer policy in Europe.

3A30

EuroresearchTel.: +39 280 556 [email protected]

Euroresearch, established in 1983, operates in different areas of pharma-ceutical field, with particular attention to R&D and marketing, licensing and trading of human and veterinary drugs, as well as own-branded collagen based med-ical devices and pharmaceutical products.

3D21

EurotapeTel.: +31 356 091 [email protected]

Eurotape is a dynamic manufacturer and developer of top quality self-adhesive products for reusable & disposable surgical covering materials.

3A36

EWMA Education Lounge In the “EWMA Education” lounge you will find information about – and may get a copy of - EWMA materials for educational purposes as well as clinical practice support. A representative of the EWMA Education Committee will be present all days at 12.00-12.30.

3C13

Ferris Mfg. Corp. (PolyMem)Tel.: +1 817 900 [email protected]

PolyMem is a unique and patented multi-functional polymeric membrane dressing (not a foam dressing). PolyMem = More Healing & Less Pain.

2B30

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

163

Fidia farmaceutici S.p.A.Tel. : +39 498 232 [email protected]

Fully integrated Italian healthcare company, with R&D, manufacturing, marketing and sales capabilities, Fidia is world-leading manufacturer of hyaluronic acid, using proprietary, validated processes, for use in Wound Care, Mucosal Health and Aesthetics among others. Operations are FDA-inspected and approved.

2B26

FLEN PHARMA SATel.: +352 263 406 [email protected]

Flen Pharma develops, manufactures and markets a range of unique advanced wound and skincare products, including Flaminal® and Flamigel®. Flen is committed to the research and develop-ment of innovative products in woundcare and the care of the skin.

3E01

FrescoTel.: +34 932 314 [email protected]

A medical device manufacturer since 1975, Fresco has developed products for pressure redistribution/management as well as decubitus ulcer prevention. Using polymer gel and other materials we bring prevention products to the market.

3B11

Freudenberg Performance Materials SE & Co. KGTel.: +49 620 180 [email protected]

Freudenberg is a family-owned, global company. With a long term experience in the medical market we offer innovative solutions for medical devices in advanced and active wound care. New in the portfolio: PU-foams and bioresorbable nonwovens.

2B02

Frontier Medical GroupTel.: +44 149 523 [email protected]

Frontier Medical Group is a market leading company manufacturing and supplying innovative pressure area care solutions for healthcare providers both in the UK and internationally including the Repose®, Ultracore and TotoTM ranges.

3B04

Genadyne BiotechnologiesTel.: +1 516 470 [email protected]

Genadyne Biotechnologies offer a full range of wound healing products, including XLR8- the smallest, lightest and quietest fully functioning NPWT system, UNO single patient NPWT offering 16 days of therapy and Nanogen a revolutionary treatment for hard to heal wounds, proven to heal even the most difficult of wounds.

2C05

GERGONNE INDUSTRIETel.: +33 447 473 [email protected]

Gergonne Industrie / Laboratoires Coluxia offer high performance components designed for advanced woundcare applications: high MVTR PU films, skin-friendly adhesives and wound contact layers, as well as a clean room conversion and packaging service.

2C10

164

Getinge GroupTel.: +33 680 731 [email protected]

Getinge Group is a global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions.

3D02

Haddenham HealthcareTel.: +44 184 420 [email protected]

Haddenham Healthcare are specialists in providing proven and market leading products for the treatment of patients with Lymphoedema, Chronic Oedema and Wound Care.

3A22

m e d i c a l t e c h n o l o g i e s

Haromed B.V.B.A.Tel.: +32 932 605 [email protected]

Haromed offers a full product range for NPWT (Exsudex®), skin repair and scar treatment (SurgHydra® – SurgBarrier® – Scar Gel).

3E40

HistocellTel.: +34 946 567 [email protected]

Leading company in regenerative medicine presenting Reoxcare: Bioactive wound dressing with unique antioxidant properties to promote the natural wound healing process in skin wounds.

3E10

HuntleighTel.: +44 292 048 5885sales@huntleigh-diagnostics.co.ukwww.huntleigh-diagnostics.com

Huntleigh “Assessment & Treatment” portfolio specialises in the Lymphoedema, Oedema and Wound Care fields, providing market leading products and clinical training to meet the needs for both clinicians and patients.

2D40

Initiative Chronische Wunden (ICW)Tel.: +49 645 575 939 [email protected]

The ICW – a German Wound Healing Society The Initiative Chronische Wunden was founded in 2002. The society counts more than 3000 members. Its major objectives are to promote knowledge of chronic wounds and to train therapists from all fields who are concerned with wound healing. In 2012 ICW e.V. got an official admission as a science-based society.

3D22

Inotec AMD LtdTel.: +44 122 366 [email protected]

Inotec AMD Ltd developed NATROX®, a small portable device that delivers humidified oxygen directly to the to the wound bed to initiate and accelerate healing. It is available in over 15 countries worldwide.

3D05

International LymphoedemaFramework (ILF)Tel.: +45 702 003 [email protected]

The aim of the International Lymphoede-ma Framework (ILF) is to develop and evaluate appropriate health care services for patients with all forms of lymphoe-dema in countries throughout the world. Central to framework is partnership and collaboration at a number of levels.

3E18

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

165

Invitalis BeneluxTel.: +31 624 575 [email protected]

Invitalis stands for high quality health products that people can use at home. We will bring our Vitaly Med Flexi and ViViBo to demonstrate. We develop, produce and sell our owm products.

3C17

JeNaCell GmbHTel.: +49 364 150 [email protected]

JeNaCell has a goal: the best and most pleasant treatment of human skin.

3E45

Journal of Wound Care (JWC)Tel.: +44 207 738 [email protected]

JWC, which has an impact factor and is MedLine listed, is the leading monthly international wound care journal. JWC publishes the EWMA daily newspaper and will be holding the JWC awards in 2018. For more information and a copy of the paper visit our stand.

3E08

Juzo Julius Zorn GmbHTel.: +49 825 190 [email protected]

At Juzo, we put all our know-how and passion into developing compression garments, supports and orthoses that accompany patients during their treatment. Our medical aids are being exported worldwide.

3E04

Kerecis™Tel.: +1 202 999 [email protected]

Kerecis™ Omega3 Wound fish skin graft with natural omega3 polyunsaturated fatty acids accelerates wound healing and enables tissue reconstruction. Also from Kerecis, a range of dermatological formulations with patented mOmega3™ treating a number of skin conditions.

2C36

KLOX Technologies Inc.Tel.: +1 866 653 [email protected]

KLOX, a specialty pharmaceutical company dedicated to the healing of skin and soft tissue disorders. Through its revolutionary, proprietary BioPhotonic technology, KLOX harnesses the power of light, its fluorescence and oxygen to accelerate healing.

2B01

Levabo ApSTel: +45 207 009 [email protected]

Heel up and all up are Levabo’s new products in the treatment and prevention of pressure ulcers.Heel up and all up are user-specific disposable products with an ergonomic design. The external layer is made of soft, flexible, heat and moisture absorbent nonwoven material.

3B22

LifeNet HealthTel.: +1 757 464 [email protected]

LifeNet Health helps save lives, restore health, & give hope to 1000s of patients each year. We are the world’s most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies.

3E46

166

Waterproof protectors

LimbO Waterproof ProtectorsTel.: +44 124 357 3417Tel.: +44 122 383 [email protected]@bodyblock.co.ukwww.limboproducts.co.ukwww.bodyblock.co.uk

LimbO lets patients shower or bath & keep dressings casts or PICC lines 100% dry. Easy to use & comfortable. UK made; distributed worldwide.BodyBlock – versatile, lightweight limb positioning device.

2E32

LINET GroupTel.: +42 312 576 [email protected]

LINET - the biggest European manu-facturer & supplier of hospital beds and active therapy mattresses for healthcare and long-term care.

2D34

L-MesitranTel.: +31 433 251 [email protected]

L-Mesitran antibacterial medical grade honey products, stimulate wound healing. L-Mesitran creates a moist wound bed, anti-inflammatory, debrides and reduces malodour. These innovative Dutch products are cost effective and speed up healing wounds naturally!

2A01

Lohmann & Rauscher GmbH & Co KGTel.: +49 263 [email protected]

L&R is a supplier of medical devices and hygiene products with more than 160 years expertise and a sales volume of more than 589 million euros in 2016.

2C01

Lymed OyTel.: +358 207 792 [email protected]

Lymed, awarded many times for their quality & design, manufactures techno-medical pressure garments. LYMED® garments are used for scar management, compression treatments and neurological indications. Bespoke range also includes athletes & animals.

2A12

MedaxisTel.: +41 628 238 [email protected]

Medaxis is a Swiss medical technology company, whose gentle, efficient, thorough and tissue preserving micro water jet debridement debritom+ sets new standards in the modern wound debridement.

3C10

MedelaTel.: +41 415 625 [email protected]

Medela is dedicated to making it easier for healthcare professionals to help their patients heal. Medela has 18 subsidiaries in Europe, North America and Asia, and together with independent partners distributes its products in more than 100 countries.

3B05

Medi GmbH & Co. KGTel.: +49 921 [email protected]

medi is one of the world’s leading manufacturers of compression hosiery. medi supplies medical compression and antiembolism stockings, lymphedema sleeves, wound care products and orthopaedic products.

3C02

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

167

Mediq MedecoTel.: +31 186 634 [email protected]

For over 75 years Mediq Medeco has been a partner of healthcare professionals in different healthcare sectors.Mediq Medeco does its utmost to support professionals in delivering good and affordable care. By delivering products, services and knowledge.

2D44

Medprin (Shenzhen) Regenerative Medical Technologies Co., Ltd.Tel.: +49 695 800 599 [email protected]

Medprin Biotech GmbH is a high-tech enterprise co-founded by outstanding biomedicine scientists in 2008, specializing in R & D and manufacturing of human tissue regenerative implanta-ble devices. Our first products have been CE marked and sold to more than 40 countries, set up branches in America, Germany and China.

3B17

MESI, development of medical devices, LtdTel.: +38 616 203 [email protected]

MESI Medical provides 1-minute solution for Ankle-Brachial Index measurement, which is crucial in Wound Compression Therapy. The MESI ABPI MD substitutes the Doppler probe and assures objective performance, 95% accuracy and an option for print-out.

2D28

MiMedxTel.: +1 866 477 [email protected]

MiMedx is the leading regenerative medicine company utilizing human placental tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare.

3C06

MisonixTel.: +1 631 927 [email protected]

Misonix utilizes ultrasonic technology in the form of a debridement modality which provides safe and effective removal of all nonviable tissue while safely preserving healthy structures.

2D16

MolecuLight Inc. Tel.: +1 647 362 [email protected]

MolecuLight offers point of care solutions for wound care diagnostics. The MolecuLight i:X Wound Intelligence Device allows clinicians to visualize bacteria & measure wounds providing maximum insights for accurate treatment and accelerated healing.

2C20

MTF Musculoskeletal Transplant FoundationTel.: +1 732 661 [email protected]

MTF Wound Care is a division of the Musculoskeletal Transplant Foundation (MTF), USA’s leading non-profit tissue bank, dedicated to developing advanced, safe and cost-effective wound care solutions.

3A12

168

Mölnlycke Health Care ABTel.: +46 317 223 [email protected]

Mölnlycke is a world-leading medical solutions company. We’re here to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. We collabo-rate with customers to understand their needs. We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home.

3B01

Nederlandse Organisatie Voor Wondprofessionals (NOVW)Tel.: +31 332 453 [email protected]

Improving the position of woundprofes-sionals in The Netherlands. Improving the quality of woundcare in general. Discussion meetings. Theme meetings. All and individual support of members of the NOVW.

3D20

Neoplas Tools GmbH Tel.: +49 383 455 4370renate.schönebeck@neoplas- tools.euwww.neoplas-tools.eu

The Leibniz Institute for Plasma Science and Technology is Europe’s largest non-university institute in the field of low temperature plasmas. It carries out research and development from idea to prototype. One main topic is physical plasma for medical treatment.

2A02

Neubourg skin care GmbH & Co. KGTel.: +49 257 157 [email protected]

neubourg skin care is a family business and invented „Foot Foam Cream“ in the late 90s. The portfolio covers footcare and medical skincare products based on patented technologies.

2D30

medicalNewT E C H N O L O G Y

Newmedical Technology, Inc.Tel.: +1 847 412 [email protected]

DevraSorb Advanced Wound Care Dressings: Advanced Foam category dressings. NewGel+ Silicone Scar Management products: Advanced Silicone Sheeting and Gel for the management of scars.

2E08

Nicast Ltd.Tel.: +972 891 530 [email protected]

NICAST, a pioneer in the development of medical devices made of electrospun polymer nano-fabrics, presents the SpinCare hand-held portable device, for patient-personalized nano-fibrous dressings.

3A40

NidicareTel.: +43 541 261 [email protected]@nidicare.comwww.sini-medik.comwww.woundbag.com

Our enterprise looks back to many years of experience and our idea of innovative solutions for wound care and NPWT enables us to offer not only an excellent and easy to apply medication system but also professional and effective high quality products making wound healing a matter of choice.

2D41

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

169

NITOMS Inc.Tel.: +44 755 734 [email protected]/english/medical

NITOMS inherited the superior technological assets of Nitto Denko to manufacture new unique products which provide consumers with the greatest of benefit. Our proprietary technology in polymer synthesis and adhesives offers purpose-built solutions to customers’ new product development.

2E35

Nutricia Advanced Medical NutritionTel.: +31 204 569 [email protected]

Nutricia is focused on pioneering nutritional discoveries that help people live healthier and longer lives. The Company aims to establish medical nutrition as an integral part of health-care.

3A01

Oculus Innovative Sciences Tel.: +31 475 318 [email protected]

Oculus Innovative Sciences develops, manufactures and markets a family of products intended to treat chronic- and acute wounds and dermatological conditions.

3D14

OrthoMedicoTel.: +32 545 040 [email protected]

Innovative wound care treatment through ESWT (Sanuwave shockwave technology). Studies, specialized protocols and concepts for postcare available.

3E14

Perfectus BiomedTel.: +44 192 586 [email protected]

Perfectus Biomed is a leader in customized microbiological testing. Within the Healthcare and Environmen-tal sectors, we specialise in understand-ing the client company’s needs intimately and assessing the ideal assay methodol-ogy that will generate the most meaningful result.

3A14

Perimed ABTel.: +46 858 011 [email protected]

PERIMED is a global provider of diagnostic solutions for patients with peripheral vascular diseases and complex diabetic foot ulcers. Our new PeriFlux 6000 offers a unique combination of tests: ABI, toe pressure and transcutane-ous oximetry (tcpO2).

3E42

Permobil ROHO Seating and PositioningTel.: +1 618 277 [email protected]

Permobil ROHO Seating and Positioning is the worldwide leader in providing seating solutions that prevent & treat pressure injuries. ROHO product technology provides skin protection & positioning in a variety of applications: from wheelchair cushions, to therapeutic mattresses, to wheelchair backs & more.

3B24

PHAMETRA Pharma und Medica-Trading GmbHTel.: +49 232 317 [email protected]

PPM-Fisteladapter™-Set CVS – closed/cavity vacuum sealing.

3C16

170

PhytoceuticalsTel.: +41 434 991 [email protected]

Phytoceuticals is a Swiss life science company founded in 2007. We develop innovative medicinal applications from traditionally used natural extracts by making smart use of nature. The current focus is to develop and market first-in-class advanced wound care products. For further information, please visit:

3C10

Plinth MedicalTel.: +44 1449 767 [email protected] [email protected]

Plinth Medical in association with Plinth 2000 are proud to exhibit our innovative suite of specialist lower limb access equipment.

2E12

PluroGen Therapeutics, LLCTel.: +1 610 539 [email protected]

PluroGel® products utilize the exclusive PluroGel® Micelle Matrix Surfactant- based Biomaterial which has multiple unique functions. Come learn about them at our booth!

3D23

Polish Wound Management Association (PWMA)Tel.: +48 618 738 [email protected]

Spreading knowledge about wound treatment in Poland.Organizing courses and conferences in wound treatment area.Preparing national guidelines on modern wound treatment.Sharing experience between all multidisciplinary people involving in wound treatment area in Poland.

3B29

Practical Patient Care (PCC) Tel.: +44 115 924 7122martinjohn@globaltrademedia.comwww.practical-patient-care.com

Practical Patient Care is the leading international magazine for the latest insight and innovations in the healthcare market with a particular emphasis on wound care, diagnostics and infection control.

3E44

Praxis PharmaceuticalTel.: +34 673 691 [email protected]

PolyHeal Micro - Suspension of Negatively Charged Microspheres, is an Active device that stimulates patients own cells to accelerate wound healing, rapidly producing granulation and epithelization, including in wounds with exposed bones and tendons.

2A03

PressCise ABTel.: +46 739 739 [email protected]

PressCise develop and produce innovative compression products for patients with venous insufficiency and mixed arterial insufficiency. The award winning product Lundatex® system gives precise resting and working pressure.

3A10

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

171

PrevorTel.: +33 130 347 [email protected]

PREVOR, a toxicological laboratory specialised in the development of chemical accidents emergency treatment and wounds, has recently developed a new dressing, the Dressilk® barrier, an interface made 100% natural silk designed for superficial wounds.

2A24

Principelle B.V.Tel.: +31 853 035 [email protected]

In pursuit of excellence in wound and skin care, Principelle is manufacturing technically advanced products. Practical application of inventiveness, creativity, and product support leads to surprisingly beneficial clinical outcomes. We do have a Distributor close to you!

3B10

Protex HealthcareTel.: +32 475 548 [email protected]

Protex Healthcare is a provider of advanced wound management solutions, supplying clinicians with dynamic Vacutex products for difficult to heal wounds. Worldwide, Protex delivers easy to use, innovative products that help to expedite wound healing.

3D06

PulseFlow TechnologiesTel.: +44 129 667 [email protected]

We look forward to showing you PulseFlowDF, cutting edge wearable technology combining offloading and intermittent pneumatic compression with state-of-the-art treatment monitoring software, to optimise wound healing in the diabetic foot.

3D04

QuantificareTel.: +33 492 915 [email protected]

Since 2001, QuantifiCare has been marketing innovative imaging solutions for 2D & 3D photography of the skin.The founders had a unique vision to create a CRO capable to bring evidence based medicine.

2E03

Rigenera – Multimed srlTel.: +39 116 307 [email protected]

Rigenera -Multimed is an Italian leading company in distribution and commer-cialization of medical devices and regenerative medicine device. Since 2014 Multimed is the distributor of Rigenera Technology.

3C05

S2Medical ABTel.: +46 870 000 [email protected]

S2Medical is a manufacturer of advanced wound healing products. We supply a full range of products from debridement to re-epithelization. Our aim is to supply superior products that are available regardless of culture, religion or economy.

3A10

SaluberTel.: +39 424 570 [email protected]

Saluber is the manufacturer of “made in Italy” non-custom orthotics and the FORS offloading insole for diabetic foot ulcers,

3B27

172

Salvatelli S.r.L.Tel.: +39 733 801 [email protected]

Salvatelli S.r.L. is a company that produces orthopaedic shoes (Molliter) and dynamic Walkers for the manage-ment of the Diabetic foot ulceration or post-surgery/trauma (Optima).

2B10

SastoMed GmbHTel.: +49 540 136 519 [email protected]

Granulox is a worldwide patented medical device to significantly shorten healing time for complex and chronic wounds. The oxygenation of the wound base is increased by facilitated diffusion of Oxygen via natural Hemoglobin.

3C03

ScitonTel.: +1 888 646 [email protected]

Sciton offers high-quality medical devices for laser-assisted lipolysis, fractional and full-coverage skin resurfacing, hair removal, phototherapy, wrinkle reduction, treatment of vascular and pigmented lesions, scar reduction, and acne.

3C14

SIGVARIS Management AGTel.: +41 522 650 [email protected]

The Swiss Group SIGVARIS has its headquarters in Switzerland and is the global market leader in the manufacture of medical compression garments.

2D02

simexTel.: +49 742 092 [email protected]

simex will be displaying innovative NPWT Systems and dressing kits incl. the patented FloSure™ Ventilation Patch to help prevent stagnation and pooling and to improve exudate removal and optimizing outcomes.

2D46

Smith & Nephew Advanced Wound ManagementTel.: +44 148 222 5181www.smith-nephew.com/wound

Improving outcomes for patients Conserving resources for health care systems. Offering imaginative solutions in advanced wound dressings & NPWT for healthcare professionals.

3C01

SOFAR S.p.A.Tel.: +39 290 936 [email protected]

Sofar is a leading manufacturer of pharma-ceuticals and medical devices that are developed with clinicians to improve patients’ quality of life aiming at becoming the preferred partner in some highly specialized therapeutic areas.

3D01

Spring MedicalTel.: +31 553 560 544 [email protected]

SpringMedical joins Derma Sciences at our stand for EWMA and is our partner in and for the Benelux.

2C21

StrykerTel.: +31 202 192 [email protected] patientcare.eu.stryker.compatienthandling-eu.stryker.com

Stryker’s Medical Acute Care portfolio focuses on quality and prevention with a proven, performance based approach that impacts both clinical and financial outcomes for healthcare facilities.

2B06

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

173

SYMATESE AESTHETICSTel.: +33 614 311 357l.brones@symatese.comwww.symatese-group.comwww.symatese.comwww.symatese-aesthetics.com

SYMATESE AESTHETICS will present its dermal regeneration matrix NEVELIA® to achieve dermal reconstruction close to native skin thanks to:• Our expertise in the field of SKIN AND

REGENERATION• Our SCIENTIFIC APPROACH to

development and manufacturing• Our know-how in COLLAGEN

TRANSFORMATION

3B19

SöringTel.: +49 410 661 [email protected]

For more than 4 decades Thomashilfen has been working to make people feel good. In support of all people suffering from disease or disability our goal is your health, well-being and positive develop-ment. Our staff of specialists strives to meet a constant demand to excel in the rehabilitation field. They are experts in seating, lying, positioning, but above all - movement and mobility.

3D08

TalleyTel.: +44 179 450 3500 www.talleygroup.com

TALLEY is a manufacturer with 60 years of experience in Pressure Area Care, with a range of Quattro Therapy mattress systems, compression therapy for DVT prevention and Negative Pressure Therapy pumps and consumables.

3D12

The Lindsay Leg Club Foundation [email protected]

The aims of the Lindsay Leg Club Foundation (CRN 1111259) include both the dissemination of the principles of the socioeconomic Leg Club model and implementation of Leg Clubs.

3E16

[email protected]@thereson.comTel.: +39 039 914 0115Tel.: +39 393 881 8546www.thereson.com

THERESON – the TMR® Company (Therapeutic Magnetic Resonance), a proprietary technology and method to treat acute and chronic skin wounds of all aetiologies, pain management and orthopaedic disorders.

3E47

Tissue Viability Society (TVS) [email protected]

The TVS is probably the world’s oldest society dedicated to all tissue viability issues. Formed in 1981 we are a UK registered charity. The Society attracts members from all health care professions involved with tissue viability.

3B26

TWE GroupTel.: +32 514 268 [email protected]

TWE Group produce innovative nonwovens for the medical industry. Finished bandages for fracture and compression therapy, exudate manage-ment layers (AWC) and high resiliency products for NPWT dressings.

2D22

174

Urgo MedicalTel.: +33 380 545 000www.urgomedical.com

URGO Medical is the Healing Company committed each day to improve wound care treatments for both patients and health care professionals by offering highly innovative solutions.

2B20

Van Heek MedicalTel.: +31 882 208 [email protected]

Van Heek Medical was founded in 1926 in Losser and is one of the oldest suppliers of bandage materials in the Netherlands. Van Heek Medical has specialized itself in products related to wound-, continence, diabetic care and First-aid.

2C25

Vancive Medical TechonologiesTel.: +32 144 048 [email protected]

Vancive is a global medical technology company with more than three decades of expertise in adhesive chemistries and material technologies for medical applications using pressure sensitive adhesives.

2D01

Varodem BVTel.: +31 475 589 [email protected]

Varodem is fabrikant van Therapeutisch Elastische Kousen, VaroCare aanpasbare compressie verbanden, TinkFit compressiebroeken en distributeur van Curetex, moisturemeterD en Kikuhime.

3A26

Vemamed BVTel.: +31 103 032 [email protected]

VEMAMED BV is an importer and distributor of high quality and innovative products. Vemamed has a strong focus on both wound prevention as wound care.

2A20

VivisolTel.: +31 135 231 [email protected]

VIVISOL is a Dutch supplier of products and nursing services for TNPWT. We work with Exsudex products and our main goal is to deliver individual woundcare with a strong focus on patients and their needs.

3A34

Wacker Chemie [email protected]

WACKER is a globally active chemical company with some 17,000 employees and annual sales of aroundς5.3 billion (2015). WACKER has a global network of 25 production sites, 22 technical competence centers and 50 sales offices.

2C03

WCS Kenniscentrum [email protected]

WCS Wound Care Knowledge Centre aims to increase the knowledge of health professionals, in order to improve the quality of wound and skin care. WCS seeks to achieve this objectives through courses, conferences, publica-tions and by encouraging research.

3A11

Welcare Industries SpaTel.: +39 763 316 [email protected]

Unique wound and skin cleansing/ hydrating products proven superior for critical, chronic patients as well as patients undergoing chemo/radiotherapy.

3C02

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

175

WE-medical B.V.Tel.: +31 462 049 [email protected]

WE MEDICAL - Your partner in OSTOMY and WOUND care.

3B16

WHO Hand Hygine ICN and EWMA in have joined their forces to relay the World Health Organization’s (WHO) campaign aimed to raising awareness among healthcare professionals and of the critical importance of hand hygiene in improving patient outcomes and strengthening healthcare systems.

3D10

Woulgan c/o Biotec BetaGlucans ASTel.: +47 776 489 [email protected]

Woulgan® Bioactive Beta-Glucan Gel is a wound dressing developed and manufac-tured by Biotec BetaGlucans. Woulgan® is a primary dressing for stalled wounds which promotes healing by activating white blood cells.

2C30

Wound Zoom, Inc. Tel.: +1 888 237 [email protected]

WoundZoom Inc. creates advanced & affordable technology for better wound care & patient outcomes. Our Wound Management System provides hardware & software to streamline workflows & evaluate treatments.

3E12

Woundcare-CircleTel.: +49 880 792 [email protected]

The 3 Woundcare-Circle founders, OPTIMA, Heelift and DARCO are international market leaders providing innovative product solutions. The group permanently supports research & science as well as the advancement of foot disease management

2B10

WOUNDCHEK™ LaboratoriesTel.: +44 175 663 [email protected]

We are focused on the development of novel wound diagnostic products to help improve therapeutic outcomes in wound care. WOUNDCHEK™ Protease Status detects elevated protease activity (EPA). WOUNDCHEK™ Bacterial Status detects bacterial pathogenesis.

2C20

Wounds InternationalTel.: +44 203 735 [email protected]@omniamed.comwww.woundsinternational.com

Wounds International is the essential online wound management resource for clinicians worldwide offering a range of downloadable and interactive education-al opportunities.

3B18

Wund D.A.CHTel.: +43 160 225 [email protected]

Wund-D.A.CH is the umbrella associa-tion for wound healing associations in the German speaking countries.

2A16

176

XotonicsMED GmbHTel.: +49 374 687 6470 Tel.: +49 172 348 [email protected]

XotonicsMED presents the XotoCAM 1.1 - a medical camera for mobile photo - and wound documentation. To photo-graph, video record, measure, comment and archive on one multimedia device eases wound and quality management.

2A18

We’re proud that Mepilex® dressings have delivered proven patient and economic value since 2001. And that healthcare professionals like you trust Mepilex as a true solution when facing your daily challenges. We’re always looking for new ways to help you improve your patient and economic outcomes. That’s why Mepilex dressings come in many shapes and forms – with solutions for both treatment and prevention. And did you know the Mepilex range is supported by more than 300 pieces of evidence?

Together we will continue to drive the future of treatment and prevention. And, we’re proving it every day.

Mölnlycke Health Care AB, Box 13080, Gamlestadsvägen 3C, SE-402 52 Göteborg, Sweden. Phone +46317223000.The Mölnlycke and Mepilex trademarks, names and logos are registered globally to one or more of the Mölnlycke Health Care Group of Companies. © 2017 Mölnlycke Health Care AB. All rights reserved. HQWC0190

Find out more at www.molnlycke.com

Mepilex® rangeInnovation driven. Evidence based.With patients at heart

Mepilex® Border Post-OpMepilex® Border Flex Mepilex® Border Sacrum Mepilex® XTMepilex® Border Heel

Mepilex Border EWMA ad.indd 1 10/04/17 16:33

178

3M 3D16

Abigo Medical AB 2D12

Acelity™ 2B12

Adhesives Resarch 3D09

Adtec Healthcare 2A28

ADVAMEDICA INC 2E10

Advanced Oxygen Therapy Inc. (AOTI) 2A22

Advancis Medical 2C04

Anatomi Metrix Inc. 2E09

Andover Healthcare 3B14

APR Applied Pharma Research s.a. 3C04

ARANZ Medical 2A30

Argentum Medical LLC 3A20

Arion 3D13


2A16

ATD emolda 2A26

ATGmed - AT Technologies GmbH 2E30

Avita Medical 3E06

B. Braun Medical 2D14

BAP Medical BV 2E02

Bauerfeind AG 2E06

BDK 3C15

Beier Drawtex Healthcare 3B12

BenQ Mateerials 2D42

Bfactory Health Products B.V 3D14

Bio Compression Systems, Inc 3E20

Biofilm Test Facility 2A08

BiologiQ International 3D14

BioMonde GmbH 2E01

Bioskinco GmBH 3E45

BRH Medical 3E43

BSN Medical GmbH 3B02

Chemviron 2B28

Cica Biomedical Ltd 2E20

CINOGY GmbH 2D20

Coloplast 2C02

COLUXIA LABORATOIRES 2C10

Contipro a.s. 3C08

ConvaTec 2B04

Covaleo 3D03

Covalon Technologies Ltd. 2A04

Coveris Advanced Coatings 2C11

Covestro Deutschland AG 2A14

Crawford Healthcare 3C09

curasonix GmbH 2C31

curea medical GmbH 2C25

DAEWOONG PHARMA 3B25

Dale Medical Products Inc. 2E04

DARCO (Europe) GmbH 2B10

Datt Medical 3A08

DEBRA International 3B28

Deka mela srl 3D18

DermaSciences 2C21

DeRoyal 2D06

Diabetic Foot Study Group (DFSG) 2A16

DM Systems' Heelift 2B10

Don & Low 2D26

Ehob Inc 3E41

EXHIBITIONEXHIBITION FLOOR PLAN Please see exhibition floor plan on the following pages

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

179

European Council of Enterostomal Therapy (ECET)

2A16

European Pressure Ulcer Advisory Panel (EPUAP)

3A30

Euroresearch 3D21

Eurotape 3A36

EWMA Education Lounge 3C13

Ferris Mfg. Corp. (PolyMem) 2B30

Fidia farmaceutici S.p.A. 2B26

FLEN PHARMA SA 3E01

Fresco 3B11

Freudenberg Performance Materials SE & Co. KG

2B02

Frontier Medical Group 3B04

Genadyne Biotechnologies 2C05

GERGONNE INDUSTRIE 2C10

Getinge Group 3D02

Haddenham Healthcare 3A22

Haromed B.V.B.A. 3E40

Histocell 3E10

Huntleigh 2D40

Initiative Chronische Wunden (ICW) 3D22

Inotec AMD Ltd 3D05

International Lymphoedema Framework (ILF)

3E18

Invitalis Benelux 3C17

JeNaCell GmbH 3E45

Journal of Wound Care (JWC) 3E08

Juzo Julius Zorn GmbH 3E04

Kerecis 2C36

KLOX Technologies Inc. 2B01

Levabo ApS 3B22

LifeNet Health 3E46

LimbO Waterproof Protectors 2E32

LINET Group 2D34

L-Mesitran 2A01

Lohmann & Rauscher GmbH & Co KG 2C01

Lymed Oy 2A12

Medaxis 3C10

Medela 3B05

Medi GmbH & Co. KG 3C02

Mediq Medeco 2D44

Medprin (Shenzhen) Regenerative Medical Technologies Co., Ltd.

3B17

MESI Ltd 2D28

MiMedx 3C06

Misonix 2D16

MolecuLight Inc. 2C20

MTF Musculoskeletal Transplant Foundation 3A12

Mölnlycke Health Care AB 3B01

Nederlandse Organisatie Voor Wondprofessionals (NOVW)

3D20

Neoplas Tools GmbH 2A02

Neubourg skin care GmbH & Co. KG 2D30

Newmedical Technology, Inc. 2E08

Nicast Ltd. 3A40

Nidicare 2D41

NITOMS Inc. 2E35

Nutricia Advanced Medical Nutrition 3A01

Oculus Innovative Sciences 3D14

OrthoMedico 3E14

180

Perfectus Biomed 3A14

Perimed AB 3E42

Permobil ROHO Seating and Positioning 3B24

PHAMETRA Pharma und Medica-Trading GmbH

3C16

Phytoceuticals 3C10

Plinth Medical 2E12

PluroGen Therapeutics, LLC 3D23

Polish Wound Management Association (PWMA)

3B29

Practical Patient Care (PCC) 3E44

Praxis Pharmaceutical 2A03

Prevor 2A24

PressCise AB 3A10

Principelle B.V. 3B10

Protex Healthcare 3D06

PulseFlow Technologies 3D04

Quantificare 2E03

Rigenera – Multimed srl 3C05

S2Medical AB 3A10

Saluber 3B27

Salvatelli S.r.L. 2B10

SastoMed GmbH 3C03

Sciton 3C14

SIGVARIS Management AG 2D02

simex 2D46

Smith & Nephew Advanced Wound Management

3C01

SOFAR S.p.A. 3D01

Spring Medical 2C21

Stryker 2B06

SYMATESE AESTHETICS 3B19

Söring 3D08

Talley 3D12

The Lindsay Leg Club Foundation 3E16

Thereson 3E47

Tissue Viability Society (TVS) 3B26

TWE Group 2D22

Urgo Medical 2B20

Van Heek Medical 2C25

Vancive Medical Techonologies 2D01

Varodem BV 3A26

Vemamed BV 2A20

Vivisol 3A34

Wacker Chemie AG 2C03

WCS Kenniscentrum Wondzorg 3A11

Welcare Industries Spa 3C02

WE-medical B.V. 3B16

WHO Hand Hygine 3D10

Woulgan c/o Biotec BetaGlucans AS 2C30

Wound Zoom, Inc. 3E12

Woundcare-Circle 2B10

WOUNDCHEK™ Laboratories 2C20

Wounds International 3B18

Wund D.A.CH 2A16

XotonicsMED GmbH 2A18

SATE

LLIT

E SY

MPO

SIA

SPO

NSO

RS

&

EXH

IBIT

OR

SO

VER

VIE

WPR

OG

RA

MM

ED

ETA

ILED

PR

OG

RA

MM

E SE

SSIO

NS

E-PO

STER

SG

ENER

AL

INFO

RM

ATI

ON

INFO

RM

ATI

ON

181

E-POSTER AREA& POLYMEM LOUNGE

CAFÉ

CAFÉ

RESTAURANT

TO SESSION ROOMSELICIUM 1+2, G & E SESSION

& MEETING ROOMS

3E473E46

3E45

3E44

3E43

3E423E41

3E40

3E20

3E14

3E16

3E18

3E12

3E10

3E08

3E06

3E04

3E01

3D233D22

3D213D20

3D18

3D16

3D143D13

3D12

3D10 3D09

3D08

3D063D05

3D043D03

3D02

3D01

3C173C16

3C153C14

3C103C09

3C08

3C06

3C053C04

3C03

3C02

3C01

3B293B28

3B273B26

3B253B24

3B22

3B193B18

3B173B16

3B14

3B12 3B11

3B10

3B05

3B04

3B02

3B01

3A46

3A40

3A36

3A34

3A30

3A26

3A22

3A20

3A14

3A12

3A11

3A10

3A08

3A01

2E35

2E34

2E32

2E30

2E20

2E12

2E10

2E09

2E08

2E06

2E04

2E03

2E02

2E01

2D46

2D44

2D42

2D41

2D40

2D34

2D30

2D282D26

2D22

2D20

2D162D14

2D12

2D06

2D02

2D01

2C36

2C312C30

2C25

2C21

2C112C10

2C052C04

2C03

2C02

2C01

2B30

2B282B26

2B20

2B12

2B10

2B06

2B04

2B02

2B01

2A30

2A28

2A26

2A24

2A22

2A20

2A18

2A16

2A14

2A12

2A08

2A04

2A03

2A02

2A01

2C20

EWMA EDUCATION

LOUNGEEXHIBITIONGround floor

182

THANK YOU TO OUR SPONSORS:

Pocket programmesponsored by B. Braun

Lanyardssponsored by BSN Medical

APP and Loungesponsored by Ferris

Conference bagssponsored by medela

Note padssponsored by smith&nephew

TM

Simply brilliant

TM

Simply brilliant

TM

Simply brilliant

Senza titolo-1.indd 1 07/03/17 14:41

SMARTXIDE2 A New Light in Wound Healing Management

Innovative CO2 Laser Treatment* for Debridement and Tissue Regeneration Enhancement

*Patent Pending

• Diabetic foot ulcers• Pressure ulcers• Venous leg ulcers• Wound dehiscence

Discover more at: www.dekalaser.com

JOIN USSTAND 3D18

185

SMARTXIDE2 A New Light in Wound Healing Management

Innovative CO2 Laser Treatment* for Debridement and Tissue Regeneration Enhancement

*Patent Pending

• Diabetic foot ulcers• Pressure ulcers• Venous leg ulcers• Wound dehiscence

Discover more at: www.dekalaser.com

JOIN USSTAND 3D18

195

J368100. 3M and Cavilon are trademarks of the 3M company. © 3M 2017. All rights reserved.

Want to see for yourself our 2017 innovations in skin and wound care? Then make sure to pass by our stand 3D16.

End IAD today, prevent it tomorrowThursday 4th May 16:00 – 17:00 in ForumPreventing and treating skin breakdown due to the devastating influences of incontinence, leading to IAD, remains a clinical challenge.

Attend the IAD symposium to learn more. Key speakers include Prof. Lisette Schoonhoven, Prof. Dimitri Beeckman, Dr. Jan Kottner, Mary Brennan rn mba cwon faacws and Debra Thayer Msc.

Pressure ulcer prevention and management: do we all agree? Expert panel discussion Friday 5th May 12:45 – 13:45 in EmeraldAttend an interactive session with European experts in the field of pressure ulcer prevention and management, chaired by Prof. Dimitri Beeckman. The audience can vote live during the session to engage with the expert panel. Panel members include Ms Jacqui Fletcher, Prof. Lisette Schoonhoven and Dr. Jan Kottner.

And do come to listen to the experts we have invited for our two symposia:

3M welcomes you to EWMA 2017

3M.co.uk/EWMA2017

CORPORATE SPONSORS

CORPORATE A

CORPORATE B

LAYO

UT

& P

RIN

T: K

AIL

OW

GR

APH

IC ·

DEN

MA

RK

201

7

27TH CONFERENCE OF THE EUROPEAN WOUND …...amsterdam, the netherlands 3 - 5 may 2017 programme in...

Documents

Transcript of 27TH CONFERENCE OF THE EUROPEAN WOUND …...amsterdam, the netherlands 3 - 5 may 2017 programme in...